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Major depressive disorder (MDD) is a highly prevalent and disabling condition with a 
heritability of around 37%. Key symptoms of MDD include low mood and 
psychological distress, but the mechanisms underlying MDD and its symptoms are 
unclear. Genetic and neuroimaging techniques are important methods with which to 
better understand the aetiology and mechanisms of depression. Recently, through 
the availability of the UK Biobank and ENIGMA datasets, it has been possible to 
conduct well-powered imaging studies of heterogeneous traits like MDD, with 
genome-wide genetic data. These genetic data can act as causal instruments and 
can be utilised to identify differences in neurobiological mechanisms. 
The current thesis presents neurobiological associations with depressive symptoms 
and genetic risk for MDD using data from the UK Biobank imaging project (N range 
from 5,000 to 12,000). My overall aims were to investigate the neurobiological basis 
of MDD status, depressive symptoms and MDD polygenic risk. 
First, MDD case-control differences in subcortical volumes and white matter 
microstructure indexed by fractional anisotropy and mean diffusivity, are presented 
using the largest structural neuroimaging samples to date. MDD was associated 
with worse white matter microstructure in the thalamic-radiation subset and forceps 
major (posterior corpus callosum). No group difference was found for the volume of 
any subcortical structure.  
Next, associations between depressive symptom severity (including longitudinal and 
cross-sectional measures) with white matter microstructure were tested. Over 8,000 
participants had repeated measure of depressive symptoms assessed on 2-4 
occasions across 5.89 to 10.69 years. I found several novel associations between 
measures of depressive symptom severity (at the time of imaging, their variance 
within individuals over time, and with longitudinal increasing depression severity) all 
associated with lower white matter microstructure in the thalamic radiations. This 
was the first study of this size looking at imaging associations with longitudinal 
symptom measures and demonstrates consistent findings implicating 
thalamocortical connections. 
The third study presents results of phenotype wide association (‘PheWAS’) analysis 




total, 1,744 phenotypes were tested, covering sociodemographic, physical health, 
mental health, subcortical volumes, white matter microstructure assessed with FA 
and MD (mean diffusivity) and resting-state connectivity. I found that MDD polygenic 
risk was associated with MDD-related phenotypes including severity of depression 
and neuroticism, sleep, smoking, subjective well-being as well as neurobiological 
phenotypes including white matter microstructure and resting-state connectivity. 
In my final data chapter, neurobiological associations with cognition, as an important 
risk factor of major depressive disorder, were also reported. I found that higher 
connectivity related to the default mode network was associated with better 
cognitive performance.  
These studies suggest two features of neurobiology related to MDD traits and 
genetic risk. First, they implicate microstructure of thalamic white matter connections 
as an important biomarker for MDD risk, psychological distress and genetic risk, as 
reflected by its consistent associations with depressive status, depressive 
symptoms, within-subject variability of depression and MDD polygenic risk. 
Secondly, the aberrant connections within the default mode network were related to 
MDD phenotypes and polygenic risk. These findings, therefore, provide evidence 






Major Depressive Disorder (MDD) is the leading cause of disability worldwide. 
Approximately 322 million people worldwide live with depression, affecting all age 
ranges, ethnicities and countries. Genetic studies of psychiatric disorders including 
MDD have indicated the importance of large sample sizes for such complex disorders. 
Until recently, however, due to the expense, neuroimaging studies have been largely 
restricted to sample sizes of often less than 200 people, which has led to inconsistent 
and contradictory findings. 
This thesis has therefore used the largest neuroimaging cohort currently available, 
(initially n=5,000, then 12,000 people with further releases of data), to explore 
differences in brain structure and function in individuals with and without depression. 
Other advantages of this cohort data include longitudinal assessment of depressive 
symptoms and the availability of genetic data.  
The main findings indicate that in white matter, the structural connections between the 
thalamus and other parts of the brain are associated with having major depression, 
with higher level of psychological distress, and with greater genetic risk. In terms of 
functional brain changes, ‘over connectedness’ of regions within a circuit called the 
‘default mode network’ was also associated with higher genetic risk of depression. The 
default mode network has greater synchrony of activity at rest and is involved in 
internalized thought processing, rumination and negative thoughts.  
In conclusion, imaging findings may be important biomarkers for depression, which can 
potentially give clinical insights into its mechanisms, eventually leading to potentially 
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Chapter 1: Introduction 
Major Depressive Disorder (MDD) 
1 Epidemiology of MDD 
MDD is one of the most crucial health concerns in the world (Vigo et al. 2018). In a recent 
report by World Health Organization in 2015 conducted on 138, 602 people interviewed 
in 10 low-income and 14 high-income countries across five continents, the prevalence of 
lifetime MDD was 11.2% (Kessler et al. 2015), ranking at a high tier of prevalence among 
major psychiatric illnesses (Sullivan et al. 2012). Approximately 322 million people 
worldwide are living with depression, with wide coverage across age ranges and 
ethnicities (World Health Organization 2017). The reported prevalence for lifetime 
depression has had a significant increase over the last two decades. Taking the statistics 
for United States as an example, the rate of lifetime depression was 5.2% in 1996 
(Weissman 1996), 16.2% in 2003 (Kessler et al. 2014), and 20.6% in 2018 according to 
the most recent national survey of 36,309 US adults (Hasin et al. 2018). This could due 
to a true increase in the number of affected individuals, or a higher level of awareness of 
the disease.  
MDD is severe in terms of its impact on educational attainment (Ritsher et al. 2001; Bulik-
Sullivan et al. 2015), job performance (Ritsher et al. 2001; Gavin et al. 2010), mental 
health of off-spring (Ensminger et al. 2003; Lewinsohn et al. 2005), and even mortality 
(Kessler et al. 1996). By the year 2017, suicide deaths caused by MDD has reached a 
number close to 800,000 per year (World Health Organization 2017). According to the 
most up-to-date national survey of the US published in 2018, mean age of onset for 
depression was 29.05 years, indicating that a large proportion of MDD cases suffer from 
the negative impacts of the disorder impacting long-term life course trajectories (Hasin 
et al. 2018).    
Chapter 1: Introduction 
2 
 
According to a systematic review by Geddes et al. (2003), 16-18% of patients relapse in 
a year after one to six months’ treatment, with the relapse rate increasing to 24-33% after 
two years (Geddes et al. 2003). A very recent meta-analysis by Cipriani et al. (2018) 
reportedly analysed the responses of 21 anti-depressant drugs on 116,477 adult patients. 
Low to moderate odds ratio for response rate for active drugs versus placebo were 
reported (ranged from 1.37 to 2.13), and high variability of treatment efficiency was 
observed for all anti-depressants. Among all the major anti-depressant, only Fluoxetine 
and Agomelatine showed lower dropout rates than placebo (Cipriani et al. 2018). These 
findings reflect the uncertainty in MDD treatment. One of the major causes for the 
uncertainty is the individual variations among MDD cases, which is reflected on both 
drug response and depressive symptomology. Various reasons such as side effects and 
individual differences of drug response hinder individual-level interventions. The first step 
to meet the imminent need for effective treatment is to find reliable empirical evidence to 
help us understand the underlying mechanism of MDD.  
One big challenge for understanding MDD is its inherent heterogeneity. According to the 
definitions for MDD in DSM-V (Diagnostic and Statistical Manual of Mental Disorders, 
5th Edition) and ICD-10 (International Classification of Diseases: 10th revision), MDD 
can be diagnosed if five of nine symptoms were met. However, some of those symptoms 
are antagonistic. For example, psychomotor retardation, hypersomnia and weight gain 
are opposite to psychomotor agitation, insomnia and weight loss. This may result in 
having people with almost opposite symptoms diagnosed under the same category. 
There are two approaches that can potentially empower the interpretations for the 
underlying mechanism of MDD, bearing with the difficulties brought by its heterogeneity. 
First, we need to have reliable, replicable findings on case-control differences to help 
understand the general aetiology of MDD, because the heterogeneity of the trait hinders 
drawing confident conclusions based on small samples. Large cohort studies are 
therefore needed to find neurobiological and genetic associations of MDD, of which small 
effect sizes are expected due to a variety of manifestations in the sample. Second, 
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stratification of subtypes of depression having different biological mechanisms would 
largely benefit future studies to test whether specifying subtypes would help to undertake 
personalised treatments. The second approach again would require large statistic power 
to allow subgrouping populations that have MDD. 
 
2 Definition of MDD and its major risk factors 
MDD is a clinical status that is marked by depressed mood with excessive severity, 
assessed according to the impact and duration. According to major diagnostic criteria 
such as DSM-V, MDD is expressed in mainly four categories  (Fava and Kendler 2000; 
Sullivan et al. 2012). (i) Declined mood health, reflected by constant and prolonged 
psychological distress, higher mood variability. (ii) Disrupted neurogenerative functions, 
mainly observed as a rapid and substantial change of appetite or sleep. (iii) Irrational 
cognition, such as unnecessary guilt, shame and worthlessness. Finally, (iv) abnormal 
psychomotor activity, presented as either overly active (agitation) or lack of activity 
(tiredness).  
The onset of MDD is contributed by mixed effects from genetic, neurobiological and 
social factors (Yirmiya et al. 2015). One of the most consistently found risk factor is family 
history, which incorporates variances contributed by genetic variants (Wray et al. 2018) 
and familial environment (Ensminger et al. 2003). Higher prevalence of MDD is also 
found in females (Kessler et al. 2014), people with childhood trauma (Heim, Newport, et 
al. 2008), social deprivation (World Health Organization 2017), people with lower 
educational attainment (Ensminger et al. 2003), cardiovascular conditions (Davidson et 
al. 2005) and obesity (Heo et al. 2006),  
Biological factors include genetic risk and neurobiological disruptions. For 
neurobiological factors, various mood disorders, including MDD, have been reported by 
some studies to be the outcome of brain tumours/lesions, especially in emotion-related 
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brain regions (Starkstein et al. 1987; Sharpe et al. 1990; Fornito et al. 2015) – a summary 
of the neuroimaging literature is described below. In terms of genetic risk, the latest 
genome-wide association studies (GWAS) found 44 genetic loci associated with lifetime 
onset of depression, most of which are associated with neural development and have 
high levels of expression in brain tissues (Wray et al. 2018). In the remainder of this 
chapter, major biological models for MDD are introduced. 
 
3 Biological mechanisms 
In this section, four main models/mechanisms are introduced. The first and second 
described are neurobiological models underpinning emotional processing and emotion 
regulation respectively. Vulnerable brain regions and network utilities involved in these 
two types of processes in MDD are discussed. The third is the Hypothalamic-Pituitary-
Adrenal-axis (HPA-axis) model. HPA-axis through its role in neuroendocrine function is 
particularly involved in the stress response and regulation of other physiological 
responses including immune function and circadian timing. The interaction and possible 
mediation effect of HPA-activity with brain development and behaviour patterns (such as 
circadian rhythm) are discussed. Finally, the fourth mechanism introduced is the 
polygenic model relating to the genetic effects contributed by common genetic variants. 
This part describes the causal relationship between genetic risk and the presence of 
MDD, as well as and the overlapping genetic aetiology between MDD and other heritable 
traits. I have selected these main models to introduce key concepts underlying studies 
presented in the thesis.  
3.1 Cognitive models for emotion processing (Model 1) and emotion regulation 
(Model 2) in MDD 
Emotion is cognitive, subjective and highly associated with brain and hormonal activities 
(Etkin et al. 2015). Normally, emotion is a responsive activity, elicited by given 
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environmental stimuli (Dolan 2002). A positive stimulus triggers positive emotional 
processes and leads to repetitive behaviour to continue seeking similar stimuli, and a 
negative stimulus processed by negative emotional systems, triggers a “fight-or-flee” 
response, in order to either eliminate or avoid future negative stimuli. Emotional 
processing thereby involves a complex series of steps including an established past 
memory of the environment, the evaluation of current input stimuli, the regulation and 
response to current inputs, and finally the updating of memory and cognitive systems 
associated with emotional processing (Etkin et al. 2015).  
One important network associated with emotion processing is the limbic system. It 
includes regions involved in negative emotion processing like amygdala, thalamus, 
insula, and regions that relate to emotional memory including hippocampus and para-
hippocampus, and finally, positive-emotion/reward-related areas include caudate, ventral 
striatum and nucleus accumbens (Dalgleish 2004). These have a key role in primary 
emotion evaluation for negative or positive stimuli and attention allocation (Dalgleish 
2004). Prefrontal and cingulate cortex are also important regarding executive control and 
down-stream regulation (Bush et al. 2000; Etkin et al. 2015). These regions have 
complex interactions and often work in a synchronous network manner (Etkin et al. 2015). 
These networks can be roughly categorised into: networks within the limbic system itself 
for processing of different attributes of emotions (Dalgleish 2004; Russo and Nestler 
2013), and networks involving anatomically distant regions including high-level 
integrative and regulative regions like prefrontal and cingulate cortex, connecting to the 
limbic system (Etkin et al. 2015) (see Figure 1). 




Figure 1. Brain regions related to emotional processing and emotional regulation in the brain 
(Dalgleish 2004). 
In terms of MDD, aberrance of emotional processing often manifests in two ways: (1) 
biased cognitive processing of emotional stimuli (Disner et al. 2011), and (2) aberrant 
emotion regulation (Etkin et al. 2015). Though these two aspects may have different 
behavioural expressions, they could involve similar neural pathways. For example, the 
attention regulation pathway that mainly involves the activity of dorsal lateral prefrontal 
cortex (DLPFC) and limbic system, may be activated in paradigms like reappraisal that 
require spontaneous emotion regulation to deactivate negative emotional processing 
(Wager et al. 2008). Also, when discussing the neural basis of these two networks, 
although the regionally segregated functions are important for interpretation, network 
integration (functional/structural connectivity) is important for forming a complete 
behavioural pattern. More details about how networks could associate with emotion 
processing and regulation are described and discussed below in the sections for each 
model. 
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3.1.1 Model 1: Biased cognitive processing of emotional stimuli in MDD 
In many studies, MDD cases typically show pessimistic processing of emotional stimuli, 
expressed as hypersensitivity to negative stimuli and an attenuated response to positive 
ones. This could be explained by biased attention, biased evaluation, and biased 
memory (see Figure 2). 
 
Figure 2. The cognitive model of emotional processing in MDD (Disner et al. 2011). 
3.1.1.1 Biased attention in MDD 
Biased attention in MDD could be explained by (1) over-loaded allocation of attention to 
negative stimuli (Posner and Rothbart 2000; Gotlib and Krasnoperova 2004), and/or (2) 
or a lack of ability to detach attention from negative stimuli (Mitterschiffthaler et al. 2008; 
Eugène et al. 2010). Behaviourally, individuals with MDD typically show much faster 
reaction time and higher recall rate of negative stimuli compared with positive/neutral 
ones (Mitterschiffthaler et al. 2008).  
On the neuronal level, activations in the superior parietal cortex (involved in coordinating 
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shifts in gaze), ventral lateral prefrontal cortex (allocating attention), anterior cingulate 
cortex (conflict detection and executive regulation to downstream brain regions), and 
dorsal lateral prefrontal cortex (executive control and integrating sensory information 
from downstream brain regions) have been reported to be the main putative regions that 
may have key roles in such biased attention (Corbetta et al. 1998; Kastner et al. 1998). 
In addition, reduced functional connectivity between the regions has been found 
associated with the inability of balancing attention allocation and disengaging from 
negative stimuli, which has been found as one of the major funcitonal deficits in patients 
with MDD (Fales et al. 2008). 
3.1.1.2 Biased emotion processing in MDD 
Biased emotional processing, which is also referred to as ‘biased evaluation’ of emotional 
stimuli in some articles, is mainly expressed in patterns of: biased valence, abnormal 
arousal levels, and unusual durations (Dolan 2002; Bressler and Menon 2010; Etkin et 
al. 2015). Behaviourally, individuals with MDD have higher ratings for negative visual 
stimuli and pain (Leppa 2006; Bylsma et al. 2008), and higher neuronal arousal to 
negative scenarios revealed by a greater N2 component in event-related potential 
(Proudfit et al. 2015). MDD patients are also more likely to interpret ambiguous or neutral 
inputs as negative in various experimental contexts, such as short scenarios and 
emotional pictures (Mogg et al. 2006; Moser et al. 2012).  
Brain regions found to be associated with biased evaluations of emotional stimuli include 
those involved in reaction to negative stimuli (amygdala, thalamus and subgenual 
cingulate (Dalgleish 2004) and those associated with reward processing (ventral 
tegmental area, ventral striatum and putamen (Dalgleish 2004; LeDoux 2012)). In 
individuals with MDD, it is typically reported that there is hyperactivity of negative 
systems along with blunted activation in the reward system (Grimm et al. 2011). The 
negatively biased process is presented in both self-related scenarios, and other-related 
circumstances, which is reflected by, for instance, stronger empathy with other people’s 
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physical and emotional pain (Schreiter and Pijnenborg 2013; Fujino et al. 2014). Blunted 
reward-response has also been abundantly found to be associated with treatment 
response (Dichter et al. 2012; Pechtel et al. 2013). Balanced evaluations of emotional 
stimuli also require sufficient regulation from dorsal lateral prefrontal cortex (DLPFC) and 
dorsal anterior cingulate cortex (ACC). Both DLPFC and ACC receive inputs from the 
limbic system and give mainly suppressive feedback when cognitive regulation is 
necessary (Bush et al. 2000; Bae et al. 2006; Kolling et al. 2016).  
3.1.1.3 Biased ruminative thoughts in MDD 
Previous studies have found that MDD demonstrates negative-biased memory and 
excessive self-referent cognition of negative stimuli. These lead to rumination of negative 
thoughts seen clinically in patients with MDD patients (Spasojević and Alloy 2001).  
Putative brain regions involved in these biased processings include: (1) hippocampus, 
related to memory, (2) amygdala and subgenual cingulate, responsible for negative 
emotion processing, especially for stressful stimuli, (3) medial prefrontal cortex (MPFC), 
involved in self-related cognition, and finally (4) DLPFC and ventral lateral prefrontal 
cortex (VLPFC), responsible for executive control and information integration (Denson 
et al. 2009; Cooney et al. 2010). Hyperactivity of the hippocampus, amygdala, subgenual 
cingulate and MPFC would therefore be hypothesised in patients with MDD 
(Ray  Ochsner, K.N., Cooper, J.C., Robertson, E.R., Gabrielle, J.D.E. & Gross, J.J. 2000; 
Denson et al. 2009; Cooney et al. 2010). The activity of DLPFC and VLPFC and 
attenuated connectivity between these regions and limbic system were found associated 
with recalls of negative memories and self-referent rumination in MDD under episodic 
memory paradigms (Gusnard et al. 2001; Cooney et al. 2010). 
 
To summarise, therefore, the above neurocognitive models of MDD mainly imply the 
involvement of two main brain systems: (1) the limbic system, responsible for primary 
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emotional processes, and (2) the executive system located in DLPFC and ACC, 
providing down-stream regulation to the limbic system. The above model gives insights 
into the main cognitive components of MDD and gives a broad summary based on 
numerous cognitive paradigms for MDD. However, this model gives a very limited 
explanation of down-stream regulation and the complex structural and functional 
connectivity between DLPFC/ACC and limbic system. Emotion regulation is complex 
because it is not always explicit and whether consciousness processing is involved may 
indicate different patterns of neuronal connectivity. More details of emotion regulation will 
be explained in the next section where the emotion regulation model proposed by Etkin 
et al. is introduced and discussed (Etkin et al. 2015). 
3.1.2 Model 2: Emotion regulation model 
Emotion regulation involves in chains of decisions, which can be either conscious 
(explicit) or unconscious (implicit), to achieve desired emotional status (Etkin et al. 2015).  
Explicit emotion regulation is top-down, conscious, effort-demanding and relatively slow 
compared to primary sensory processing and implicit emotion regulation (Etkin et al. 
2015). Main regions involved in this process include the DLPFC, ventral lateral prefrontal 
cortex, parietal cortex and pre-supplementary motor area. The DLPFC, in particular, has 
been most consistently found associated with executive control (Wagner et al. 2001). 
Anatomically, DLPFC is connected to the limbic system through cortico-cortical white 
matter tracts, for instance, superior longitudinal fasciculus and anterior thalamic radiation 
(see Figure 3) (Mori et al. 2002). Functionally, activity in DLPFC connects to the thalamus, 
and DLPFC studies found that enhanced activity in DLPFC leads to higher activations in 
limbic systems such as amygdala and thalamus (Meyer-lindenberg et al. 2005; Fox et al. 
2012). 




Figure 3. Demonstration of association and commissural fibres. White matter tract maps 
were generated based on the first release of UK Biobank imaging data. 
The importance of the DLPFC to MDD patients has been emphasised by studies on 
treatment and treatment prediction (Meyer-lindenberg et al. 2005; Fox et al. 2012). For 
example, some recent studies reported that anti-depressant treatment and Cognitive 
Behavioural Therapy for MDD patients results in strengthened regulatory functional 
connectivity from DLPFC to limbic regions (Rosenblau et al. 2012; Shou et al. 2017).  
Further, a meta-analysis of 60 studies in which 1,569 MDD cases were included showed 
that antidepressant medication increased the activity in DLPFC (Ma 2015). Enhancing 
effects of transcranial manipulation such as transcranial direct current stimulation and 
transcranial magnetic stimulation on DLPFC have also been used to strengthen 
emotional regulation, showing a behavioural improvement of emotion regulation and 
stronger regulatory connectivity between DLPFC and amygdala (Rosenblau et al. 2012; 
Shou et al. 2017). Improvements were also surprisingly shown in drug-resistant patients 
using these transcranial methods to enhance activity in the DLPFC (Palm et al. 2012). 
The above studies suggest that DLPFC may serve as the emotion stabiliser in subjects 
that particularly suffer from excessively variable mood (Brunoni et al. 2013). Aberrant 
functions and connectivity related to this region, either in white matter or grey matter, 
indirectly influences downstream regulation. The structural changes may be 
hypothesised to be caused by various factors such as early developmental deficits of 
maturation of myelination, degeneration of cortical functionality and structure due to 
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premature or accelerated ageing, and excessive neuronal pruning (Dolan 2002; Bressler 
and Menon 2010).  
 
Figure 4. The explicit and implicit emotional regulation model proposed by Etkin et al., 2014 (Etkin 
et al. 2015). 
Implicit emotion regulation indicates non-conscious modulation in emotional processing 
areas. Important regions for this type of emotional regulation are anterior cingulate cortex 
(ACC) and ventral medial prefrontal cortex (VMPFC) (Etkin et al. 2015). They are 
responsible for the detection of emotion evaluation, integrating conflicting inputs, 
monitoring unexpected stimuli (Botvinick et al. 2004). All these functions are mainly 
conducted in an automated, relatively fast, bottom-up manner. Another important role for 
implicit emotion regulatory regions is to moderate between DLPFC and primary sensory 
processing system in limbic areas (Rosenblau et al. 2012). ACC integrates the upstream 
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regulatory signal from DLPFC and downstream inputs from primary processing systems. 
Therefore, activity in ACC helps neurobiological response to antidepressants to expand 
across neural networks (Ho et al. 2017). 
Functions of the above brain regions and pathways are not restrictively associated to 
processes involves in emotion, but also highly important in broader aspects such as 
decision making (Glimcher and Rustichini 2004; Fehr and Camerer 2007), in which the 
involvement of emotions is much more implicit and subtle compared with classical 
emotion regulation paradigms. Healthy performance in these regions ensures optimal 
goal-directed decisions, which enables the inference for the functionality of emotion 
regulation system to reach to a much broader context (Glimcher and Rustichini 2004; 
Fehr and Camerer 2007). Social decision making takes place on a daily basis. Quality of 
decisions broadly influences whether subjects have desirable social interactions and 
whether they are able to maintain a reciprocal inter-personal environment. Many studies 
suggest that social support is one of the most important interventions of MDD (Leskelä 
et al. 2006).In addition, the symptoms of depression, including decreased enthusiasm 
and poor social decision making in MDD patients, contribute to a reduction of social 
support, leading to a spiral of negative influences (Meyer-Lindenberg and Tost 2012). 
Improvements in emotion regulation may, therefore, help to break away from the effect 
of the vicious spiral caused by impaired social interactions in MDD patients. 
The above two models mainly intend to explain the affective abnormalities associated 
with MDD. However, MDD is far more complex than mere affective symptomology. 
Cognitive and somatic symptoms may be strong contributors to MDD condition, but their 
roles are not explained in the above models. For some somatic symptoms, such as 
weight gain, are not well studied in the field of neuroscience. Take body mass index as 
an example, which has been consistently found associated linearly with MDD condition, 
showed linear association with white matter microstructure in some studies (Xu et al. 
2013; Mazza et al. 2017), but also showed a non-linear association in some others, 
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indicating that high body mass index may be protective of brain integrity in some groups 
(Stanek et al. 2011). These unclear associations may indicate that some of the somatic 
symptoms may have contributions to the presence of MDD, independent from direct 
neurobiological mechanism or having regulatory influence to the association between 
brain phenotypes and the presence of MDD. 
Another limitation of these two models is that psychological factors may not be the only 
reasons for brain alterations. Functional signals have local heterogeneity in the brain, 
largely defined by the vascular localisation in some areas of the brain heavier than the 
other regions. One example is posterior cingulate cortex (PCC), although has been found 
involved in psychological activities, has a naturally high level of BOLD signal (especially 
at a low frequency) even without explicit tasks. It has been suggested that the dense 
vessel layout in this region may contribute to this phenomenon (Szikla et al. 2012), which 
can potentially reflect individual differences of cardiovascular conditions (Szikla et al. 
2012). 
In general, the above limitations suggest a need for other models that give explicit 
explanations about the behavioural patterns and physical conditions that associate with 
MDD symptomology. One of the most well studied of these models is the HPA-axis model, 
which will be introduced in the following section. 
3.2 Model 3: the HPA-axis model 
The hypothalamic pituitary adrenal (HPA) axis is the central stress response system and 
therefore of key importance to MDD since onset is often linked with stressful life events 
(Pariante and Lightman 2008). Compared with other biological models, since HPA axis 
is highly associated and sensitive to behavioural patterns such as sleep, the model gives 
particular insights for linking behavioural patterns with neurobiological activities and the 
presence of mood disorder. The activity of HPA axis consists of the release of 
adrenocorticotrophic hormone releasing factor and vasopressin from the hypothalamus, 
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adrenocorticotrophic hormone from the pituitary (regulated by adrenocorticotrophic 
hormone releasing factor), and glucocorticoids from the adrenal cortex (regulated by 
adrenocorticotrophic hormone) (see Figure 5). One such glucocorticoid in humans is 
cortisol. Secretion of cortisol has a negative feedback mechanism to hypothalamic and 
pituitary activities therefore to remain homeostasis within the system (Pariante and 
Lightman 2008).  
HPA axis has an anatomical basis in the brain and is also highly associated with 
hormonal activities in the peripheral nervous system. Cortisol, in particular, is one of the 
few hormones that can pass the brain-blood barrier. HPA axis forms a key component 
linking psychiatric symptoms and physiological patterns like sleep, appetite and addiction 
(Nemeroff and Vale 2005). Compared with previous brain functional models which were 
found mainly in specific behavioural paradigms, the activity in HPA axis is broadly 
associated with various complex behavioural patterns (Yehuda et al. 2004; Heim, 
Newport, et al. 2008). This system has rapid response to acute stress stimuli and has a 
circular regulate-feedback mechanism to sustain allostasis. Allostatic overload is often 
considered to contribute to the pathophysiology of mood disorders, particularly when the 
overloaded status remains unsustainably long/strong (Pariante and Lightman 2008; 
Rilling 2013). 
There is substantial evidence to suggest that elevated activation of the HPA axis is 
presented in MDD patients, consistently supported by evidence of high cortisol level 
(Brown et al. 2004). Though HPA axis is directly associated with acute stress response, 
exposure to stressful life events such as childhood trauma/early adversity can cause 
aberrantly hypersensitive HPA-axis activity, with long-term consequences extending into 
adolescence and adulthood (Heim, Mletzko, et al. 2008). These indicate that aberrant 
HPA-axis activity may not only be a feature of MDD but also a vulnerability factor (Heim 
and Nemeroff 2002).  
Dysfunction in the negative feedback pathway from cortisol to hypothalamus and pituitary 
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is the most consistently found contributor of HPA-axis hyperactivity (Pariante 2006). This 
failed inhibition mechanism can be caused by insufficient binding between cortisol and 
glucocorticoid/mineralocorticoid receptor (Pariante 2006) and lack of affinity of cortisol to 
P-glycoprotein as the carrier of cortisol and antidepressant across the blood-brain barrier 
(Uhr et al. 2008). Deficit in these mechanisms overlay with metabolic and immune 
system abnormality as expressed as peripheral inflammation (Gordon et al. 2015) and 
disrupted circadian and ultradian rhythm (Stetler and Miller 2011; Scheiermann et al. 
2013). 
Neurobiologically, glucocorticoid and mineralocorticoid receptors are located mainly in 
the limbic system and particularly enriched in hypothalamus and hippocampus (Gordon 
et al. 2015). Abnormality of these receptors is often associated with abrupted regional 
functions of these brain regions, which could explain the behavioural patterns in 
depressed individuals, expressed as impaired spatial memory in rodents, and worsened 
verbal and episodic memory in human MDD patients (Vythilingam et al. 2004; Gandy et 
al. 2017). This is supported by a recent meta-analysis from the ENIGMA consortium 
project (Enhancing Neuro Imaging Genetics Through Meta-Analysis, 
http://enigma.ini.usc.edu/), incorporating 15 international studies of 1,728 MDD cases 
and 7,199 controls, which found that, in the eight major subcortical structures, only 
hippocampal volume was associated with lifetime MDD (Schmaal et al. 2017). This study 
further supports that the brain alterations which may suggest HPA-axis abnormality could 
be an important biomarker expressed in neurogenesis and neural development. 




Figure 5. HPA-axis system and its hormonal regulations, adapted from Pariante et al., 2008 
(Pariante and Lightman 2008). 
The main brain regions associated with HPA-axis model, to some extent, overlap with 
models for emotional processing, because the limbic system is important for both types 
of models (HPA-axis hormones are enriched in the limbic system, and limbic system is 
important for primary emotional processing). However, compared with models for 
emotional processing, HPA-axis model gives more insight into how depression is related 
to lifestyle, cardiovascular and metabolic traits like sleep patterns and activity in the 
immune system such as inflammation, and how these factors may associate with the 
limbic system. Therefore, the additional information provided by HPA-axis model may 
give further insights into how shared genetic architecture between MDD, HPA-axis and 
metabolic/immune system interact, and enrich understandings of possible biological 
pathways between neural development and MDD genetic risk, and how this pathway can 
be mediated by HPA-axis related physical and behavioural patterns, such as circadian 
rhythm and cardiovascular conditions. 
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3.3 Model 4: Polygenic model 
Genome-wide association studies (GWAS) has made great contributions to the 
understandings of genetic markers for MDD (Wray et al. 2018). However, variance 
explained by single SNPs is small, therefore the potential of using those significant hits 
to predict and understand the genetic contribution of predicting MDD based on common 
variances is limited (Wray et al. 2014). Gandal et al. summarised that the genetic 
variance of MDD is mainly contributed by common genetic variants. Also, the effects of 
the genetic variants are largely additive (Gandal et al. 2016). Therefore another approach 
was introduced as “polygenic risk profiling”, which takes whole-genome variances into 
account, at a less stringent significance level compared to that of traditional genome-
wide level studies (Wray and Maier 2014; Bulik-Sullivan et al. 2015; Wray et al. 2018). 
To calculate polygenic risk scores, summary statistics of a GWAS conducted on a training 
sample of a given trait is applied on genomic profile for each individual in a test sample, 
and the effect sizes of each genetic variants were treated as weights. The weighted sum 
of whole-genome variances is the polygenic risk score of the trait. A higher score for a 
person indicates a higher whole-genome-level genetic risk (Wray et al. 2014). 
Transferability of the technique was also successfully validated by a cross-ethnicity study 
which successfully used a European training sample to predict MDD status of Han 
Chinese woman (Edwards et al. 2018). The increased sample sizes of MDD GWAS have 
significantly contributed to the increased accuracy of MDD polygenic risk profiling, as 
many more genome-wide significant genetic risk variants have been found in recent 
studies (Wray et al. 2018), which indicate increasingly better estimates for the effects of 
MDD compared than smaller samples used previously (Wray et al. 2013). 
Polygenic risk of MDD is associated with various traits, such as neuroticism (Navrady et 
al. 2018), psychological distress (Musliner et al. 2015), comorbidity for/with and 
childhood trauma (Peyrot et al. 2018). Higher risk scores of MDD is also associated with 
physical conditions like pain (McIntosh et al. 2016) and body mass index (Clarke et al. 
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2015), cognitive performance and educational attainment (Hagenaars et al. 2016). 
However, very little literature has investigated the relationship between MDD polygenic 
risk score and wider phenotypes including brain measures. There are several reasons 
for this: first, under-powered training samples may introduce a significant amount of 
uncertainty for the estimation of SNP effects, (Wray et al. 2013); and second, only 
recently, large neuroimaging cohorts that also include genetic data have been available 
(Elliott et al. 2018); finally, though meta-analyses had significantly larger power 
compared with traditional small-sample studies, more flexible phenotypes such as 
resting-state connectome data would be extremely hard to merge based on inconsistent 
protocols between sites. However, biologically, it is extremely important to investigate 
this association, as most of the depressive symptoms like sleep, anhedonia and mood 
variability may be more relevant to contemporaneous brain activity, along with the less 
temporally fluctuating structural brain changes. Many of the top hits found in a recent 
GWAS were associated with brain phenotypes and some directly expressed in brain 
tissue (Wray et al. 2018), along with the evidence that many structural and functional 
brain phenotypes can have heritability up to 80% (Elliott et al. 2018), these facts together 
suggest that potentially there is an association between brain features and genetic risk 
for MDD. 
4 Limitations of the above models and questions to ask in the present thesis 
The biggest limitation of the above neurobiological models is the inconsistency of 
previous findings. Although MDD is one of the most severe and disabling diseases, its 
aetiology is largely ambiguous, not simply because of the paucity of data, but results are 
heterogeneous or even contradictory. A massive number of regions, including the lateral 
and medial side of the prefrontal cortex, sensorimotor regions, parietal cortex that 
associate with attention and finally visual cortex in the occipital cortex have all been 
found in some studies associating with MDD case-control differences. If all these results 
were true associations, the conclusion may be that MDD is related to whole-brain 
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disturbance, which has no specific neurobiological basis and is contradictory to the 
nature of the brain with regional functionality. A very likely explanation for the overly wide 
coverage of brain structure and activities appeared in previous studies, is that there may 
be a very large number of false positive results. It is likely due to the fact that most of the 
previous studies are underpowered, limited to sample sizes of less than 50 MDD cases 
(Linden 2012). MDD is highly prevalent and heterogeneous. It would be extremely 
difficult to represent the overall population of MDD well enough if only less than 50 people 
were selected. It is likely that a small number of severe cases in such studies may be 
able to drive the effects to reach statistical significance, nonetheless, noise may be 
introduced as those individuals that brought the largest effects may only be a particular 
subtype of MDD, therefore the results would reflect their own particular symptoms only. 
Despite these hypothetic inferences that previous findings may contain many false 
positive findings, previous findings have indeed shown results in opposite directions. For 
example, Eijndhoven et al. tested the differences in cortical thickness between 
medication-naïve patients and medication-free remitted patients. They found that 
patients with current symptoms had greater thickness in the temporal pole and anterior 
cingulate cortex (van Eijndhoven et al. 2009). Some found the depressive symptoms 
were exclusively associated with the limbic system (Nebes et al. 2001), whereas others 
report associations in lateral prefrontal cortex only (Taylor et al. 2004). In addition to 
these studies, Lenze et al. found no significant group difference either in white matter 
hyperintensity or grey matter volume (Lenze et al. 1999). Previous heterogeneous 
findings, to some extent, led the hypothesis overly broad and spread across the whole 
brain, as can be seen in the models introduced above. Though the models above give 
detailed descriptions of MDD-related cognition/affection biases, genetic factors and 
hormonal reactivities, an overall additive effect of biased attention, evaluation and 
rumination on the brain is needed to build up learn-able models to help predict symptoms, 
liability and treatment outcomes. As a first step however, reliable estimation of the 
associations between depressive symptoms and brain structures and functions are 




Second, investigations and models for mood variability is needed. The above biased 
emotional processing is often investigated based on one-shot trials (i.e. unrelated 
events). Studies of cognitive learning models, which describe the dynamics of updating 
emotional inputs based on previous history of both negative and positive stimuli (Forbes 
and Dahl 2012; Whitton et al. 2015), show that longitudinal mood variation could be 
another important component of MDD symptoms. Longitudinal variation can be 
presented in different forms such as longitudinal linear progression and over-time 
variability. Studying the fluctuating nature of mood status may therefore give particular 
insights into emotion-reaction dynamics in MDD in the long run (McFarland and Klein 
2009; Forbes and Dahl 2012; Pechtel et al. 2013). 
Another limitation is that it is unclear whether structural and functional connectivity is 
associated with genetic risk of depression. Previous studies have provided evidence that 
using genetic risk of a brain-related disorder to directly predict brain phenotypes is a 
reasonable path. For example, the latest GWAS by Wray et al. and Howard et al. 
revealed that top genome-wide significant SNPs (Single-nucleotide polymorphism) 
associated with MDD condition were expressed in brain regions (Howard, Adams, Shirali, 
et al. 2018; Wray et al. 2018). Other examples are family studies that found some 
evidence that corticolimbic connectivity was altered in people with familial risk, although 
whether it remains true when only genetic effect is taken into account needs further 
investigation (Pariante 2009; Huang et al. 2011; Meyer-Lindenberg and Tost 2012). The 
above evidence is not yet enough, because the brain is highly integrated as a network, 
a single alteration that can be potentially caused by gene expression associated with a 
disorder may not result in a single region (Bressler and Menon 2010). Also, 
compensatory mechanisms against neurobiological deficits, such as enhanced activity 
in DLPFC in high-functioning groups (Cabeza et al. 2002), can be found in people that 
show disease resilience, therefore gene expression may not necessarily end up having 
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phenotypic impact on the phenotypes in a matured brain. The gap of understanding of 
genetic risk factor to brain structural and functional connectivity associated with emotion 
regulation is mainly due to a lack of samples that contain both genetic and neuroimaging 
data. The opinion of this thesis is that the linkage between the brain and genetic risk of 
depression may enrich the interpretation of the genetic architecture of MDD and lead to 
better understandings of the multifactorial relationship between behavioural patterns, 
brain phenotypes and MDD condition. According to previous studies using polygenic risk 
of MDD to predict physical/behavioural traits such as smoking and body mass index 
(BMI), a sample of at least thousands of participants were used in these studies (Wray 
et al. 2013; Musliner et al. 2015; Mistry et al. 2018). This scale of sample sizes, however, 
has been rarely seen in neuroimaging studies. 
To investigate the above challenges, I have used data from UK Biobank project and 
particularly focused on brain phenotypes such as white matter microstructure, resting-
state connectivity and their associations with behavioural and genotyping data. UK 
Biobank is a project that was established in 2006 (Matthews and Sudlow 2015), between 
then and 2010, 500,000 volunteers from 40 to 70 years old were recruited (Muñoz et al. 
2016; Bycroft et al. 2017a). To date, over 90% of all participants have been genotyped 
and part of the sample was selected to attend imaging assessments. The imaging project 
started in 2015, and data collection is still on-going (Miller et al. 2016). The first release 
covered approximately 5,000 people, and the most up-to-date release in 2018 covered 
around 12,000 people. Behavioural and part of physical measures were assessed both 
at the initial assessment and at the same time with the later imaging assessment. This 
cohort has several advantages despite its impressive sample size. Genetic and 
neuroimaging data were quality-checked under standard protocols, and the biology data 
was in general assessed in depth, as revealed by a larger number of genetic variants 
assessed compared to other large cohorts such as PGC and 23andMe (Howard et al., 
2018), and a large range of different types of neuroimaging data was collected, including 
T1, DTI (diffusion tensor imaging), T2, and resting-state functional data (Miller et al. 
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2016). Especially the imaging data has exceptionally good data quality compared with 
other big cohorts because all data were collected in a single scanner. Homogeneity of 
imaging data, on the other hand, is expected to be able to provide larger statistic power. 
Another advantage is the longitudinal clinical data. A large proportion of the self-reported 
physical and mental health conditions were assessed at multiple time points, which 
makes UK Biobank a unique dataset with large-scale longitudinal assessments that may 
cover up to thousands of people. For other features of the dataset, details will be 
introduced in the data chapters. 
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White Matter Microstructure and MDD 
1 White Matter Microstructure 
Early developments of neuroimaging techniques, especially MRI, have largely enriched 
our understanding of the brain maps for regional functions (Soares and Mann 1997). 
However, more recent studies found that many psychiatric diseases are ‘connectome 
disorders’. Rather than the structural deficit of a single segregated region, the lack of 
healthy integrated connections is proposed to contribute to disrupted psychological 
functions (Rubinov and Bullmore 2013).  
White matter (WM) fibres construct the structural bridges within the brain. The most 
popular method to test the integrity of these structures is diffusion tensor imaging (DTI), 
which captures the diffusion of water molecules. In oriented environments such as WM, 
diffusion is anisotropic (see Figure 6). Reduced directionality of diffusion is, in general, 
associated with worse psychiatric symptoms and worse connectome caused by lesions 
(Denk et al. 2012).  
Conventional DTI measures include FA (fractional anisotropy) and MD (mean diffusivity) 
(see Figure 6). These two measures are both derived from direct observations of 
diffusion in three spatial axes (L1 to L3). FA describes the fractional directionality, and 
MD is the mean diffusion of L1 to L3. By definition, higher FA would usually be interpreted 
as better/increased white matter integrity, whereas lower MD would be interpreted and 
decreased integrity. These two measures are both sensitive to white matter 
microstructure, and each of them has its own advantages and limitations. FA is much 
more restricted to the variances in WM (see Figure 6), whereas MD is comparatively 
more easily influenced by partial-volume contamination and the boundaries between WM 
and grey matter. The generalised sensitivity over all tissues for MD has its advantage 
however for areas of cross-over fibres, where FA is typically less sensitive (Jones et al. 
2013). Therefore, although FA and MD usually have opposite directions, it does not 
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necessarily mean that they are measures that only differ in polarisation, but rather two 
validated methods for representing white matter microstructural variations. In the present 
thesis, both FA and MD results were reported for transparency. 
 
Figure 6. Comparison of whole brain maps between T2W, FA and MD images. 
FA and MD are general microstructure variances that describe the pathway features of 
white matter tracts. However, different structural changes could contribute independently 
to FA and MD variation, such as intensity loss which contributes to white matter 
disconnection, the proportion of myelin, which has different diffusive attributes compared 
with neurons (Jones et al. 2013).  
The newly developed neurite orientation dispersion and density imaging (NODDI) 
measures provide complementary data to explore cellular contributors of FA and MD 
differences analysis (see Figure 7). These include ICVF (intercellular volume fraction, 
describing neurite density), ISOVF (isotropic of free water volume fraction, i.e. 
extracellular water proportion describing the proportion of water outside of cellular space) 
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and OD (orientation dispersion index, describes morphology of tract organisation, for 
instance, fanning and bending of axon bundles) (Zhang et al. 2012). There is increasing 
interest in the use of NODDI measures as complementary dMRI measures, in addition 
to FA and MD, since these measures depict additional sources of FA and MD variations 
which conventional DTI measures cannot distinguish (Beaulieu 2002). These NODDI 
measures are relatively new but are encouragingly robust (Zhang et al. 2012), and 
importantly have been shown to demonstrate distinct sensitivity to different biological 
processes, for example in relation to healthy aging (Cox, Ritchie, et al. 2016) and 
between clinical samples (Rae et al. 2017). The analysis in this thesis therefore 
incorporates these NODDI measures along with the traditional FA and MD variables to 
provide deeper insights into the pathophysiology of MDD.  
2 White Matter Microstructure and MDD 
Higher FA and lower MD in structural connections between prefrontal cortex and limbic 
system have been associated with MDD (Liao et al. 2013). For specific tracts categorised 
in this subset, worse FA microstructure in anterior thalamic radiation has been observed 
in MDD patients according to a meta-analytic study (Liao et al. 2013). This tract connects 
thalamus and bilateral dorsal prefrontal cortex. Functional connection between them 
involves in top-down emotional regulation and executive control (Mamah et al. 2010; 
Coenen et al. 2012). Other prefrontal-cortex-related tracts include superior and inferior 
longitudinal fasciculus (Huang et al. 2011). These structures also show significant 
associations with cognition, which implies that these regions may have associations 
concerning MDD-related cognitive deficit (Karlsgodt et al. 2008; Mamah et al. 2010; Cox, 
Bastin, et al. 2015). However, it is not always the case that white matter microstructure 
linking prefrontal cortex is found. For example, Gutman et al. found FA changes in MDD 
only located in limbic regions (Gutman et al. 2009).  
NODDI measures have been used in clinical studies but the number of studies is limited 
as it is a relatively new technique. Recent studies on mental illness, such as first-episode 
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psychosis and dementia, revealed that for mood disorders, neurite density, as measured 
by ICVF, is the main contributor for microstructural variances (Mahoney et al. 2014; Rae 
et al. 2017). On the other hand, neurodegenerative mental illnesses, such as Parkinson’s, 
has been associated with poorer ISOVF (Kamagata et al. 2017). So far there is no study 
that directly investigates MDD-related NODDI changes, and this topic will be studied and 
discussed in the present thesis (chapter 3). 
  




Figure 7. Comparison between FA and neurite orientation dispersion and density imaging 
(NODDI) measures. NODDI measures described here include: ICVF (intercellular volume 
fraction, describing neurite density, therefore also referred to as ND in the figure), ISOVF 
(isotropic of free water volume fraction, referred to as ISO in the figure) and OD (orientation 
dispersion index, referred to as ODI in the figure). The figure was adapted from Rae et al., (Rae 
et al. 2017).  
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Resting-state connectivity and MDD 
1 Resting-state fMRI 
Structural and event-related fMRI studies have consistently identified prefrontal brain 
regions as having the strongest associations with general cognitive ability (Kievit et al. 
2014; Rosenberg et al. 2016). These regions play a crucial role in executive control 
(Koechlin and Summerfield 2007) and multisensory integration (Wunderlich et al. 2011), 
and can be assessed using various task-based paradigms (MacDonald et al. 2000; 
Weissman et al. 2006; Goldin et al. 2008). However, it has recently been demonstrated 
that the brain is highly active in the absence of experimental stimuli, i.e. when it is in 
‘resting state’. The activity of the brain under resting state is metabolically demanding 
and topologically efficient; it has been proposed that this actively maintains neural 
signalling in preparation for quick adaptions (Bullmore and Sporns 2012; Hahn et al. 
2012). Such spontaneous modulations at rest are temporally correlated between distant 
brain regions, forming the linkage known as functional connectivity.  
The spatial patterns of functional connectivity are known as resting-state networks (RSN). 
It is well established that these RSN can be robustly extracted from fMRI data (Power et 
al. 2011), and they have been consistently verified in several independent cohorts (Fox 
et al. 2006; van den Heuvel et al. 2008; Braun et al. 2012). The RSN approach provides 
a non-invasive, task-free way of studying such a distributed functional dynamics of the 
brain (Turk-Browne 2013). In addition to its broad practicability, functional networks found 
under resting-state are spontaneous, and they are therefore free from confounding 
effects due to external input (Sporns 2014). This approach therefore provides the 
possibility of examining the simultaneous involvement of multiple networks, whose 
temporal organisation is relevant to MDD which is associated with various high-level, 
integrative mechanisms that involve in emotional and cognitive processing (Cocchi et al. 
2013; Sporns 2014). 
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Major RSN include the default mode network (DMN) and various of task-relevant 
networks such as the salience, executive control, sensorimotor, dorsal attention and 
visual networks (see Figure 8) (Buckner and Krienen 2013). The DMN is a network 
mainly consist of medial prefrontal cortex, posterior cingulate cortex and temporal-
parietal junction, was first discovered to be deactivated while the brain is engaged in a 
goal-directed task and activated under resting-state (Raichle 2015). This network has 
been hypothesised to be associated with thought rumination and various automated 
processes (Raichle 2015). The task-relevant networks, on the other hand, were found 
associated with the functions that they were named after (Buckner and Krienen 2013). 
 
Figure 8. Major resting-state networks (Buckner and Krienen 2013). 
  
Chapter 1: Introduction 
31 
 
2 Resting-state networks and MDD 
Early studies of resting-state networks involved largely the low-frequency BOLD-signal 
(blood-oxygen-level dependent) amplitudes in networks of interest (Zou et al. 2008; Han 
et al. 2011). MDD patients typically showed hyperactivity in DMN in task-related phase 
when DMN activity is normally suppressed (Sambataro et al. 2014). Inference for the 
abnormally active DMN is that the network involves spontaneous processes, such as 
rumination of negative thoughts (Hamilton et al. 2011). Studies about cognition have 
shown that DMN deactivation in resting-state is associated with lower global network 
efficiency (Hearne et al. 2016). Therefore the activity of DMN is essential for remaining 
whole-brain alertness (Greicius et al. 2008), and overly activated DMN may lead to 
disrupted performance in task-related networks (Bartova et al. 2015).  
 
Figure 9. Connectivity between bulk resting-state networks that associate with the onset of MDD 
Chapter 1: Introduction 
32 
 
based on a meta-analysis of resting-state connectivity (Kaiser et al. 2015). In the figure, 
FN=frontoparietal network, DAN=dorsal attention network, DN=default mode network, 
AN=affective network, and VAN=ventral attention network. The white arrow means hyper-
connectivity in MDD, black arrows indicate weaker connections in MDD, and grey arrows 
represent inconsistent weakening/strengthening in MDD from different studies. 
 
Other than early discussions about arousal level of resting-state networks, topology of 
functional connectivity in resting-state brings much more dynamic and biologically 
interpretable phenomenon that can implicate clinically significant inferences. 
Resting-state network properties can be presented in several ways. The most widely 
used measure is functional connectivity, which describes the temporal correlation 
between remote brain regions (van den Heuvel and Hulshoff Pol 2010) (see Figure 9). 
MDD case versus control differences has been shown in bulk network connections 
between DMN and salience network (Bressler and Menon 2010). Studies suggest that 
the salience network has a mediating role in facilitating the dynamic switch between DMN 
and the executive control network (see Figure 11). Aberrant connection between DMN 
and salience network may indicate impaired ability to suppress DMN when goal-directed 
tasks are involved, therefore hyper-activation in DMN may become a counter-active lever 
for task-positive networks (Bressler and Menon 2010). 
Other properties of resting-state include regional homogeneity (Zhu et al. 2008) and 
graph-theory topologies, such as small-worldness and global degree (van den Heuvel et 
al. 2008; Braun et al. 2012). Higher regional homogeneity and global degree were shown 
in dorsal lateral prefrontal network and temporal-parietal networks in healthy people 
compared with MDD, which may indicate higher efficiency within networks themselves, 
and it serves for better functionality (Wu et al. 2011). Previous resting-state studies about 
MDD suffer from common disadvantages like structural studies that lack statistic power. 
An additional gap is the extremely limited understanding between the activity of 
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functional network and genetic risk of MDD, which so far, to our knowledge, has not been 
investigated in cohort data. 
 
 
Figure 10. The counterbalanced relationship between DMN and central-executive network, 









Subcortical volume and white matter integrity abnormalities in major 
depressive disorder: findings from UK Biobank imaging data 
 
1 Chapter introduction 
This chapter presents a study of group differences between MDD cases and controls in 
subcortical volumes and white matter microstructure, using the first release of UK 
Biobank imaging data that includes 1,157 and 1,089 people for subcortical and white 
matter microstructural measures respectively. Previous studies on MDD case-control 
differences often used small samples (N<100), therefore led to heterogeneous results. 
This study aimed to employ a very large sample and investigate the MDD case-control 
differences, which has been summarised in a published paper entitled, “Subcortical 
volume and white matter integrity abnormalities in major depressive disorder: findings 
from UK Biobank imaging data” (Shen et al. 2017), in which I was the first author. I 




Previous reports of altered grey and white matter structure in Major Depressive 
Disorder (MDD) have been inconsistent. Recent meta-analyses have, however, 
reported reduced hippocampal grey matter volume in MDD and reduced white matter 
integrity in several brain regions. The use of different diagnostic criteria, scanners and 
imaging sequences may, however, obscure further anatomical differences. In this 
study, we tested for differences in subcortical grey matter volume (n=1157) and white 
matter integrity (n=1089) between depressed individuals and controls in the subset of 
8590 UK Biobank Imaging study participants who had undergone depression 
assessments. Whilst we found no significant differences in subcortical volumes, 
significant reductions were found in depressed individuals versus controls in global 
white matter integrity, as measured by fractional anisotropy (FA) (β=-0.182, p=0.005). 
We also found reductions in FA in association/commissural fibres (β=-0.184, 
pcorrected=0.010) and thalamic radiations (β=-0.159, pcorrected=0.020). Tract-specific FA 
reductions were also found in the left superior longitudinal fasciculus (β=-0.194, 
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pcorrected=0.025), superior thalamic radiation (β=-0.224, pcorrected=0.009) and forceps 
major (β=-0.193, pcorrected=0.025) in depression (all betas standardised). Our findings 
provide further evidence for disrupted white matter integrity in MDD. 
2.2 Introduction 
Major Depressive Disorder (MDD) is a common psychiatric illness, affecting between 5 
and 30% of the population which accounts for around 10% of all days lived with 
disability(Marcus et al. 2012). There is therefore an urgent need to identify the 
mechanisms underlying MDD and human in vivo MRI has been widely applied in this 
search(Gamazon et al. 2015). 
Many brain imaging studies have measured grey matter volume differences between 
healthy individuals and, predominantly clinically ascertained, individuals with MDD. 
Prefrontal cortex and limbic areas are fundamental to emotion processing and mood 
regulation(DeRubeis et al. 2008), and these areas have also been consistently 
implicated in imaging studies of MDD(Bora et al. 2012; Maller et al. 2014; Meng et al. 
2014). As the use of automated methods such as voxel-based morphometry(Soriano-
Mas et al. 2011; Wagner et al. 2011) and Freesurfer(Sacchet et al. 2015) have 
increased, this has expanded the search across the whole brain. In general, structural 
abnormalities have been reported across diverse brain networks in MDD. Regions 
including the thalamus(Nugent et al. 2013), amygdala(Bora et al. 2012), 
insula(Soriano-Mas et al. 2011), caudate(Sacchet et al. 2015), anterior cingulate 
cortex(Bora et al. 2012), along with prefrontal areas such as orbital prefrontal cortex 
(OFC)(Fried and Kievit 2015) and dorsal lateral prefrontal cortex (PFC)(Amico et al. 
2011) have been reported to be smaller in MDD versus healthy controls. However, 
other studies have found conflicting results(Kong et al. 2014; Sacchet et al. 2015), or 
have reported null findings(Wagner et al. 2011). This inconsistency may be due to 
limited sample sizes and other sources of heterogeneity such as sample 
characteristics, recruitment criteria, data acquisition and image processing(Arnone et 
al. 2012). 
The lack of a single anatomically circumscribed abnormality in MDD has led many to 
suggest that the disorder might be due to abnormalities of brain networks affecting 
connections between several regions. In support of this, findings from individual studies 
of white matter structure in MDD have shown patterns of alteration using diffusion 
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tensor imaging (DTI). Proxy measures of white matter integrity, including fractional 
anisotropy (FA) and mean diffusivity (MD), have been used to infer connectivity 
differences between groups. Decreased FA indicates lower directionality of water 
molecule diffusion along fibre pathways and is a proxy of decreased tract integrity, 
whilst increased MD indicates less constrained water molecule diffusion and a proxy for 
lower integrity. 
White matter integrity of frontal-limbic tracts have been suggested to underlie clinical 
features in MDD due to a lack of frontal cortical control over brain regions that involve 
in emotion processing(Korgaonkar et al. 2014). Studies have reported altered water 
diffusivity of white matter tracts in MDD compared to healthy controls, but the tracts 
identified are often inconsistent. Some studies reported decreased white matter 
integrity in tracts that connect prefrontal areas (e.g. fronto-occipital fasciculus, superior 
longitudinal fasciculus) (Sexton et al. 2012) . While some studies using similar sample 
sizes also found consistent results (Liao et al. 2013), other groups reported FA deficits 
in limbic areas (e.g. posterior thalamic radiation, posterior corona radiata) (Korgaonkar 
et al. 2014). Similar to the studies of subcortical volumes described above, DTI 
investigations of MDD have often used relatively small sample sizes (Murphy and Frodl 
2011; Liao et al. 2013). 
Meta-analytic methods may help to overcome issues related to small sample sizes and 
are also able to quantify and test for between-study heterogeneity. A recent meta-
analysis of subcortical structures by Schmaal et al. tested over 1650 MDD patients and 
around 7000 healthy controls across 15 studies, and reported hippocampal grey matter 
volume reductions in MDD. No other case-control differences were found (Schmaal et 
al., 2016a). Meta-analyses of white matter integrity measures in MDD have also 
reported FA reductions in superior longitudinal fasciculus, fronto-occipital fasciculus, 
and thalamic radiations (Murphy and Frodl 2011; Liao et al. 2013). These studies, 
however, often require the combination of imaging data from different scanners, using 
different ascertainment criteria and methodology, different clinical instruments and 
have differing levels of phenotypic data to pursue further research questions. Meta-
analytic findings therefore highlight the pressing need to measure brain structural 
abnormalities in MDD using larger single-scanner samples where robust conclusions 
can be made in the absence of differing study methodologies. 
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In the current study, we examined the volumetric structural imaging data of subcortical 
brain structures and tract-specific white matter integrity measures from the UK Biobank 
imaging study. UK Biobank is a study of 500,000 subjects recruited from across the 
United Kingdom (Sudlow et al. 2015). The dataset used in the current study is the 
latest release of imaging data on 8590 participants who participated in the brain 
imaging assessment (Miller et al. 2016). For our current purposes this included 
354/342 MDD and 803/762 controls respectively who provided usable for T1-
weighted/DTI data from a single scanner, along with available data regarding 
diagnostic and phenotypic information. The scanning protocol and pre-processing 
pipelines were devised by UK Biobank, with consistent, compatible setting of scanner 
parameters and participant-friendly experimental procedures. This data therefore 
allowed us to explore structural changes associated with depression in a single large 
population-based sample using data from an individual study source with unified 
depression classification, and with scanning sequences and image processing 
procedures applied consistently across all subjects, all of whom were imaged on a 




In the latest release of imaging data from UK Biobank, 5797 people completed the 
subcortical brain structural MRI measurements and 5171 completed DTI assessment 
(Fig S1). The study has been approved by the National Health Service (NHS) 
Research Ethics Service (approval letter dated 17th June 2011, reference: 
11/NW/0382), and by the UKB Access Committee (Project #4844). Written informed-
consent was obtained from each subject. All assessments were performed in 
accordance with the regulations and protocols from the committees. 
Individuals from the initial pilot phase of imaging using different acquisition parameters 
were excluded from the current study, as were those that did not complete pre-
processing quality checks conducted by UK Biobank. In addition, scans from 
individuals that were identified by our internal quality check as having a structural 
measure that lay more than three standard deviations from the sample mean were 
excluded (Appendix 1: Fig S2, S3, Table S1). Any participants that had a diagnosis of 
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Parkinson’s Disease, bipolar disorder, multiple personality disorder, schizophrenia, 
autism or intellectual disability were also excluded from the current analysis (ICD-10/9 
or self-report). This resulted in data from 5397 participants with T1-weighted subcortical 
volumes and 4590 participants with DTI measures. Mean ages were 55.47 +/- 7.49 
years for those with T1-weighted, grey matter data and 55.46 +/- 7.41 years for those 
with DTI, white matter integrity. The proportions of male participants are were similar in 
both datasets (45.78% for those providing T1-weighted data and 47.12% for those with 
DTI measures). Details of data exclusions are detailed within supplementary materials 
(Method, Participants; Fig S1). 
MDD definitions 
The definition of MDD used in the current study was generated based on the putative 
MDD category summarized previously by Smith et al., as presented in supplementary 
materials (Fig S4) (Smith et al. 2013). They generated the criteria of single episode 
major depression, recurrent major depression (moderate), recurrent major depression 
(severe) and those who were absent of depression. This category was benchmarked 
by testing its prevalence in the sample, and by testing for association with a number of 
traits, such as neuroticism (Jylha et al. 2009), that have previously been associated 
with MDD (Kendler et al. 2004). However, since the category is based on hospital 
admission data and depressive symptoms, which were both self-reported, rather than 
more formal ICD/SCID criteria, cases should be considered ‘probable’ MDD rather than 
operationally defined on the basis of an interview. 
We generated two definitions of probable MDD. One was the principal MDD definition 
that compared all MDD patients (recurrent and single episode) with healthy controls, 
while the other was based on recurrence and compared recurrent MDD patients with 
non-recurrent and non-MDD individuals. 
The principal MDD definition therefore included those who were categorised in single 
and multiple episode major depression as cases. The corresponding control group 
contained participants that were absent of depression according to the putative MDD 
category described by Smith et al (Smith et al. 2013). For the recurrent MDD definition, 
the case group only included recurrent major depression. The corresponding control 
group therefore referred to the participants without recurrent MDD, which included 
single episode major depression, those who were absent of depression and those who 
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reported depressive symptoms but not enough to be specified as MDD. Participants 
who did not answer one or more of the questions necessary for classification were 
excluded from this analysis.  
For each definition of probable MDD, the participants with subcortical volume data 
consisted of 354 MDD cases and 803 controls and 261 MDD cases and 1196 controls 
respectively for principal and recurrent definitions. Participants with DTI data consisted 
of 335 MDD cases and 754 controls and 242 MDD cases and 1113 controls for 
principal and recurrent definitions respectively. Method used to derive the samples into 
analyses were presented in supplementary materials, Fig S1. 
The descriptions and demographic characteristics of each MDD definition are shown in 
supplementary materials (Appendix 1: Table S2, S3). For the purposes of the current 
analysis, we used the principal definition of depression as the main definition as it most 
closely resembles the general application of typical clinical criteria. We also report 
results of the recurrent definition of MDD to highlight differences associated with a 
more severe recurrent MDD diagnosis. (Appendix 1: Supplementary materials, Table 
S3). 
MRI acquisition and analyses 
We used the imaging-derived phenotypes (IDPs) generated by UK Biobank. The MRI 
acquisition, pre-processing and imaging analysis for subcortical volumes and FA 
values of white matter tracts were all conducted by UK Biobank using standard 
protocols(Miller et al. 2016), see supplementary material. Briefly, all imaging data was 
collected on a Siemens Skyra 3T scanner 
(https://www.healthcare.siemens.com/magnetic-resonance-imaging) and was 
preprocessed using FSL packages. For T1-weighted data, segmentation of brain was 
conducted in two steps: firstly, a tissue-type segmentation using FAST (FMRIB's 
Automated Segmentation Tool)(Zhang et al. 2001) was applied to extract cerebrospinal 
fluid, grey matter and white matter; then subcortical structures are extracted using 
FIRST (FMRIB's Integrated Registration and Segmentation Tool)(Patenaude et al. 
2011). For DTI data, parcellation of tracts were conducted using AutoPtx (De Groot et 
al. 2013). 
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The summary data contained volumes of grey matter, white matter, cerebrospinal fluid, 
thalamus, putamen, pallidum, hippocampus, caudate, brain stem, amygdala and 
accumbens (Fig S2). DTI data provided tract-averaged FA for 27 major tracts (12 
bilateral tracts in both hemispheres and 3 tracts that pass across brain): (a) association 
and commissural fibres: forceps major and minor, inferior fronto-occipital fasciculus, 
uncinate fasciculus, cingulum bundle and superior longitudinal fasciculus; (b) thalamic 
radiations: anterior, superior and posterior thalamic radiations; (c) projection fibres: 
corticospinal tract, acoustic radiation, medial lemniscus, middle cerebellar peduncle. 
Scans with severe and obvious normalization problems were excluded by UK Biobank. 
In addition we also excluded observations that were more than three standard 
deviation from the sample mean for the analysis of subcortical volumes. For DTI 
measures, participants with at least one outlier of tract-averaged FA from the sample 
mean were excluded for that measure. Descriptions of the sample were reported in 
supplementary materials (Method, MRI preprocessing; Fig S1-3). For transparency, the 
results without excluding outliers are also presented in the supplementary materials. 
Statistical methods 
Subcortical volumes: First, differences in global intracranial volume (ICV) associated 
with a probable MDD diagnosis were examined by modelling ICV as dependent 
variable, controlling for age, age2, sex and assessment centre. ICV was measured by 
adding up volumes of white matter (WM), grey matter (GM) and cerebrospinal fluid 
(CSF). For bilateral subcortical volumes, age, age2, sex, hemisphere, assessment 
centre and ICV were set as covariates in a repeated-effect linear model to test for an 
association between both probable MDD definitions on subcortical volumes, adjusted 
for whole brain size. For unilateral structures, a general linear model was applied as 
above, without controlling for hemisphere. We also examined the interaction of 
hemisphere and MDD definitions on bilateral structures. Where there was a significant 
MDD by hemisphere interaction, analyses on both lateralised structures were 
conducted separately. All subcortical volumes were rescaled into zero mean and 
unitary standard deviation in order that effect sizes represent standardized scores. 
False Discovery Rate (FDR) multiple comparison correction was applied for tests of the 
8 subcortical volumes plus additional tests on ICV, conducted separately for the two 
probable MDD definitions (Fig 1, Table 1, S5). 
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White matter integrity: In order to test for an association between probable MDD and 
FA, as above we used a general linear model with age, age2, sex and assessment 
centre as covariates and the definition of MDD as a fixed factor. First we examined for 
the effects of diagnosis on global whole brain white matter integrity. The brain’s white 
matter tracts have been shown to share a considerable proportion of variance in their 
microstructural properties in this (Cox, Ritchie, et al. 2016) and other samples (Penke 
et al. 2010, 2012). Global integrity was determined using standardised approaches by 
applying principal component analysis (PCA) on the 27 tracts to extract a latent 
measure (Cox, Ritchie, et al. 2016). Scores of the first un-rotated component of FA 
were extracted and set as the dependent variable of the general linear model to test 
the effect of probable MDD diagnosis (variance explained=36.5%). Then we separately 
examined three subsets of white matter tracts: (a) association and commissural fibres 
which include tracts connecting cortex to cortex, (b) projection fibres which consist of 
tracts connecting cortex to spinal cord and brainstem, as well as sensory tracts that 
connect cortex to thalamus and (c) thalamic radiations that connect thalamus with 
cortical areas (Cox, Ritchie, et al. 2016). Scores of the principal un-rotated component 
for each subset was extracted (variance explained=44.1%, 60.1% and 38.1% 
respectively for A/CF, TR and PF) for further general linear modelling as with the global 
latent measure. Loadings and scree plot of PCA analyses are in supplementary 
materials (Appendix 1: Table S10, Fig S5). Finally, we examined the effects of 
depression on each tract individually. Repeated-effect linear models were used for the 
measures of bilateral white matter tracts correcting for hemisphere as above, while 
random-effect general linear models were used for the unilateral midline tracts. Both 
the main effect of MDD definition and its interaction with hemisphere were tested. 
Where the interaction was significant, tests were applied individually for left and right 
sides separately. FDR correction was individually applied over the three subsets of 
white matter tracts as well as individual tracts (Benjamini et al. 1995). 
 
2.4 Results 
The effect of MDD definitions on subcortical volumes 
We found no significant group effect for ICV based on the principal definition of MDD 
(β=-0.046, puncorrected=0.341). There were also no significant differences between groups 
based on the principal definition of MDD for any of the subcortical brain regions, 
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including the hippocampus (βs=-0.050~0.064, psuncorrected>0.199, pscorrected>0.834); see 
Fig. 1, Table 1. No region demonstrated significant interaction of hemisphere, therefore 
no region was examined separately on different hemispheres. 
The same models were also applied to compare recurrent MDD and controls, see 
above. No subcortical regions reached significance in this definition of recurrent cases 
versus controls. The largest nonsignificant effect size was observed for the caudate 
(β=0.064, puncorrected=0.231). 
 
Figure 1. (A) Subcortical structures of interest in left, inferior and anterior view. (B) The effect of 
principal definition of probable MDD on subcortical volumes. Linear models were conducted, 
controlling the effect of age, age2, sex, assessment centre and intracranial volume (and 
hemisphere for the regions that have bilateral values). The x-axis shows the standardised effect 
size of MDD definition, and y-axis is the layout of the subcortical structures. The error bar 
represents standard deviation of mean. 
















The effect of probable MDD on measures of white matter integrity 
Firstly we tested the effect of probable MDD on general white matter FA (gFA). For 
both the principal and recurrent definitions, gFA was lower in probable MDD cases 
versus controls (β=-0.182, p=0.005; β=-0.160, p=0.022 respectively). 
We then examined tracts categorised into association/commissural fibres (gAF), 
thalamic radiations (gTR) and projection fibres (gPF). We found effects of probable 
MDD on measures of FA in two of the three groups of tracts. Probable MDD at principal 
and recurrent definitions showed smaller values in gAF (Probable MDD: β=-0.184, 
pcorrected=0.010; Recurrent MDD: β=-0.170, pcorrected=0.045) and gTR (Probable MDD: 
β=-0.159, pcorrected=0.020; Recurrent MDD: β=-0.141, pcorrected=0.068). No effect was 
found for gPF (Probable MDD: β=-0.115, pcorrected=0.073; Recurrent MDD: β=-0.057, 
pcorrected=0.401). The above findings were checked in self-declare depression, and the 
results were found to be similar (see supplementary materials, MDD definitions). 
We then proceeded to compare FA values in the individual tracts between cases and 
controls. Initially, we tested the tracts controlling for hemisphere effects. Then we 
tested the interaction of hemisphere and probable MDD definitions on bilateral tracts to 
identify any lateralised effects. There was a significant interaction of hemisphere in 
superior longitudinal fasciculus for recurrent definition of probable MDD (β=0.117, 
pcorrected=0.026). The left and right superior longitudinal fasciculi were therefore tested 
separately. 
We found reduced FA in the left superior longitudinal fasciculus for both definitions of 
MDD versus controls (Probable MDD: β=-0.194, pcorrected=0.025; Recurrent MDD: β=-
0.221, pcorrected=0.025) (Fig. 2, Table 2). No significant association was found with right 
superior longitudinal fasciculus (Principal MDD: Probable MDD: β=-0.057, 
pcorrected=0.379; Recurrent MDD: β=-0.029, pcorrected=0.684). Significant FA decrease 
was found in superior thalamic radiation and forceps major, but only for principal MDD 
definition (Probable MDD: β=-0.224, pcorrected=0.009; β=-0.193, pcorrected=0.025. 
Recurrent MDD: β=-0.179, pcorrected=0.080; β=-0.133, pcorrected=0.150 respectively for the 
two tracts). In order to check whether the decreased FA in the above tracts was due to 
global changes in gFA, the effect of MDD definitions was tested again with gFA 
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included as a covariate (Appendix 1: Table S6). Left superior longitudinal fasciculus 
remained significant in both definitions (Probable MDD: β=-0.194, pcorrected=0.038; 
Recurrent MDD: β=-0.221, pcorrected=0.025). Forceps major showed decreased FA in 
probable MDD definition (β=-0.193, pcorrected=0.038) but not in recurrent MDD (β=-0.133, 
pcorrected=0.350). The effect MDD definitions on superior thalamic radiation didn’t reach 
significance after correcting for gFA (Probable MDD: β=-0.110, pcorrected=0.162; 
Recurrent MDD: β=-0.077, pcorrected=0.568). The above results of individual tracts turned 
null if outliers weren’t excluded, but the standard effect sizes were in similar trend 
(Appendix 1: Table S7). 
 
Figure 2 (see the next page). (A) White matter tracts in each anatomical subset in left, posterior 
and anterior view. (B) The effect of principal definition of probable MDD on FA value of tracts. 
Linear models were conducted, controlling the effect of age, age2, sex and assessment centre 
(and hemisphere for the tracts that have bilateral values). Left superior longitudinal fasciculus 
was presented because there was a significant interaction between recurrent MDD definition 
and hemisphere. Follow-up analysis showed a lateral effect of probable MDD definition on left 
superior longitudinal fasciculus. The x-axis shows the standardised effect size of MDD 
definition, and y-axis is the layout of the white matter tracts. The error bar represents standard 
deviation of mean.













In the current study, we sought to determine whether MDD was associated with 
differences in subcortical grey matter volume or white matter integrity in a large 
imaging dataset from a single scanner of more than 8000 people, and among them 
over 1000 were included as cases and controls in the analyses for the present study. 
The sample sizes of MDD cases and controls included in the analysis of white matter 
integrity is by far the largest to our knowledge. Also, the present study considered two 
important brain structural modalities in two highly overlapping samples. Whilst we did 
not find any statistically significant subcortical volumetric differences between 
unaffected participants and individuals with probable MDD (using any of the definitions 
with increasing severity), we did find substantial evidence of reduced white matter 
integrity in MDD. This was seen globally, in two of the three categories of tracts 
(association/commissural fibres and thalamic radiation tracts), and in individual tracts 
(bilateral superior thalamic radiation, forceps major and left superior longitudinal 
fasciculus). Similar patterns of findings were seen for both principal and recurrent 
definition of depression with generally greater effect sizes in recurrent cases, with the 
exception of the localised differences in the superior thalamic radiation and forceps 
major. 
Our study notably did not find evidence for bilateral hippocampal volume reduction as 
previously reported in the large collaborative meta-analysis of MDD(Schmaal et al. 
2016). We also did not find evidence of reductions in hippocampal volume when 
looking at recurrent MDD as published in the same study. The lack of subcortical 
volumetric differences associated with probable MDD diagnoses in the current study 
therefore does not support the widely held belief that there are subcortical volumetric 
changes associated with the disorder. There are several potential explanations for this. 
Firstly, the UK Biobank dataset included only community-dwelling, ambulant individuals 
who could independently complete the health and cognitive assessments, and attend 
the follow-up imaging assessments. This approach arguably selected MDD groups that 
were more well/better functioning but equally more representative of the general 
population than purely clinically ascertained samples. We also used a composite 
‘probable’ MDD diagnosis that was based on self-report symptoms and hospital 
admission statistics, and the cases were selected based on self-report lifetime 
experience of probable depression. In contrast, many other studies previously used a 
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structured clinical interview schedule, such as the Structured Clinical Interview for 
DSM-IV (SCID), to define MDD according to standard criteria. Some studies have 
specifically studied people who were certainly experiencing depression at the time of 
imaging assessment(Turner et al. 2012). Whilst the probable MDD definitions used in 
the current paper were not based on an interview, they showed many of the same 
epidemiological and risk-factor associations as clinically defined cases (Smith et al. 
2013; Okbay et al. 2016).  
Although we do not report subcortical volume differences, we did find substantive 
evidence for robust deficits in both global and local white matter integrity. We found 
that MDD patients had global loss of FA which was also found to be reduced in 
association and commissural fibres as well as in thalamic radiations, but not in 
projection fibres. FA in these structures was also more severely reduced in the 
recurrent MDD patients. The above results indeed reflect previous findings from 
previous small-sample and meta-analytic studies (Sexton et al. 2009; Liao et al. 2013; 
Chen et al. 2016), while extending them to a more generalizable population-based 
cohort excluding potential methodological confounds as associated with the previous 
studies. A previous meta-analytic study that compared 231 MDD patients with 261 
healthy participants found reduced FA in inferior longitudinal fasciculus, inferior fronto-
occipital fasciculus, posterior thalamic radiation and corpus callosum, which belong to 
the association/commissural fibres and thalamic radiations(Liao et al. 2013). Following 
the above study, another two recent meta-analyses found integrity reductions in the 
same categories, i.e. dorsal lateral PFC area, commissural fibres (Wen et al. 2014; 
Chen et al. 2016). The global loss of FA in these regions could be the result of general 
neurodevelopmental alterations in MDD patients (Korgaonkar et al. 2011), and findings 
within defined subsets of white matter tracts could reflect the neurological basis of 
MDD as a disconnection within an integrated network of cortex-cortex and cortical-
limbic pathways (Veer 2010). The general FA reductions in groups of tracts is also 
consistent with findings from resting-state fMRI studies, which reported abnormalities in 
MDD populations in regional networks rather than just individual regions or structures 
(Greicius et al. 2007; Meng et al. 2014). The networks that derive from prefrontal cortex 
and thalamus has been found largely contribute to emotional and social cognition 
processes (Korgaonkar et al. 2011). The reduced integrity in these groups of tracts 
may therefore reflect the repeatedly found impairment of emotion regulation (Kanske et 
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al. 2012; Heller et al. 2013), reward processing (Gradin et al. 2011) and executive 
control (Snyder 2013) in MDD populations. 
In the tests of single white matter tracts, we found significantly altered integrity in left 
superior longitudinal fasciculus and superior thalamic radiation both in the overall MDD 
population and recurrent MDD patients. Reduction of left superior longitudinal 
fasciculus was notably larger in recurrent MDD patients. Reduction of integrity in 
forceps major was also found in MDD compared with healthy subjects, however 
showed no specific change of FA in recurrent MDD. 
Superior longitudinal fasciculus, as a part of association fibres, connects prefrontal 
cortex and other lobes (Huang et al. 2011). Small-sample studies have specifically 
reported reduced integrity in superior longitudinal fasciculus in various depressive 
samples, including elderly patients with depression (Sheline et al. 2008; Korgaonkar et 
al. 2011), depressive adolescents (Cullen et al. 2010) and adolescents with familial risk 
for depression (Huang et al. 2011), compared with controls. Meta-analytic studies (de 
Schotten et al. 2011; Chen et al. 2016) and a review (Sexton et al. 2009) also 
ascertained that the reduction of white matter integrity specifically in superior 
longitudinal fasciculus may be an important biomarker of the presence of depression. A 
recent study combined genetic and neuroimaging techniques found that people with 
higher polygenic risk of depression have greater loss of FA in superior longitudinal 
fasciculus (Whalley et al. 2013), suggesting that it may also therefore be a useful trait-
related marker of risk. Loss of integrity in superior longitudinal fasciculus has also 
previously been reported to be associated with various cognitive dysfunctions, like 
working memory (Karlsgodt et al. 2008) and attention (de Schotten et al. 2011). 
Severity of depressive symptoms was also found correlate with FA loss in superior 
longitudinal fasciculus (Lai and Wu 2014). There is increasingly convincing evidence 
therefore that reduced integrity in superior longitudinal fasciculus might be an important 
feature of the neurobiology of MDD and may underlie impaired emotional process and 
cognitive abilities in MDD population (Murphy and Frodl 2011). 
Another strength of the present study is that cross-modality assessment was 
conducted on both subcortical volumes and white matter integrity. Though the findings 
were largely found in white matter integrity instead of subcortical volumes, this is 
consistent with another cross-modality study by Sexton et al.(2012), which presented 
that no significant group difference was found between late-life depression and healthy 
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control, whereas white matter integrity was reduced in many regions (Sexton et al. 
2012). Another study on 358 people similarly found that depressive symptoms of 
elderly subjects also showed significant deficit in white matter, but not in grey matter 
measures (Allan et al. 2016). The age range for the present study is from 40 to 70, 
which covers a notable range of elderly participants. This feature of our sample could 
be the reason why it showed similar contrast of findings between white matter and grey 
matter measurements. 
Potential limitations of the current study should be considered, these include the 
absence of a face-to-face structured diagnostic interview schedule and the lack of 
hospital-based sampling. The large sample size may, however, overcome some of 
these difficulties and community based population sampling may yield more 
generalizable findings than those based on clinically ascertained samples alone 
(Benedetti et al. 2011; Soriano-Mas et al. 2011). The current investigation, by avoiding 
the combination of clinically and methodologically diverse samples, may also have 
ameliorated several important confounds such as differences due to different 
healthcare systems and illness related conditions including age of onset and duration 
of illness. Another factor of interest for future studies is the effect of hospital treatment. 
As studies have reported changes of depressive symptoms caused by medication or 
cognitive treatment (DeRubeis et al. 2008), investigates on the neurological effect of 
treatment should be conducted. The prevalence of the present study is lower than 
10%, which is less than the prevalence of ~20% in overall sample of the cohort in the 
study by Smith et al. (2013) (Smith et al. 2013). This was mainly due to the difference 
of sizes between the two samples. There were ~5500 participants in the sample with 
T1-weighted/DTI data, whereas over 30 times of people were included in the full cohort 
(N=172,751). This difference therefore supports the necessity of studying MDD in a 
large sample to minimise the bias of selecting study sample. A further potential 
limitation is that for the volumetric analysis we only focused on the subcortical volumes 
in the current study. We can therefore not exclude the possibility of cortical differences 
in MDD, including regional volume differences, as well as measures of cortical 
thickness and gyrification for example.  
Our study presents a comprehensive comparison of brain structural changes related to 
MDD using the largest single sample available to date from a single scanner with 
uniform methodologies for clinical categorisation and scanning. We mainly report 
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reductions of white matter FA in general latent measures of association and 
commissural fibres as well as thalamic radiations, and in left superior longitudinal 
fasciculus both in MDD and recurrent MDD. Future work would be potentially focusing 
on structural changes in cortical areas as well as richer stratification of MDD into 
informative biologically-based subgroups. 
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Table 1. The effect of MDD definition on the volumes of subcortical regions and brain matters.  
Subcortical regions 




t value p value pcorrected  
Effect 
size 
Standard deviation t value p value pcorrected 
Accumbens -0.010  0.049  -0.211  0.833  0.838   -0.018  0.052  -0.348  0.728  0.819  
Amygdala -0.045  0.050  -0.896  0.371  0.834   0.038  0.053  0.711  0.477  0.819  
Caudate 0.064  0.053  1.198  0.231  0.834   0.025  0.056  0.453  0.650  0.819  
Hippocampus -0.034  0.050  -0.682  0.495  0.838   -0.040  0.053  -0.758  0.449  0.819  
Pallidum 0.019  0.051  0.372  0.710  0.838   -0.022  0.054  -0.414  0.679  0.819  
Putamen 0.018  0.047  0.386  0.700  0.838   -0.008  0.049  -0.162  0.871  0.871  
Thalamus -0.050  0.039  -1.284  0.199  0.834   -0.059  0.041  -1.428  0.154  0.819  
Brain stem -0.011  0.053  -0.205  0.838  0.838   0.045  0.056  0.794  0.428  0.819  
ICV -0.046  0.048  -0.953  0.341  0.834   -0.049  0.051  -0.959  0.338  0.819  
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Table 2. The effect of MDD definition on FA values of DTI tracts. 
 
DTI tracts 









t value p value pcorrected 
Acoustic radiation -0.083 0.059 -1.410 1.59E-001 0.231  -0.094 0.063 -1.485 1.38E-001 0.221 
Anterior thalamic radiation -0.077 0.063 -1.221 2.22E-001 0.254  -0.065 0.067 -0.973 3.31E-001 0.441 
Cingulate gyrus part of cingulum -0.131 0.059 -2.213 2.71E-002 0.085  -0.102 0.064 -1.601 1.10E-001 0.195 
Corticospinal tract -0.077 0.058 -1.321 1.87E-001 0.236  -0.049 0.062 -0.795 4.27E-001 0.488 
Inferior fronto-occipital fasciculus -0.091 0.061 -1.489 1.37E-001 0.219  -0.059 0.065 -0.901 3.68E-001 0.453 
Inferior longitudinal fasciculus -0.122 0.062 -1.983 4.76E-002 0.109  -0.124 0.066 -1.891 5.89E-002 0.150 
Medial lemniscus -0.133 0.062 -2.148 3.19E-002 0.085  -0.141 0.066 -2.155 3.14E-002 0.100 
Parahippocampal part of cingulum -0.040 0.058 -0.683 4.94E-001 0.494  -0.018 0.060 -0.304 7.61E-001 0.761 
Posterior thalamic radiation -0.080 0.061 -1.306 1.92E-001 0.236  -0.089 0.065 -1.373 1.70E-001 0.247 
Superior longitudinal fasciculus 
(bilateral) -0.142 0.063 -2.246 2.49E-002 0.085 
 
-0.151 0.068 -2.229 2.60E-002 0.100 
Superior longitudinal fasciculus (left) -0.194 0.066 -2.951 3.23E-003 0.025  -0.221 0.070 -3.165 1.59E-003 0.025 
Superior thalamic radiation -0.224 0.065 -3.461 5.58E-004 0.009  -0.179 0.069 -2.580 9.99E-003 0.080 
Uncinate fasciculus -0.105 0.058 -1.810 7.06E-002 0.141  -0.107 0.062 -1.718 8.60E-002 0.172 
Forceps major -0.193 0.068 -2.834 4.69E-003 0.025  -0.133 0.072 -1.842 6.57E-002 0.150 
Forceps minor -0.112 0.065 -1.723 8.52E-002 0.152  -0.159 0.070 -2.266 2.36E-002 0.100 
Middle cerebellar peduncle -0.066 0.064 -1.024 3.06E-001 0.326  0.039 0.068 0.576 5.65E-001 0.602 
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3 Chapter conclusion 
We found that MDD case-control differences were mainly shown in white matter 
microstructure measured by FA in general variance of thalamic radiations, the tract-
specific variance in superior longitudinal fasciculus, forceps major and superior 
thalamic radiation. The results provided evidence that significant MDD case-control 
difference has a moderate Cohen’s d of 0.1 to 0.3 in a population-based sample. This 
very large sample confirmed the important role of white matter connecting to 









White matter microstructure is related to the mean and within-subject 
variance of depressive symptoms 
 
1 Chapter introduction 
Following the findings of MDD case-control differences in white matter microstructure, 
the study in this chapter investigated how white matter microstructure was associated 
with depressive symptoms measured at multiple time points, of which the importance 
has been discussed in Chapter 1. The longitudinal measures of depressive symptoms 
were assessed on 2-4 occasions across 5.89 to 10.69 years. Over 8,000 people had 
data for two or more assessments. Using the longitudinal data, three types of longitudinal 
measures were derived: (1) variability of depressive symptoms, (2) mean depressive 
level over time and (3) longitudinal trajectory of depressive symptoms. The 
neurobiological associations in white matter microstructure with these different cross-
sectional measures were assessed, and the differences and similarities across 
measures of depressive symptoms were discussed. 
This study is presented as a paper entitled, “White matter microstructure is related to the 
mean and within-subject variance of depressive symptoms”. It is now ready for 
submission. As the first author of the paper, I conceived the idea, ran the data analyses, 
and wrote the manuscript independently under supervision. 
2 Paper 
2.1 Abstract 
Background: Assessments of white matter integrity in depression typically show 
reductions in depressed individuals but are frequently limited by small sample sizes 
and the absence of longitudinal measures of depressive symptoms. We sought to test 
if greater levels of depressive symptoms or an individual’s propensity to emotional 
variability over time are associated with reductions in white matter microstructure.  
Methods: We sought to address the cross-sectional and longitudinal relationships 
between depressive symptoms and white matter microstructure using the UK Biobank 
Imaging Study. Depressive symptoms were assessed on 2-4 occasions using the 
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PHQ-4 across 5.89 to 10.69 years and imaging data was collected at a single time 
point. Depressive symptom measures were available in approximately 8,660 
individuals on at least two occasions, and in approximately 1,940 individuals on 4 
occasions. We tested the associations between depressive symptoms (cross-sectional, 
mean and within-subject variability in depressive symptoms over time) with white 
matter microstructure (Fractional Anisotropy, FA; Mean Diffusivity; MD) in 27 major 
tracts.  
Results: We found that greater mean diffusivity (MD) of the thalamic radiations was 
associated with increased depressive symptom levels measured at the imaging 
assessment, increased variability of depressive level, and also with increasing 
depressive symptoms over time (β>0.024, pcorr<0.043). Greater MD in association 
fibres that connect prefrontal areas was associated with increasing levels of depression 
over time (β=0.050, pcorr=0.034). In contrast, increased projection fibre MD in the brain 
stem, cortex and connected limbic areas (β=0.045, pcorr=0.001) was associated with 
greater variability in depressive symptoms. No association was found in FA (pcorr>0.11). 
Conclusions: Our results provide evidence that higher MD in thalamic radiations is 
associated with a higher number, variability and increasing trajectory of depressive 
symptoms. Variability and longitudinal change showed separate associations with 
projection fibres and association fibres, respectively. This suggests that white matter 
microstructure may be selectively important for aspects of the pathophysiology and 
progression of depressive symptoms. 
 
2.2 Introduction 
Major depressive disorder (MDD) is a disabling disorder with a high heritability (Sullivan 
et al. 2000; Vos et al. 2012) and prevalence (Kessler et al. 2003). It is a heterogeneous 
illness (Howard, Clarke, et al. 2017; Whalley et al. 2018), often studied in modest 
sample sizes (Liao et al. 2013). These limitations have led to diverse findings (Fava 
and Kendler 2000) and to an uncertain relationship between quantitative measures of 
depressive symptoms and associated neurobiology.  
A possible contributor to the heterogeneous imaging findings in MDD is the longitudinal 
variability of depressive symptoms (Kendler and Gardner 2011). Although MDD is often 
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diagnosed based on a single assessment in most studies, depressive symptoms are 
inherently dynamic (Kendler and Gardner 2016). For instance, some people may have 
a highly variable mood state but have a low mean level of depressive symptoms, 
whereas others may show higher mean levels of depressive symptoms, or a 
progressively increasing level of symptoms over time. Observations based on multiple 
assessments of depressive symptoms would therefore allow the mean, variance and 
longitudinal pattern of depressive symptoms to be assessed. Recent studies found 
data-driven clusters based on different patterns of trajectories of depressive symptoms, 
suggesting a possibility of stratifying depression according to dissociated patterns on 
the basis of fluctuations over time (Lin et al. 2016). 
Recent cohort studies found emerging evidence for the association between mood 
disorders and reductions of white matter microstructure in thalamic radiations (Shen et 
al. 2017; Barbu et al. 2018), which contains important tracts involved in emotional 
processing (Hall et al. 2008) and regulation (Phillips et al. 2008). Deficits in these 
functions is associated with the onset and severity of MDD (Leppa 2006). However, 
these studies used diagnosis limited to one occasion or lifetime diagnosis (Liao et al. 
2013). The present study aims to use so far the largest neuroimaging cohort with 
longitudinal depressive symptoms assessed, to test whether measures of the mean, 
variability, and longitudinal pattern of depressive symptoms show shared or different 
associations with white matter microstructure, and thereby to provide a better 
understanding of the neurobiological mechanisms of depression based on 
prospectively collected longitudinal data. 
In this study, depressive symptoms were assessed on up to four separate occasions 
and across a maximum time span of 5.89 to 10.69 years. One depressive symptom 
assessment coincided with an MRI imaging assessment. Based on these repeated 
measurements, we generated four measures, which include an assessment of 
depressive symptoms at the same time as the imaging assessment, the mean level of 
depressive symptoms and their variance (i.e. variability of depressive symptoms), and 
finally, the slope of depressive symptoms within individuals over time, as a measure of 
longitudinally worsening of depressive symptoms. 
In the current study, we tested for associations between these 4 depressive symptom 
measures and white matter microstructure in the UK Biobank Imaging Study of 8,837 
people(Miller et al. 2016). Within this database, more than 8,000 people provided 
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The UK Biobank team recruited ~500,000 people across the United Kingdom (Sudlow 
et al. 2015) and an ongoing imaging assessment was undertaken for a subset of 
11,293 participants (Miller et al. 2016). For the current analyses, the most recent 
release of imaging data was used which included  8,837 individuals who provided data 
that passed the quality check performed by UK Biobank imaging team after data 
preprocessing(Alfaro-Almagro et al. 2018). In this total sample, the mean age was 
62.53 years (standard deviation=7.42) and 47.52% were men. We then conducted 
further data quality control of the removing outliers, and then the imaging data was 
merged with other data (steps listed below and presented in Figure S1).  
UK Biobank data acquisition was approved by Research Ethics Committee (reference 
11/NW/0382). The analysis and data acquisition for the present study were conducted 
under application #4844. Written consent was obtained for all participants. All the 
imaging preprocessing was undertaken under the protocol released from UK Biobank 
(https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). 
Depressive symptoms 
Depressive symptoms were measured by a 4-item physical health questionnaire (PHQ-
4)(Batty et al. 2016). PHQ-4 has an AUC (area under the curve) of 0.79 for its 
correlation with depression diagnosis (Khubchandani et al. 2016). This measure also 
shows association with measures of disability (Kroenke et al. 2009) and risk factors for 
depression (Löwe et al. 2010; Batty et al. 2016). See more details in the URL: 
http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100060, and items in supplementary 
methods. 
PHQ-4 was assessed repeatedly up to a maximum of four times. Time points included: 
(a) the first assessment visit (2006-2010, N=8,782), (b) a repeat visit on a sub-sample 
(2012-2013, N=2663), (c) the imaging visit (2014-2017, N =8,309) and finally the (d) 
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online follow-up (2015-2017, N =6,676). Further details can be found on UK Biobank 
website: http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100060.  
Based on the repeated PHQ-4 measures, we generated four measures of depressive 
symptoms (Figure 1, S2): (i) First, a single PHQ-4 score measure acquired at the same 
time as the imaging assessment. (ii & iii) Then the mean and variability of depressive 
symptoms across all available assessments, where the mean depressive level was the 
average of PHQ-4 over at least two time points, and variability of depressive symptoms 
was the standard deviation of PHQ-4 scores over a minimum of three time points. (iv) 
Finally, we estimated the longitudinal slope of depressive symptoms within each 
individual with all four PHQ-4 assessments, using a linear growth curve model. A 
positive slope indicated depressive symptoms becoming more severe over time, and a 
negative slope when they reduced over time. Details of the growth curve model 
estimation are detailed in the supplementary methods. Descriptive statistics for the 
above PHQ-4 measures were presented in Figure S1, Table S1 and supplementary 
results.  
 
Figure 1. The measures for depressive symptoms generated for this study. There were four 
measures generated: (1) fundamental one-time measurement for depressive symptoms 
acquired with imaging assessment, (2) mean of depressive symptoms generated based on at 
least two multiple assessments, (3) variability of depressive symptoms which was the standard 
deviation of at least three time-points, and finally (4) linear growth curve denoting longitudinal 
trajectory of depressive symptoms derived from all four time-points. 
 
 





We used IDPs (imaging-derived phenotypes) for DTI data release by UK Biobank 
Imaging Study. Data acquisition, data preprocessing, estimation of white matter 
microstructure and quality check after the above steps were conducted by UK Biobank 
imaging team using a standard protocol described in the Primary Brain Imaging 
Documentation (URL: https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf) and two 
protocol papers(Miller et al. 2016; Alfaro-Almagro et al. 2018). The major procedures 
are described in brief below. 
All imaging data were acquired using a 3T Siemens Skyra (software platform VD13) 
machine, using a standard (“monopolar”) Stejskal-Tanner pulse sequence. FSL 
packages were used for data preprocessing and microstructure estimation (Andersson 
et al. 2007b). Preprocessing included correction for eddy currents, head-motion and 
gradient distortion, using the Eddy tool(Andersson and Sotiropoulos 2015a). Five dMRI 
microstructure measures were estimated after preprocessing. DTI measures including 
FA and MD were generated using DTIFIT (Anthofer et al. 2015). These are the 
measures that were used as main proxies and reported in the main text. Three newly 
developed neurite orientation dispersion and density imaging (NODDI) measures were 
also generated using AMICO tool (Daducci et al. 2015). These measures depict 
additional sources of variation to FA and MD such as neurite density, extracellular 
water proportion, and morphology of tract organization. For completeness, findings 
using these measures are detailed in the supplementary materials and briefly 
discussed where necessary (Appendix 2: Figures S3 and S4). 
The processed data was then fed into AutoPtx package from FSL 
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx), which uses probabilistic-tractography 
based method to map 27 major tracts over the whole brain(Miller et al. 2016). The 
processed tracts included 12 bilateral and 3 unilateral tracts (Figure 2 and Appendix 2: 
supplementary methods). FA data was used for mapping and the masks of tracts for 
each individual were used to locate the tracts on MD and NODDI measures. Weighted 
means of DTI measures for each tract were generated. 
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Figure 2. Illustration of WM tracts. The tracts were defined by tractography mapping on FA 
(fractional anisotropy) data using AutoPtx (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx). They 
were categorised into three subsets as shown in the figure. Forceps major, forceps minor and 
uncinate fasciculus are unilateral structures and the rest are bilateral. For the purpose of clear 




Before any analysis was performed, outliers were first removed (Shen et al. 2017). This 
was achieved by performing separate PCA for each DTI measure on the overall 
sample of 8,837 people, and those who were outside of +/- 3 standard deviations from 
mean were removed (Shen et al. 2017). This resulted in ~8,780 people remaining (see 
Appendix 2: Figure S1) for further analysis. Results for the sample without outliers 
removed can be found in Appendix 2: Figure S5.  
First, we tested the associations between the measures for depressive symptoms i) 
quantified at the imaging assessment as a single time point, ii) as the overall mean 
depressive level, (iii) as the variability of depressive level and (iv) as the slope of 
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longitudinal trajectory with global WM microstructure changes (trajectory modelled by a 
growth curve model, see supplementary methods). For each of the DTI measures, we 
performed PCA on all the tracts and three major subsets of WM tracts that included 
association and commissural fibres, thalamic radiations and projection fibres (Shen et 
al. 2017). These three subsets are distinct in both anatomy and function (Cox, Ritchie, 
et al. 2016). Association fibres are the tracts that connect cortical areas, thalamic 
radiations connect thalamus with other parts of the brain, and finally projection fibres 
are the tracts associated with subcortical/spinal cord. Categorisation of the subsets can 
be found in Figure 2. The scores of the first un-rotated principal component for each 
microstructural metric were then extracted to index the common properties of white 
matter microstructure shared across tracts, denoted as gTotal, gAF, gTR and gPF. In 
our previous published papers on the same cohort (Cox, Ritchie, et al. 2016; Shen et 
al. 2017), there was a substantial component of shared variance across white matter 
tracts for each microstructural parameter (Appendix 2: Figure S6 and Table S2). 
Following the analysis of the g variations, we tested the associations of microstructure 
of individual tracts and four types of measures for depressive symptoms. 
We used “glm” function in R to test the above associations (Chatfield et al. 2010). Age, 
age2, gender were set as covariates. Other covariates include: head position in the 
scanner (on x, y and z axis) to control for systematic unevenness of static field in the 
scanner, smoking status and alcohol consumption at the time of imaging assessment 
to control for depression-related behaviour patterns that may influence brain structure, 
and finally stressful life events occurring within 2 years before imaging test to control 
for response bias to PHQ-4. Each of the covariates are described in supplementary 
materials (Appendix 2: supplementary methods and Table S1, S5 and S6). For 
completeness, we also reported results that did not control for smoking status, alcohol 
consumption, stressful life events (Figure S7). FWE correction was applied on each set 
of measures with a whole brain as a unit by using “p.adjust” function using FDR 




Associations between white matter microstructure and depressive symptoms at 
the imaging assessment 
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Global differences (g) of MD over all tracts (gTotal), and tracts separated into the 
categories of association fibres (gAF) and thalamic radiation (gTR) were positively 
associated with depressive symptoms measured at the time of imaging assessment (β 
ranged from 0.023 to 0.029, pcorr<0.032, see Appendix 2: Figure 3, Table S3). In 
individual tracts, higher MD in the anterior thalamic radiation (β=0.036, pcorr=0.002), 
cingulate part of cingulum (β =0.027, pcorr=0.025), corticospinal tract (β =0.031, 
pcorr=0.022) and superior thalamic radiation (β =0.024, pcorr=0.030) were all associated 
with higher depressive symptoms at the imaging assessment. No significant 
associations were found either globally (pcorr>0.114), or regionally in individual tracts 
(pcorr>0.148) between FA and depressive symptoms  at the time of the imaging 
assessment.  
Associations between white matter microstructure and mean and variability of 
longitudinal depressive symptoms  
No association was found between global or subset measures of MD (all pcorr>0.126) 
and mean depressive symptoms. However, MD in thalamic radiations (β=0.024, 
pcorr=0.043) and in projection fibres (β=0.045, pcorr=0.001) were both positively 
associated with within-subject measures of variability in depressive symptoms. 
For specific tracts, higher MD in anterior thalamic radiation was significantly associated 
with higher mean depressive symptoms (β=0.032, pcorr=0.013). Higher MD in anterior 
thalamic radiation (β=0.032, pcorr=0.015), and middle cerebellar peduncle (β=0.045, 
pcorr=0.003) were associated with greater variability of depressive symptoms. 
No association was found for FA (all pcorr>0.199) in any global or tract-specific measure 
and any measure of depressive symptoms. 
Associations between the longitudinal slope of depressive symptoms and WM 
microstructure 
Higher global, association fibres and thalamic radiations MD were each associated with 
progressively increasing levels of depressive symptoms (β ranged from 0.050 to 0.056, 
pcorr<0.031). No significant individual tract-wise analysis reached significance after 
multiple correction. However, forceps major (β=0.053, pcorr=0.073), superior thalamic 
radiation (β=0.052, pcorr=0.073) and corticospinal tract (β=0.050, pcorr=0.073) were 
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nominally significant. No association for FA was found for either g measures or tracts 
(pcorr>0.450).  
Associations between the measures for depressive symptoms and NODDI 
measures 
Among all the NODDI measures, ISOVF showed similar results with MD. Detailed 





Figure 3. Associations between cross-sectional depressive symptoms and dMRI (heatmap) and 
the map for significant regions (brain map). FA=fractional anisotropy, MD=mean diffusivity. 
Depre=one-time assessment of depressive symptoms, Depre.mean=mean depressive level, 
Depre. variability=variability of depressive symptoms, and Depre.longitudinal=slope of growth 
curve model trajectory of depressive symptoms. Colour depth represents the standard effect 
size of a measure. As FA has negative direction with MD, here in this figure, the effect sizes for 
FA was reversed (×-1). The results were separated in two sections. The upper sections were the 
results for g measures and the lower sections showed the results of individual tracts. To aid 
comprehension, the lower part where results of tracts were shown, checks were divided into 
three categories by dashed lines as the tracts were in different subsets, i.e. association fibres, 
thalamic radiations and projection fibres (see Methods). Significant associations after FWE 
correction on 15 tracts/four g measures (pcorr<0.05) were marked with an asterisk. Significant 
associations in the g measures may not necessarily result in associations in individual tracts, as 
shown in the columns for Depre.longitudinal. 
 (see Figure 3 in the next page)











Figure 4. Venn graph for results of g measures for the distress measures that showed significant results in g measures. The overlapping association 
was shown in thalamic radiations (gTR) for all three distress measures. Dissociated effects were shown in association fibres (gAF) for depressive 
symptoms based on one-time assessment and slope of longitudinal trajectory, and projection fibres (gPF) was significant for variability of depressive 
symptoms.  




We found several novel associations between greater depressive symptom measures 
and ostensibly poorer WM microstructure as indexed by higher MD. Higher depressive 
symptoms at the time of the imaging assessment and a higher mean and variance of 
depressive symptoms over time were both associated with higher MD in the ATR. 
Higher general thalamic radiation (gTR) MD was also associated with higher 
depressive symptoms at the time of the assessment, higher variability in depressive 
symptoms over time, and with worsening depressive symptoms over time. Lower 
association fibre microstructure in MD was found in association with greater depressive 
symptoms at the time of the imaging assessment and with a longitudinal trajectory of 
worsening depressive symptoms over time. The association fibres subset includes 
tracts that localise to the prefrontal cortex and its connections. Higher MD in projection 
fibres, which locate in or connect to limbic areas, were also associated with high 
variability of depressive symptoms (Figure 4). The above results in MD were confirmed 
by ISOVF. 
Lower microstructure of the anterior thalamic radiation has appeared repeatedly in 
association with the presence of several psychiatric illnesses, including depression 
(Coenen et al. 2012), psychosis (Sprooten et al. 2009) and schizophrenia (Young et al. 
2000). The linkage built by ATR between prefrontal regions and thalamus is an 
important path of executive control and emotion regulation (Royall et al. 2002; Cheon 
et al. 2011). It is particularly interesting that ATR has been repeatedly found in patients 
in their adolescence or early adulthood (Lai and Wu 2014).  Thalamic radiations as a 
tract category subset also showed significant effect of one-time measure, cross-
sectional longitudinal variability and trajectory of depressive symptoms. Consistent 
associations of thalamic radiations with different distress measures may due to 
environmental impacts that had influenced neuronal maturation in early life (Voineskos 
et al. 2012), and thus the developmental gaps prolonged into adulthood. Alternatively, 
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those with early life psychiatric disorders may be subject to a different clinical 
mechanism which is influenced by gene structures (Frodl et al. 2012), and therefore 
lasts through-out the lifespan. These findings are also supported by a recent study that 
found thalamic radiations were associated with the polygenic risk profile derived from 
NETRIN-1 pathway, which was found in various genetic pathway studies for MDD 
(Barbu et al. 2018). 
Deficit of microstructure in association fibres was associated with greater depressive 
symptoms at the time of the imaging assessment and with worsening depressive 
symptoms over time. The largest effect sizes were seen for a worsening longitudinal 
trajectory of depressive symptoms. Association fibres pathways are robustly associated 
executive cognition (Voineskos et al. 2012; Zheng et al. 2014; Cox, Ritchie, et al. 2016) 
and connections to the prefrontal cortex have been closely related to psychological 
resilience (Walsh et al. 2007). This could contribute to both temporary depressive 
status and longitudinal decline in mental well-being (Bachmann et al. 2005). Deficit in 
these pathways may reflect a declined capacity of psychological ‘bounce-back’, thus 
causes the accumulated deficit associated with longitudinal increase of depressive 
symptoms.  
Variability of depressive symptoms showed a distinctive association with projection 
fibres. Projection fibres mainly locate in the limbic system or link limbic system with the 
cortex (Wakana et al. 2004). Previous fMRI studies found that depressive patients 
showed biased processing of emotional stimuli in both a negative emotional system 
including structures such as the amygdala and thalamus (Dalgleish 2004; Young et al. 
2004), and the reward system located in the basal ganglia and mid-brain (Gradin et al. 
2011). Variability of depressive symptoms can be the result of deficits in primary 
process for emotional input to the brain (Lammel et al. 2014; Polter and Kauer 2014). 
This may explain the treatment resistance for some MDD patients, as the conventional 
psychological treatment showed brain alterations mainly in prefrontal regions, which 
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may be less effective to those cases whose major concern was variability of depressive 
symptoms (Young et al. 2004). The distinct neurobiological associations between 
variability and mean depressive level indicate that dissociating psychological/biological 
treatment based on their different symptoms over time may help achieve better results. 
Most of the results were presented in MD rather than FA. Despite the differences in the 
level of significance, MD and FA presented in the directions of effects and the scales 
were similar for the most robust findings, especially in thalamic radiations (Appendix 2: 
Table S3). Also, our findings in MD have shown similar patterns with a NODDI 
measure, ISOVF, which is related to neuronal loss (Kamagata et al. 2017). The 
discordance between MD and FA may be rooted in differential sensitivity of MD and FA 
to a variety of complex degenerative processes via a range of distinct neurobiological 
features. Changes in FA, which could result from increased transverse diffusion due to 
myelin and axonal disruption (Jones et al. 2013), may be masked by co-occurring 
processes such as fibre reorganisation and glial reactivity; in such instances where all 
three eigenvectors of the diffusion tensor experience proportional change, it is plausible 
that MD would offer greater sensitivity (Acosta-Cabronero et al. 2010). MD reportedly 
exhibits greater sensitivity to ageing than FA (Cox, Ritchie, et al. 2016) which notably 
included poorer microstructure in ATR (Cox, Ritchie, et al. 2016). Furthermore, higher 
MD in the absence of FA differences have been found in studies of cortisol reactivity to 
mild cognitive stress in older age (Cox, Bastin, et al. 2015; Cox, MacPherson, et al. 
2015), and in ageing-associated disorders such as Alzheimer’s disease and small 
vessel disease (Acosta-Cabronero et al. 2010; Maniega et al. 2015). Altogether, the 
current observations could therefore reflect an acceleration of normal or pathological 
ageing processes in the brain resulting from, or predisposing to, adverse effects of 
depressive symptoms on the brain. 
In the present study, we used a very large single site imaging sample of over 8,000 
people. Though the sample size of longitudinal change of depressive symptoms was 
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much lower (~2,000), it is still much larger than most neuroimaging studies, especially 
considering the data is longitudinal and covers up to ten years. All of this provides high 
statistical power to reliably detect modest associations (Smith and Nichols 2018). 
However, a limitation for the present study is that the time lag between adjacent 
assessments may vary from one year to six years. Though we did adjust the difference 
by controlling for the age of each time point and the growth curve models showed good 
fit (see supplementary methods), noise can be further reduced by controlling more 
finely on time lag for future experimental design or increasing time points. Another 
limitation is that the variability of depressive symptoms we derived would not be able to 
depict all types of variations for depressive symptoms and may be very different from 
variations in a short period (e.g. diurnal mood swing). These other measures of mood 
variability would have substantial biological meaning but potentially different 
neurobiological basis. 
Our results provide evidence that deficit in WM microstructure is related to greater 
mean, variability and longitudinal deterioration of depressive symptoms. The 
longitudinal findings point towards associations between white matter integrity and 
depressive symptoms, and further causal conclusions will require examination using 
methods that are able to test for causal inferences in observational datasets.  
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3 Chapter conclusion 
MD in thalamic radiations, especially in anterior thalamic radiation, was associated with 
variability and mean depressive level. Variability of depression exclusively showed 
association with MD in projection fibres. This study provided evidence that thalamic 
radiations are important not only for MDD case-control differences, as found in chapter 
2, but also present as a common component associated with various longitudinal 
measures for depressive symptoms here in this chapter. The differences of associations 
between cross-sectional measures indicate that cross-sectional measures may provide 











Phenotype-wide association study of 212 behavioural and 1,532 
neuroimaging phenotypes in UK Biobank using polygenic risk scores for 
depression 
 
1 Chapter introduction 
Several questions remain unanswered regarding neuroimaging features of polygenic risk 
for depression. First, whether white matter microstructure is associated with depression 
polygenic risk score is under-explored. Second, no study has been conducted that the 
author is aware of that had examined the association between resting-state connectivity 
and the polygenic risk scores for depression. Finally, whether brain phenotypes mediate 
the effect of depression polygenic risk on complex behavioural traits.  
To answer these questions, a well-powered sample for finding associations with 
moderate effect sizes would be needed. Another important factor is to include a wide 
range of phenotypes, including behavioural and neuroimaging variables. This study used 
the UK Biobank imaging dataset release in May 2018, containing 14,506 people who 
attended imaging assessment. Polygenic risk scores of depression were derived using 
a meta-analysis combining data from UK Biobank, PGC (Psychiatric Genomics 
Consortium) and 23andme. A data-driven phenotype-wide association study was 
conducted to test the associations between the polygenic risk scores of depression and 
212 behavioural plus 1,532 neuroimaging phenotypes.  
The paper under preparation for submission. I independently conducted the analyses 
and completed the manuscript under supervision. 
2 Paper 
2.1 Abstract 
Depression is a leading cause of disability worldwide but there is uncertainty regarding 
its genetic, neural and behavioural associations, hindering the discovery of its causes 
and mechanisms. Depression is highly heritable and polygenic, and the increasing 
availability of replicated genetic associations provides a timely opportunity to identify 
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traits that are genetically correlated with depression in UK Biobank, where there is a 
wide range of potentially relevant traits in a large number of consistently phenotyped 
individuals. We estimated polygenic risk scores for depression in 14,506 genotyped 
participants and examined their association with 212 behavioural and 1,532 
neuroimaging phenotypes. Higher polygenic risk of depression (depression-PGRS) 
was associated with lower white matter microstructure (absolute standardised β: 0.027 
to 0.036, p: 8.08×10-5 to 1.57×10-3), hyper-connectivity under resting-state in the 
default mode network, and weaker connectivity in the prefrontal cortex (absolute β: 
0.031 to 0.046, p: 7.86×10-6 to 1.64×10-3). Other behavioural traits such as sleep, 
smoking, cardiovascular conditions and body mass were also found to be associated 
with depression-PGRS (absolute β: 0.031 to 0.017, p: 1.13×10-37 to 1.64×10-3). In order 
to address the direction of the associations between depression PRS, behaviour and 
brain, we then conducted mediation analyses of all the traits previously found to be 
associated with depression-PGRS. Sleep, smoking and general physical health 
mediated the association between polygenic risk and the presence of depression to the 
greatest extent (proportion of direct effect mediated > 6%, p: 8.55×10-9 to 8.70×10-4). 
We also found that white matter microstructure mediated the associations of 
depression-PGRS to subjective well-being, the number of major psychiatric illnesses 
diagnosed, and smoking behaviour (proportion of direct effect mediated>2.7%, p 
ranged from 4.51×10-4 to 0.021). These findings suggest that sleep, smoking and 
poorer physical health may mediate the association between genetic risk and 
depression and that the effects of genetic risk on behaviour may be partly mediated 
through disrupted functional/structural brain connectivity. 
 
2.2 Introduction 
Major Depressive Disorder (MDD) is a major contributor to the overall global burden of 
disease, affecting 322 million people worldwide, and a leading cause of disability 
(World Health Organization 2017). MDD has a high heritability estimated around 37% 
based on twin studies(Sullivan et al. 2000), approximately 25% of the genetic 
contribution can be explained by single nucleotide polymorphisms (SNP) (Lee et al. 
2013). This indicates that common genetic variants of small effect contribute a 
substantial proportion of the total genetic effect. For polygenic traits, polygenic risk 
profiling provides a way to investigate the additive common genetic risk (International 
and Consortium 2009; Wray et al. 2014). Uses allele effect weights estimated from an 
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independent genome-wide association study (GWAS), polygenic risk scores are 
generated for each individual in a second independent dataset from the product of 
allele dosages and effect sizes, summed across the genome (Howard, Adams, Shirali, 
et al. 2018; Wray et al. 2018). 
Polygenic risk for MDD is associated with heritable behavioural traits, such as other 
major psychiatric disorders like bipolar disorder and schizophrenia, neuroticism, lower 
general cognitive function, lower educational attainment and socioeconomic status, and 
a higher risk of obesity (Clarke et al. 2015; Hagenaars et al. 2016). MDD is widely 
believed to result from perturbed brain function and is associated with many 
neuroimaging phenotypes such as white matter microstructure, regional brain volumes 
and functional connectivity (Disner et al. 2011; Russo and Nestler 2013; Shen et al. 
2017). GWAS and heritability analyses conducted on brain phenotypes reveal 
significant heritability of up to 60% (Elliott et al. 2018), providing an opportunity to study 
the genetic overlap between neuroimaging phenotypes and other heritable traits with 
MDD (Glahn et al. 2007; Jahanshad et al. 2013; Kochunov et al. 2015; Centre et al. 
2017), and test for directional causal relationships between these traits.  
The associations between MDD polygenic risk and brain phenotypes have, so far, been 
poorly studied. Based on previous studies, small to moderate effect sizes are expected 
(Wray et al. 2014) and therefore most neuroimaging studies will be underpowered to 
investigate the genetic associations between depression and brain and behavioural 
phenotypes (Button et al. 2013). Higher sampling costs for MRI (magnetic resonance 
imaging) scanning, differences between functional imaging paradigms and 
inconsistencies in both quality control and statistical inferences across studies make 
meta-analysis challenging and suggest the need for single large samples and 
consistently applied methods of acquisition processing and analysis (Kaiser et al. 
2015). 
The latest neuroimaging data release from the UK Biobank imaging project (Miller et al. 
2016) includes a maximum of 11,006 people, which is the largest cross-modality 
imaging dataset up to date. Summary statistics from the meta-analysis combining three 
big cohorts: PGC, UK Biobank and 23 and me, were used to produce depression 
polygenic risk scores (depression-PGRS). There are also a wide variety of other 
phenotypes available allowing for comparisons and mediation tests between traits, 
such as structural equational modelling for the associations of gene-behaviour-health 
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and gene-brain-behaviour relationships. In the current study, building upon UK 
Biobank’s large sample size and detailed phenotyping, we conducted a phenotype-
wide association test with depression-PGRS. The phenotypes available included 
contain ten categories (Np indicates number of phenotypes): early life factors (Np=10), 
sociodemographic measure (Np=4), lifestyle (Np=69), physical measures (Np=68), 
mental health (Np=57), cognition (Np=4), intracranial/subcortical volume (Np=9), white 




A total of 14,506 people participated in the UKB Data release included in the current 
study. Data came from the latest release of the ongoing UK Biobank Imaging Project 
(released in May 2018, where age at the imaging assessment ranged from 44.58 to 
80.25 years, mean age=62.69, standard deviation=7.48, and 47.91% were men). In 
total, 500,000 people were initially recruited for UK Biobank project. A subset was 
selected to attend a neuroimaging assessment following the initial visit. Behavioural 
and neuroimaging data acquisition were conducted under standard protocols (Sudlow 
et al. 2015; Miller et al. 2016). Written consents were acquired from all participants. 
Data acquisition and analyses in the present study were conducted under UK Biobank 
Application #4844. 
Depression-PGRS 
Polygenic risk scores were calculated using the summary statistics from a meta-
analysis of depression genome-wide association study (GWAS) from three cohorts, 
including 33 out of the 35 cohorts of the Psychiatric Genomics Consortium (PGC) 
analysis of major depression (Wray et al. 2018), the 23andMe discovery sample in the 
Hyde et al. analysis of self-reported clinical depression (Hyde et al. 2016), and a broad 
depression phenotype from UK Biobank non-imaging sample (Howard, Adams, Clarke, 
et al. 2018). This meta-analysis provided a total of 793,627 individuals (241,166 cases 
and 552,461 controls) with further details of this meta-analysis provided in a paper of 
meta-analysis (Howard et al., 2018). The broad depression phenotype used in UK 
Biobank, though was self-declared and comparatively lenient, showed very strong 
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genetic correlation with clinically defined MDD with a high genetic correlation of 
0.79(Howard, Adams, Shirali, et al. 2018). Training and testing datasets were ensured 
to have no overlap or relatedness (see methods in the meta-analysis in Howard et al., 
2018). In order to maximize replicable genetic variants derived from the training 
dataset, the summary statistics only included genetic variants that co-exist across all 
three cohorts, leaving 8,899,213 genetic variants left in the training sample. 
We used PRSice 2.0 (incorporating PLINK 1.9) (Euesden et al. 2015) to calculate the 
depression-PGRS. Related or non-European-ancestry people and imaging subjects 
that were included in PGC, 23&me and UK Biobank MDD GWAS were removed from 
all following analysis. All sample sizes reported below will be the numbers after this 
data removal. Genotyping and quality control were conducted by UK Biobank as 
described in a protocol paper (Bycroft et al. 2017b). Eight p-value thresholds were 
applied to select genetic variants included in calculating polygenic risk scores, as 
p<0.0005, p<0.001, p<0.005, p<0.01, p<0.05, p<0.1, p<0.5 and p<1. Details of SNP 
quality control and imputation can be found elsewhere (Barbu et al. 2018). 
Behavioural phenotypes 
The behavioural phenotypes consisted of seven broad categories, containing 212 items 
in total, sample sizes included in brackets (see Table 1 for summary and Table S1 for 
full explanations): (1) Sociodemographic measures (N=8,318 to 10,260), (2) Early life 
factors (N=7,742 to 11,020), containing physical factors such as birth weight, and 
environmental variables like adoption and maternal smoking, (3) Life style (N=2,880 to 
11,020), which include sleep, smoking, alcohol consumption and diet, (4) Physical 
health (N=2,227 to 11,020), consisting of self-declared medical conditions such as 
pain, cancer, operations, heart and artery disease and other major illnesses, and also 
machine assessed medical record for blood pressure, arterial stiffness and hand-grip 
strength, (5) Cognitive performance (N=5,247 to 6,075), which included four tests with 
acceptable biological reliability and a general measure derived based on these tests, 
(6) Mental health (N=3,788 to 8,340), including self-reported symptoms of major 
psychiatric conditions and diagnosis of major psychiatric illness under classifications of 
ICD-10 (10th revision of the International Statistical Classification of Diseases and 
Related Health Problems) based on systematic interview.  
Chapter 4: PheWAS of depression-PGRS 
82 
 
All of the behavioural phenotypes, with the exception of mental health items derived 
from online-follow up questionnaires and diagnosis from a systematic interview (see 
table 1), were acquired at the same time as the imaging assessment. For those who 
had absent behavioural data at the instance of imaging assessment but provided data 
at the initial visit, data from the initial visit was interpolated to fill the absent data at the 
imaging assessment where applicable. Sample sizes and descriptions for all the 
behavioural phenotypes used can be found in Appendix 3: Table S1. 
Where summary data were available (e.g. neuroticism total score), the individual items 
used to derive the summary data were not included. Further, phenotypes with less than 
2,000 people were excluded before the analyses. 
Neuroimaging phenotypes 
Neuroimaging data was consisted of: (1) intracranial/subcortical volume (N=11,006); 
(2) white matter microstructure, indexed by fractional anisotropy (FA, N=9,699) and 
mean diffusivity (MD, N=9,671); and finally, (3) resting-state connectivity (N=10,112). 
All four types of data consisted of the imaging-derived phenotypes (IDPs) provided by 
UK Biobank. Images were acquired, pre-processed and quality controlled by UK 
Biobank using FMRIB Software Library (FSL) packages by a standard protocol (URL: 
https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf), which was also described in 
two protocol papers(Miller et al. 2016; Alfaro-Almagro et al. 2018). All pilot study data 
with inconsistent scanner settings and data that did not pass the initial quality 
assessment conducted by UK Biobank imaging team were not included in the analysis. 
All imaging data were collected using a 3T Siemens Skyra (software platform VD13) 
machine. For clarity, major steps of pre-processing were described below for each 
modality. 
T1 data was processed to estimate intracranial and subcortical volumes. First, total 
volumes for white matter, grey matter and peripheral cerebrospinal fluid were 
calculated, and the sum of the three was the derived intracranial volume. Then 
volumes for thalamus, caudate, putamen, pallidum, hippocampus, amygdala, 
accumbens and brain stem (with 4th ventricle) were estimated. 
DTI data pre-processing included correction for eddy currents and head motion, outlier-
slices correction and grand distortion correction. FA and MD maps were generated and 
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FA maps were used to generate tract masks, using probabilistic tractography analysis 
by AutoPtx package from FSL(Mori et al. 2002). 27 tracts were generated (12 bilateral 
and 3 unilateral tracts, see supplementary Figure S1 and Table S1)(Wakana et al. 
2004). Weighted mean FA and MD were then calculated for each tract. To determine 
general variances in DTI measures and main subsets, as have validated in previous 
papers that weighted mean DTI measures for major white matter tracts are highly 
correlated, which makes generating general variances possible(Cox, Ritchie, et al. 
2016; Shen et al. 2017), we performed principal component analyses on (1) FA/MD of 
all 27 tracts (gTotal), (2) FA/MD on association/commissural fibres (gAF), which 
connect the prefrontal cortex to other cortexes, (3) FA/MD on thalamic radiations 
(gTR), consisted of tracts that link the thalamus to the cortex, and (4) FA/MD on 
projection fibres (gPF), locating within brain stem or spinal cord or link them to the 
cortex. The scores for the first unrotated principal component were used as the indices 
for general variants of total variance and variances in three major subsets. In order to 
control for the effects driven by outliers, subjects with a total gFA/MD outside of +/-3 
standard deviation from mean were excluded.  
Resting-state data was pre-processed through FSL-style motion correction, grand-
mean intensity normalisation, high-pass temporal filtering, EPI unwarping and grand-
distortion-correction unwarping. A group-level independent component analysis was 
conducted on the first 4,100 people to reduce data dimension(Alfaro-Almagro et al. 
2018). The brain was therefore parcellated into 100 independent components, and 55 
of them were left for further analyses after 45 discarded as being identified manually as 
noise components. The timeseries data for nodes was then used to calculate functional 
connectivity between node pairs. It was achieved by estimating partial Pearson 
correlation with an L2 regularisation applied (rho set as 0.5 in FSLNets). All r-scores 
were then Fisher-transformed into z-scores. This resulted in a 55*55 correlation matrix 
of functional connectivity for each participant. In order to aid comprehension, all 
connectivity values were transformed into absolute strength by multiplying the sign of 
group-mean value for each of the connection (Shen et al. 2018) (see supplementary 








The GLM function in R was used to test the PheWAS associations(Nelder and Baker 
2004), and the LME function from nlme package in R(Pinheiro et al. 2007) was used to 
test bilateral brain structures where hemisphere as a within-subject variable needed to 
be controlled for. Depression-PGRS were set as factors, and behavioural and 
neuroimaging phenotypes were set as dependent variables. depression-PGRS at 
different p thresholds were tested independently. Overall, 1,744 phenotypes (212 
behavioural phenotypes + 9 intracranial/subcortical volumes + 38 white matter 
microstructural measures + 1485 rsfMRI connectivity) * 8 depression-PGRS (under 8 p 
thresholds) = 13,952 tests across phenotypes and depression-PGRS p thresholds 
were corrected altogether by FDR-correction(Benjamini and Hochberg 2000) using 
p.adjust function in R (q<0.05). 
Common covariates for all association tests included sex, age, age2, the first 15 genetic 
principal components to control for population stratification and genotyping array 
(Howard, Adams, Shirali, et al. 2018). Scanner positions on x, y and z axis were also 
included in the models for all brain phenotypes to control for static-field 
heterogeneity(Smith and Nichols 2018). Mean motion was set as an additional 
covariate for the rsfMRI connectivity data (Bijsterbosch et al. 2017; Shen et al. 2018). 
Subcortical volumetric tests additionally controlled for intracranial volume (Schmaal et 
al. 2016; Shen et al. 2017). Hemisphere was controlled for where applicable in bilateral 
brain structural phenotypes(Shen et al. 2017). A list of covariates for each type of 
phenotype can be found in Table 1. 
 
Table 1. Summary of phenotypes. 209 behavioural phenotypes (6 categories) and 1,586 
neuroimaging variables (4 modalities) were included (see the next page). 
 




Category General description 
Number of 
traits 




UK Biobank data 
modality 
Covariates for regression 
model 
Early life factor 
Self-declared early life factors. Mainly derived based on another study in 
ref X. Items include developmental factors such as birth weight and 
comparative weight and height at early ages. Parental factors such as early 
parental death were included too. 
10 7,742-11,020 10,880 
Touchscreen; Online 
follow-up 
Sex, age, age2, genetic PCs and 
genotyping array 
Sociodemographic 
Items include education, household income, ethnicity and immigration 
status 
4 8,318-10,260 9,152 Touchscreen 
Sex, age, age2, genetic PCs and 
genotyping array 
Life style 
Self-declared life-style questions. Mainly include sleep patterns, smoking, 
alcohol consumption, electronic device usage, food and beverage intake, 
appearance, and social activities. 
69 2,880-11,020 11,020 Touchscreen 
Sex, age, age2, genetic PCs and 
genotyping array 
Physical 
This category contains data from self-declared physical conditions from the 
'touchscreen' data modality and measured physical data from the 'physical 
measures' modality. Self-declared items include overall physical health rate, 
limb pain which is related to suspicious claudication and peripheral artery 
disease, other types of pain, cardiovascular problems, general diabetes and 
cancer problems, and bone fractures. Measured physical data contains 
general and regional body mass/fat index, impedance and hand grip 
strength. 
68 2,227-11,020 10,880 Touchscreen 
Sex, age, age2, genetic PCs and 
genotyping array 
Cognition 
Three tasks were selected for having acceptable reliability, which include 
trail making task, digit substitution, numeric memory. A variable of g score 
derived from the three tasks was added. 
4 5,247-6,075 5,740 
Touchscreen; Online 
follow-up 
Sex, age, age2, genetic PCs and 
genotyping array 
Mental health 
Mental health questionnaires from touchscreen's mental health section, 
questions from online follow-up and diagnostic results were included. 
Diagnostic results were based on systematic review was conducted based 
on ICD-10 (International Classification of Disease). Items include major 
psychiatric illness. 
57 3,788-8,340 8,340 
Touchscreen; Online 
follow-up 
Sex, age, age2, genetic PCs and 
genotyping array 
Intracranial/subcortical volume 
Measures were derived from T1 data. Seven subcortical regions were 
mapped and measured. Intracranial volume was derived by adding grey 
and white matter total volumes and ventricular cerebrospinal fluid. 
9 11,006 -- Brain imaging 
Sex, age, age2, genetic PCs, 
genotyping array, scanner 
position, intracranial volume 
(for subcortical volumes), and 
hemisphere (for bilateral 
measures) 
White matter microstructure 
Weighted-mean fractional anisotropy (FA) and mean diffusivity (MD) of 
major tracts were derived for 27 major tracts (12 bilateral and 3 unilateral). 
Tracts were mapped using probabilistic tractography. We used general 




-- Brain imaging 
Sex, age, age2, genetic PCs, 
genotyping array, scanner 




Two-two paired, partial correlation matrix of 55 parcellated nodes 
generated by group-ICA was estimated and used as a measure for 
functional connectivity. 
1485 10,121 -- Brain imaging 
Sex, age, age2, genetic PCs, 
genotyping array, scanner 
position and mean motion 
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Throughout the present study, we report standardised effect sizes (β) and uncorrected 
p values. All the reported p values were significant after FDR correction. When effect 
sizes of different signs were presented together, a range of absolute effect sizes was 
reported.  
Following the PheWAS, investigations on endophenotypes were conducted using 
structural equational modelling with ‘lavaan’ package in R (Oberski 2014). Two types of 
mediation tests were conducted: (1) Mediation effect of traits that mediate the direct 
path between depression-PGRS and depression (x=depression-PGRS, m=other traits, 
and y=depression). Mediators were the phenotypes (imaging and behavioural) that 
were associated with depression-PGRS at minimum two thresholds. (2) Mediation 
effect of neuroimaging phenotypes that mediate the path between depression-PGRS 
and behavioural traits (x=depression-PGRS, m=neuroimaging phenotypes, and 
y=behavioural phenotypes). The mediators and outcome variables were associated 
with depression-PGRS at minimum two thresholds. Depression definitions were not 
included in the outcome variables for the second set of mediation tests. A full list of 
phenotypes included for these analyses can be found in Table S1 in Appendix 3. 
Mediation models were conducted separately for each set of three traits (i.e. 
x=depression-PGRS, m=g.MD.Total and y=insomnia). Before multiple correction, tests 
that had low model fits (CFI<0.9/TLI<0.9/prmsea<0.05) or with the absent association 
between mediator and outcome (nominal p>0.05) were removed. This step was 
conducted to remove redundant tests and to exclude unreliable estimates. After this, p 
values were FDR-corrected. 
In both types of mediation analyses, we used the traits that were significant in the 
PheWAS as mediators/outcomes and tested in independent models. Age, age2 and 
sex were set as covariates for all phenotypes. In addition to these variables, 
depression-PGRS had genetic principal components and genotyping array controlled 
for as well. Covariates for neuroimaging phenotypes additionally included scanner 
position variables (position x, y and z), and where applicable, hemisphere, mean 
motion, and intracranial volume were corrected for. 
 
 





We found that 91 (66 behavioural and 25 neuroimaging phenotypes) out of 1744 
examined phenotypes (212 behavioural and 1532 neuroimaging) showed significant 
associations with depression-PGRS at a minimum of two p thresholds after correction 
for multiple comparisons (absolute β: 0.024 to 0.141, p: 9.63×10-38 to 2.10×10-3). 
Overall results for selected depression-PGRS of p thresholds at 1 and 0.01 are 
presented in Figure 1. Associations for significant phenotypes are shown in Figure 2.  
Overall, the largest effect sizes were presented in mental health traits (Figure 3). 
Lifestyle and mental health showed the strongest agreements across depression-
PGRS p thresholds. Other than neuroimaging phenotypes, all other traits showed an 
overall trend of having a larger effect when the depression-PGRS p threshold was 
higher. However, for neuroimaging phenotypes, optimal thresholds were at lower p 
thresholds, such as pT<0.01 for white matter microstructure, and pT<0.1 for resting-
state amplitude and connectivity. Here in this section, we present the main results and 
the full list of significant results can be found in Figure 2. 
Depression-PGRS were associated with MDD definitions and symptomology, as 
well as other psychiatric disorders 
Higher depression-PGRS were associated with the presence of depression based on 
four definitions, including depression-broad, which was a self-declared definition of 
whether had depression, though most lenient but had the largest statistic power (β: 
0.074 to 0.141, p: 1.13×10-37 to 1.89×10-11), MDD-smith defined by Smith et al. (Smith 
et al. 2013), which was derived from self-declared symptoms of major depression and 
hospital admission history (β: 0.045 to 0.104, p: 2.24×10-18 to 1.40×10-4), MDD-ICD 
based on International Classification of Disease (ICD-10) using systematic review, with 
the smallest sample size (β: 0.055 to 0.073, p: 1.83×10-6 to 2.89×10-4), and MDD-CIDI 
based on self-answered questions from the structured Composite International 
Diagnostic Interview (β: 0.060 to 0.115, p: 3.55×10-23 to 2.48×10-7). 
Other than MDD definitions, significant associations were found in MDD symptoms, 
assessed by PHQ-4 (Patient Health Questionnaire) and CIDI questionnaires, and other 
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self-reported traits including self-harm, subjective well-being, not worth living and 
neuroticism (absolute β: 0.083 to 0.122, p: 3.31×10-27 to 2.09×10-4).  
Higher depression-PGRS were also associated with presence of other psychiatric 
illnesses based on results for diagnosis of major psychiatric illnesses such as 
psychosis (β: 0.035 to 0.066, p: 1.95×10-9 to 1.64×10-3), anxiety (β: 0.051 to 0.105, p: 
3.51×10-22 to 4.05×10-6), bipolar disorder (β: 0.036 to 0.038, p: 7.21×10-4 to 1.22×10-3) 
and post-traumatic stress disorder (β: 0.036 to 0.104, p: 1.10×10-21 to 1.25×10-3). 
 
Figure 1. Significance plot for all phenotypes at depression-PGRS p thresholds (pT) at pT<1 (top 
figure) and pT<0.01 (bottom figure). The x-axis represents phenotypes, and the y-axis shows the 
-log10 of uncorrected p values. Each dot represents one phenotype, and the colours indicate their 
according categories. The dashed lines indicate the threshold to survive FDR-correction. FDR-
correction was applied over all the traits and all depression-PGRS (see Methods). From left to 
right on the x-axis, categories were shown by the sequence of: early life risk factors, 
sociodemographic measures, lifestyle measures, physical conditions, cognition, mental health 
measures, intracranial/subcortical volume, white matter microstructure and resting-state 
connectivity. Representative top findings are annotated in the figure. For those findings replicated 
in both left and right panels are only annotated in the left panel. (see the next page) 
 
 









Figure 2. Heatmap for the traits that were significantly associated with depression-PGRS at minimum two p 
thresholds. Shades of cells indicate the standardised effect sizes (β). A larger effect size was indicated by a 
darker colour. Cells with an asterisk were significant after FDR-correction. Descriptions in detail can be found 
in Table 1 and Appendix 3: S1. 




Figure 3. Mean effect sizes for each category. The figure shows the mean effect sizes across all eight depression-PGRS at different p thresholds. 
Phenotypes included were the ones that were significant at minimum one depression-PGRS. Other than effect sizes, transparency of the dots 
indicates the proportion of significant tests within their categories. A darker dot means that at this depression-PGRS, a higher proportion of 
traits/tests were significant under the category. 
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Associations were found between depression-PGRS and white matter 
microstructure 
Brain structural phenotypes in white matter microstructure were associated with 
depression-PGRS. General changes of higher global MD (β: 0.032 to 0.037, p: 
8.08×10-5 to 6.82×10-4), higher MD in association fibres (β: 0.031 to 0.036, p: 1.35×10-4 
to 1.14×10-3) and higher MD in thalamic radiations (β: 0.028 to 0.030, p: 5.24×10-4 to 
1.57×10-3) were associated with higher depression-PGRS. For each tract in specific 
(Figure 4), significant associations with depression-PGRS was presented in FA in 
medial lemniscus (β: -0.028 to -0.027, p: 1.02×10-3 to 1.38×10-3) and forceps major (β: -
0.034 to -0.033, p: 5.76×10-4 to 8.92×10-4), and MD in inferior fronto-occipital fasciculus 
(β: 0.031 to 0.032, p: 4.68×10-4 to 6.59×10-4), superior longitudinal fasciculus (β: 0.030 
to 0.034, p: 1.99×10-4 to 1.13×10-3) and forceps minor (β: 0.030 to 0.036, p: 1.19×10-4 
to 1.34×10-3).  
 
Figure 4. Brain maps for the significant associations between depression-PGRS and white 
matter microstructure in mean diffusivity (MD) and fractional anisotropy (FA) of major tracts. The 
shade of each tract represents the effect size (β). A darker shade indicates a greater β. From 
left to right are from anterior, superior and right view. For clarity purpose, among the tracts 
presented in Figure 2, the ones that showed consistent associations across at least two 
depression-PGRS p thresholds are presented. β for the selected tracts were the mean β across 
all depression-PGRS. Results for each depression-PGRS can be found in Appendix 3: Figure 
S2. 




Depression-PGRS were associated with resting-state functional connectivity 
Novel associations were found between depression-PGRS and resting-state functional 
connectivity (absolute β: 0.031 to 0.046, p: 7.86×10-6 to 1.64×10-3). High depression-
PGRS were also correlated with hyper-connectivity in the ‘default-mode network’ areas 
such as clusters in bilateral posterior cingulate cortex (peak coordination: -10, -60, 18, 
cluster size=5,236, peak intensity=0.168) and right medial prefrontal cortex (peak 
coordination: 10, 48, -10, cluster size=22, peak intensity=0.063). Other regions 
involved in hyper-connectivity associated with higher depression-PGRS include: 
bilateral hippocampus (peak coordination: 24, -20, -16, cluster size=333, peak 
intensity=0.103), right mid-insula (peak coordination: 36, -6, 14, cluster size=130, peak 
intensity=0.010), bilateral mid-frontal gyrus (left: peak coordination: -22, 28, 40, cluster 
size=1,930, peak intensity=0.177; right: peak coordination: 26, 32, 34, cluster 
size=1,575, peak intensity=0.144). Weaker connectivity involved in orbito-superior 
frontal gyrus (peak coordination: 18, 64, -6, cluster size=13,359, peak intensity=-
0.010), inferior parietal gyrus (peak coordination: -30, -46, 38, cluster size=1,207, peak 
intensity=-0.071) and right anterior insula (peak coordination: 32, 22, 10, cluster 
size=565, peak intensity=-0.089) (Figure 5). A full list of regions was reported in 
Appendix 3: Table S3 and S4. 
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Figure 5. Brain maps for regions involved in significant associations between resting-state 
functional connectivity and depression-PGRS. In this figure, among the results presented in 
Figure 2, the ones that show consistent associations across at least two depression-PGRS p 
thresholds are presented. β for the selected tracts are the mean β across all depression-PGRS, 
regardless of whether the association was significant for each depression-PGRS.. Visualisation 
of results is achieved by calculating the mean of ICA maps, weighted by their mean β, 
respectively for positive and negative β. For clarity, the brain maps shown below have a 
threshold applied on, that values over 50% of highest intensity are shown. The shade of 
red/green represents the intensity. Maps in the top row had a cut-up at x=-1/1. The maps on the 
bottom are from left/right lateral view. 
 
Higher depression-PGRS were associated with sleep problems, smoking and 
poorer physical health 
In terms lifestyle, sleep problems (absolute β: 0.035 to 0.068, p: 3.42×10-10 to 1.66×10-
4) and smoking (absolute β: 0.033 to 0.062, p: 1.13×10-9 to 8.63×10-4) were found 
associated with depression-PGRS. 
Physical health items associated with depression-PGRS can be summarised as the 
following four categories: (1) overall health level including self-reported general health 
condition (β: 0.037 to 0.077, p: 5.68×10-16 to 1.06×10-3) and condition of long-standing 
illnesses (β: 0.040 to 0.052, p: 2.60×10-8 to 3.53×10-5), (2) pain (β: 0.032 to 0.084, p: 
1.41×10-18 to 1.25×10-3), (3) cardiovascular/heart problem (β: 0.031 to 0.040, p: 
8.54×10-4 to 3.43×10-5), and (4) body mass and weight change (β: 0.017 to 0.041, p: 
1.15×10-7 to 1.61×10-3). 
 
Mediation analysis: from depression-PGRS, via non-mental-health traits, to 
depression 
We tested the mediation effects of 57 non-mental-health traits that were significant in 
the PheWAS at minimum one depression-PGRS p threshold. In order to cut down 
redundant tests, we chose two depression-PGRS at thresholds pT<1 and pT<0.01, and 
MDD-nerves as the major definition of depression. 
There were 29 and 25 traits showed significant mediation effect for depression-PGRS, 
respectively at pT<1 and pT<0.01 (proportion of direct effect mediated (Δc): 1.11 to 
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7.57%, p: 4.08×10-6 to 8.70×10-4). Results for the two depression-PGRS pTs were 
similar, as in Figure 6. Therefore, we reported the statistics from depression-PGRS 
pT<1 below. Highest Δc were shown in overall self-declared physical health rating 
(Δc=7.57%, p=1.11×10-8) and whether there was any sleep problem (Δc=7.16%, 
p=8.55×10-9). Phenotypes related to sleep problems such as insomnia and sleep too 
much rank relatively high in terms of the proportion of direct effect mediated (Δc: 3.23 
to 6.62%, p: 4.08×10-6 to 8.70×10-4). Mediation effect of smoking (Δc: 2.79 to 2.90%, p: 
1.20×10-4 to 1.67×10-4) and physical variables including pain, long-standing illness and 
cardiovascular condition (Δc: 1.15 to 6.36%, p: 2.90×10-9 to 0.029) ranked relatively 
middle and had high variance. Body mass variables explained the least proportion of 
direct effect between depression-PGRS and MDD compared to other significant traits 
(Δc: 1.20 to 1.86%, p: 1.27×10-3 to 0.019). 




Figure 6. Proportion of direct association between depression-PGRS and MDD explained by mediators (x=depression-PGRS, y=MDD-nerve). The left 
side is the results for depression-PGRS at pT<0.01. The four absent bars are either having insignificant mediation effect or the mediation model has 
poor fits. 
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Mediation analysis: from depression-PGRS, via neuroimaging phenotypes, to 
behavioural traits 
Mainly in white matter microstructure showed a significant mediation effect between the 
direct path of depression-PGRS at pT<0.01 and behavioural traits (p: 4.51×10-4 to 
0.029). No significant mediation effect was found for the path between depression-
PGRS at pT<1 and behavioural traits (minimum p=4.74×10-3, corrected p=0.264). 
The effect between depression-PGRS and behavioural traits including subjective well-
being score (Δc: 3.56 to 3.95%, p: 8.32×10-3 to 0.021), overall number of psychiatric 
illnesses diagnosed (Δc: 1.40 to 1.50%, p: 0.016 to 0.018), smoking status (Δc: 2.70 to 
4.58%, p: 2.14×10-3 to 0.012), and ever had cardiovascular/heart problem (Δc: 7.00 to 
10.20%, p: 4.51×10-4 to 2.60×10-3) were generally mediated by multiple white matter 
microstructural variables. Global MD and MD in association fibres negatively mediated 
the effect between depression-PGRS at pT<0.01 and body mass (p: 1.63×10-3 to 
0.010). This was due to an association that higher MD was associated with higher body 
mass. We further found that it was caused by the quadratic relationship between body 
mass and MD, indicating that worse white matter microstructure was associated with 
either being under- or over-weight. When the linear terms for body mass were replaced 
by quadratic terms, then the mediation effect became insignificant (see Table S7). 
 
Table 2. Results for neuroimaging phenotypes mediating the direct association between 
depression-PGRS and behavioural phenotypes (x=depression-PGRS, m=neuroimaging 
phenotypes, and y=behavioural phenotypes). CFI=Comparative Fit Index, TLI= Tucker-Lewis 
Index, and prmsea is the p statistic of whether RMSEA was significantly different from 0. All the 
results below are significant after FDR-correction (see the next page). 
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Table 2. Results for neuroimaging phenotypes mediating the direct association between depression-PGRS and behavioural phenotypes (x=depression-
PGRS, m=neuroimaging phenotypes, and y=behavioural phenotypes). CFI=Comparative Fit Index, TLI= Tucker-Lewis Index, and prmsea is the p statistic 
of whether RMSEA was significantly different from 0. All the results below are significant after FDR-correction. 
 
Predictor Mediator Outcome Category c' 
standard 



























Well-being score Mental health -0.002  0.001  0.012  0.029  0.034  1.000  1.000  0.001  1.000  
Past tobacco smoking Life style -0.001  0.001  0.013  0.029  0.029  0.977  0.960  0.010  1.000  
Smoking status Life style 0.001  0.001  0.012  0.029  0.026  0.970  0.948  0.011  1.000  
Ever vascular heart problem 
diagnosed 
Physical 0.002  0.001  0.001  0.020  0.068  0.959  0.929  0.015  1.000  
Arm fat mass left Physical -0.001  0.000  0.019  0.034  -0.062  0.950  0.913  0.016  1.000  
Arm fat mass right Physical -0.001  0.000  0.015  0.032  -0.065  0.951  0.915  0.016  1.000  
Arm fat percentage left Physical -0.001  0.000  0.006  0.022  -0.077  0.983  0.970  0.019  1.000  
Arm fat percentage right Physical -0.001  0.000  0.005  0.022  -0.071  0.983  0.971  0.019  1.000  
Body fat percentage Physical -0.001  0.000  0.002  0.020  -0.084  0.983  0.970  0.019  1.000  
Leg fat mass left Physical -0.001  0.000  0.007  0.022  -0.062  0.983  0.970  0.016  1.000  
Leg fat mass right Physical -0.001  0.000  0.008  0.024  -0.060  0.982  0.969  0.016  1.000  
Leg fat percentage left Physical -0.001  0.000  0.001  0.020  -0.072  0.990  0.983  0.021  1.000  
Leg fat percentage right Physical -0.001  0.000  0.002  0.020  -0.069  0.989  0.981  0.021  1.000  
Trunk fat mass Physical -0.001  0.001  0.009  0.024  -0.064  0.945  0.905  0.015  1.000  
Trunk fat percentage Physical -0.002  0.001  0.003  0.020  -0.090  0.969  0.947  0.017  1.000  







l Well-being score Mental health -0.002  0.001  0.007  0.023  0.038  1.000  1.005  0.000  1.000  
Overall ICD-10 psychiatric 
conditions 
Mental health 0.002  0.001  0.018  0.034  0.014  0.996  0.992  0.005  1.000  
Ever smoked Life style 0.001  0.001  0.015  0.031  0.030  0.972  0.951  0.012  1.000  
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Past tobacco smoking Life style -0.002  0.001  0.004  0.020  0.039  0.983  0.971  0.010  1.000  
Smoking status Life style 0.002  0.001  0.003  0.020  0.037  0.978  0.962  0.011  1.000  
Addiction.ever (Self-
reported) 
Life style 0.001  0.001  0.027  0.041  0.038  0.988  0.980  0.008  1.000  
Long standing illness, 
disability or infirmity 
Physical 0.001  0.001  0.021  0.036  0.032  0.996  0.993  0.005  1.000  
Ever vascular heart problem 
diagnosed 
Physical 0.003  0.001  0.000  0.020  0.094  0.967  0.943  0.015  1.000  
Overall health rating Physical 0.001  0.001  0.013  0.029  0.032  0.984  0.972  0.009  1.000  
Arm fat percentage left Physical -0.001  0.000  0.018  0.034  -0.059  0.983  0.971  0.019  1.000  
Arm fat percentage right Physical -0.001  0.000  0.018  0.034  -0.053  0.984  0.972  0.019  1.000  
Body fat percentage Physical -0.001  0.000  0.006  0.022  -0.067  0.983  0.971  0.019  1.000  
Leg fat mass left Physical -0.001  0.000  0.021  0.036  -0.047  0.984  0.972  0.016  1.000  
Leg fat mass right Physical -0.001  0.000  0.025  0.039  -0.045  0.983  0.971  0.016  1.000  
Leg fat percentage left Physical -0.001  0.000  0.004  0.021  -0.055  0.990  0.983  0.021  1.000  
Leg fat percentage right Physical -0.001  0.000  0.006  0.022  -0.052  0.989  0.981  0.021  1.000  
Trunk fat mass Physical -0.001  0.001  0.023  0.038  -0.053  0.955  0.922  0.015  1.000  
Trunk fat percentage Physical -0.001  0.001  0.006  0.022  -0.075  0.972  0.951  0.017  1.000  







Well-being score Mental health -0.002  0.001  0.009  0.024  0.036  1.000  1.004  0.000  1.000  
Overall ICD-10 psychiatric 
conditions 
Mental health 0.002  0.001  0.016  0.033  0.015  0.998  0.996  0.005  1.000  
Ever smoked Life style 0.002  0.001  0.006  0.022  0.036  0.982  0.968  0.013  1.000  
Past tobacco smoking Life style -0.002  0.001  0.003  0.020  0.045  0.989  0.980  0.010  1.000  
Smoking status Life style 0.002  0.001  0.002  0.020  0.046  0.986  0.976  0.011  1.000  
Addiction.ever (Self-
reported) 
Life style 0.001  0.001  0.029  0.043  0.035  0.993  0.987  0.008  1.000  
Overall health rating Physical 0.002  0.001  0.004  0.020  0.043  0.991  0.984  0.009  1.000  
Ever vascular heart problem 
diagnosed 
Physical 0.003  0.001  0.001  0.020  0.101  0.976  0.958  0.016  1.000  
Long standing illness, 
disability or infirmity 
Physical 0.001  0.001  0.008  0.024  0.039  0.997  0.995  0.005  1.000  
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Other serious medical 
condition diagnosed by 
doctor 
Physical 0.001  0.000  0.024  0.039  0.054  0.995  0.992  0.006  1.000  
N30_N23 
Easy to get up in the 
morning 
Life style -0.001  0.001  0.015  0.031  0.041  0.951  0.915  0.011  1.000  




Associations between depression-PGRS, behavioural and neuroimaging phenotypes 
were found in the present study using the largest independent imaging cohort so far. 
Strongest associations were found between depression-PGRS and mental health. 
Novel associations were found that higher depression-PGRS correlated with lower 
white matter microstructure, hyper resting-state connectivity in default-mode network, 
weaker resting-state connectivity in the sensorimotor and dorsal lateral prefrontal 
cortex. Associations with MDD polygenic risk was also shown in worse sleep, smoking, 
presence of cardiovascular conditions and obesity. Sleep and general physical health 
mediated the largest proportion of the association between depression-PGRS and self-
reported MDD, and white matter microstructural variation mediated the effect of 
depression-PGRS to smoking, subject well-being, an overall number of psychiatric 
illness diagnosed and ever had heart or cardiovascular problems. 
Novel effects of depression-PGRS were found in both structural and functional 
connectivity in the brain. Recent GWAS suggest that MDD is a brain disorder based on 
gene expression results from the genome-wide significant hits (Howard, Adams, 
Shirali, et al. 2018), and our results further provided evidence for a robust association 
between the brain and subthreshold common polygenic variation (International and 
Consortium 2009). Especially, the associations involved in resting-state connectivity is, 
to our knowledge, the first to date. Findings from both DTI and resting-state data 
revealed the importance of prefrontal cortex, which is a hub for emotion regulation and 
executive control (Miller 2000; Etkin et al. 2015). Consistent with previous findings on 
MDD case-control differences (Kaiser et al. 2015; Shen et al. 2017), white matter 
anisotropic reduction and lack of functional strength involved in the prefrontal cortex 
were observed in our DTI and resting-state results respectively. The second main 
association was found in white matter alterations in thalamic radiations and FA 
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reduction in the brain stem, implying deficits in the limbic system for the processing of 
negative emotional stimuli and reward signals (Disner et al. 2011; Russo and Nestler 
2013; Etkin et al. 2015). depression-PGRS were also associated with hyper-
connectivity in the default-mode network areas (Raichle 2015), which was also found 
relevant to spontaneous rumination of negative thoughts and imbalanced goal-directed 
processing (Bartova et al. 2015; Kaiser et al. 2015; Posner et al. 2015). Compared to 
other phenotype categories, both white matter and resting-state data showed the 
largest effect sizes in lower p thresholds for MDD (for example pT<0.01 for white 
matter), along with the findings from GWAS that top-hits express in the brain (Howard, 
Adams, et al. 2017; Howard, Clarke, et al. 2017; Wray et al. 2018), these converging 
evidence indicate a heterogeneous genetic architecture for MDD, and that variation in 
the brain may be relevant to SNPs which have moderate to high effect sizes. In the 
present study, neuroimaging phenotypes generally showed smaller effect sizes 
compared to some behavioural traits such as sleep and smoking status. A major 
reason may be that self-reported lifestyle and physical conditions are likely to be 
directly associated with MDD diagnostic criteria. The importance of the associations 
found in neuroimaging phenotypes is supported by various facts. Firstly, findings in 
neuroimaging phenotypes associating with MDD is well replicated. Secondly, 
compared to behavioural patterns, neuroimaging phenotypes are much more directly 
related to currently available drugs and psychological interventions. Finally, brain 
structural and functional measures have a more certain role as endophenotypes, 
whereas it is much more difficult to define whether behavioural patterns such as self-
reported patterns of sleep and smoking are the causes or outcomes of MDD. 
Sleep, pain, smoking behaviour and whether there is any heart/cardiovascular 
condition mediated the association between depression-PGRS and self-reported MDD, 
and sleep specifically mediated by the largest proportions. Sleep disturbance is a major 
somatic symptom of MDD and an important reference of anti-depressant response 
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(Chen 1979; Winokur et al. 2003). Behavioural traits like sleeping pattern, smoking and 
pain have a significant impact or reciprocal association with activities in the 
hypothalamic-pituitary-adrenal axis (Pariante and Lightman 2008), which is responsible 
for stress response and possesses a regressive feedback system to maintain 
homeostasis (Gordon et al. 2015). Disruption of stasis in this system is a vulnerability 
factor for the onset of MDD (Pariante and Lightman 2008), and it is associated with 
brain development and synaptic formation (Maret et al. 2011; Stickgold et al. 2011). 
Mediator effect of white matter microstructure on the association between depression-
PGRS, smoking and heart/cardiovascular condition then suggest that the relationship 
between depression-PGRS and phenotypic presence of MDD may have a multi-
layered endophenotypic structure. 
The findings from the mediation models provided insights for shared variances of 
depression-PGRS related phenotypes. These tests were partially hypothesis-driven, as 
neurobiological variability is in general believed to be less biologically distant to genetic 
effects, compared with complex traits on the behavioural level. However, our results 
and the method structural equational modelling itself would not rule out other 
possibilities for directionality. Though our results give limited information about 
causality, they narrowed down the spectrum of traits for future studies on causal 
inference using a longitudinal design or statistical methods like Mendelian 
Randomisation (Lawlor et al. 2008). 
To conclude, the association tests revealed relationships between MDD polygenic risk 
and various behavioural and neuroimaging variables. These primary results were also 
accompanied by mediation analyses revealing shared variances of sleep, smoking, 
white matter microstructure and MDD polygenic risk. These findings altogether give 
insights of neurobiological and genetic mechanism of MDD, implying a multi-modality 
architecture for the biological inferences of its onset. 
 




3 Chapter conclusion 
This study provided a large scale of association tests, containing various behavioural 
and neuroimaging traits. Novel results were found that white matter microstructure and 
resting-state connectivity were associated with polygenic risk scores for depression. 
Mediation tests revealed that sleep, smoking behaviour, cardiovascular conditions and 
body mass mediated the effect of polygenic risk on the presence of depression. The 
study gave a broad presentation of major associations between behavioural, 
neuroimaging phenotypes and polygenic risk score. 
 
  




Resting-state connectivity and its association with cognitive performance, 
educational attainment, and household income in UK Biobank (N = 3,950) 
1 Chapter introduction 
Cognition, educational attainment, and socioeconomic status have been found 
associated with polygenic risk of depression and the presence of various mood disorders. 
These variables are also important factors for phenotypic variances in the brain. Although 
task-relevant fMRI studies have been conducted broadly on these traits, resting-state 
connectivity and its association with the above variables has had limited investigations. 
The study in this chapter investigated resting-state connectivity and its associations with 
cognition, educational attainment, and household income. This paper was also one of 
first papers using UK Biobank imaging data testing the association between resting-state 
connectivity and behavioral patterns. 
This study has been published as a journal paper entitled, “Resting-state connectivity 
and its association with cognitive performance, educational attainment, and household 
income in UK Biobank (N = 3,950)” (Shen et al. 2018). I conducted the analyses and 
drafted the manuscript with supervision, as the first author. 
2 Paper 
2.1 Abstract 
Background: Cognitive ability is an important predictor of lifelong physical and mental 
well-being and impairments are associated with many psychiatric disorders. Higher 
cognitive ability is also associated with greater educational attainment and increased 
household income. Understanding neural mechanisms underlying cognitive ability is of 
crucial importance for determining the nature of these associations. In the current 
study, we examined the spontaneous activity of the brain at rest to investigate its 
relationships with not only cognitive ability, but also educational attainment and 
household income.  
Methods: We used a large sample of resting-state neuroimaging data from UK 
Biobank (N=3,950).  
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Results: Firstly, analysis at the whole-brain level showed that connections involving 
the default mode network (DMN), frontoparietal network (FPN) and cingulo-opercular 
network (CON) were significantly positively associated with levels of cognitive 
performance assessed by a verbal-numerical reasoning test (standardized β ranged 
from 0.054 to 0.097, pcorrected<0.038). Connections associated with higher levels of 
cognitive performance were also significantly positively associated with educational 
attainment (r=0.48, N=4,160) and household income (r=0.38, N=3,793). Further, 
analysis on the coupling of functional networks showed that better cognitive 
performance was associated with more positive DMN-CON connections, decreased 
cross-hemisphere connections between the homotopic network in CON and FPN, and 
stronger CON-FPN connections (absolute β ranged from 0.034 to 0.063, 
pcorrected<0.045).  
Conclusion: The present study finds that variation in brain resting state functional 
connectivity associated with individual differences in cognitive ability, largely involving 
DMN and lateral prefrontal networks. Additionally, we provide evidence of shared 
neural associations of cognitive ability, educational attainment, and household income. 
 
2.2 Introduction 
General cognitive ability is positively associated with higher educational attainment 
(Marioni et al. 2014), better workplace performance (Deary 2012), and with reduced 
risk of several mental and physical diseases (Deary 2012; Lencz et al. 2014; Calvin et 
al. 2017; Russ et al. 2017). Identifying the associated neural mechanisms will help 
better understand the causes of these associations. 
Studies have been conducted to explore the relationship between resting-state network 
and cognitive ability (Dosenbach et al. 2007; Sheffield et al. 2015; Wen et al. 2018). 
Resting-state networks (RSN) involving lateral prefrontal cortex, such as executive 
control network and frontal-parietal network, have been previously reported to have 
positive associations attention and executive control (Deary et al. 2010). Newer 
evidence suggested that, other than prefrontal networks, the default mode network 
(DMN) is an important neurobiological marker for higher network efficiency as it is a 
metabolic and neural network hub for the whole brain (Broyd et al. 2009; Smith et al. 
2015), and it is associated with a large number of positive sociodemographic variables 
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(Smith et al. 2015). However, prefrontal networks and DMN show distinctive metabolic 
activity (Raichle et al. 2001), and in certain tasks, they can be neuroanatomically 
antagonistic (Raichle 2015). The ambiguity of biomarkers for cognitive performance 
therefore limits the potential of using neural-network modeling for practical purposes 
like assisting clinical diagnoses and identifying the regional targets for neuronal 
interventions. 
The variability of results in previous studies (Spreng et al. 2010; Cole et al. 2012; Smith 
et al. 2015) may be due to relatively small sample sizes, often limited to 100 
participants or fewer. This limitation is difficult to overcome using meta-analysis, as 
methods of extracting functional networks may vary considerably between studies. 
Therefore, there is a need for large-scale studies using a single scanner and consistent 
methods of estimating the association of RSN activity with consistently-collected social 
and psychological phenotypes to determine the relationship between resting functional 
connectivity and cognitive ability. 
In the current study, we examined resting-state data from the first release of the UK 
Biobank imaging project (Cox, Ritchie, et al. 2016; Miller et al. 2016). Participants from 
40 to 75 years old were recruited widely across the United Kingdom (Matthews and 
Sudlow 2015; Hill, Davies, et al. 2016; Miller et al. 2016). For the resting-state fMRI (rs-
fMRI) data used in the current study, 3,950 subjects underwent the cognitive 
assessment using a test of verbal-numerical reasoning (VNR; referred to in UK 
Biobank as a test of “fluid intelligence”). This measurement is genetically and 
phenotypically representative to the latent component of general cognitive performance 
(Davies et al. 2016; Hagenaars et al. 2016). This test had a test-retest reliability of 0.65 
between the initial assessment visit in 2006-2010 and the first repeat assessment visit 
in 2012-2013 (Davies et al. 2016; Lyall et al. 2016). It also shows a significant genetic 
correlation with childhood general cognitive ability (r=0.81) (Hagenaars et al. 2016). 
In addition to the utility of analyzing a large sample, the present study benefited from 
examining the neural associations between educational attainment and household 
income. The rs-fMRI data were available for educational attainment and household 
income on samples of 4,160 and 3,793 subjects, respectively. Both education and 
household income show phenotypic correlations and shared genetic architecture with 
cognitive ability (Davies et al. 2016; Hill, Hagenaars, et al. 2016); however, the 
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associations between cognitive ability and these two variables with respect to 
functional connectivity remain unclear.  
In order to address the above issues, our analyses were conducted following the order: 
(1) We examined whole-brain resting-state connectivity using a very large sample, to 
identify functional networks associated with cognitive performance (2) We then tested 
which resting-state connections were associated with educational attainment and 
household income, as these two traits are highly relevant to cognitive performance. (3) 
to determine which regions are involved with the above three traits, pairwise correlation 
analyses were conducted between neural associations of cognitive performance, 
educational attainment and household income on all connections over the whole brain. 
For these three steps, we conducted the analysis on a correlation matrix derived from 
high-resolution brain parcellation. Finally, (4) we moved on to examine the coupling 
between bulk resting-state networks based on a low-resolution parcellation, focussing 




The study was approved by the National Health Service (NHS) Research Ethics 
Service (reference: 11/NW/0382), and by the UK Biobank Access Committee (Project 
#4844). Written consent was obtained from all participants. 
In total, 4,162 participants undertook a rs-fMRI assessment and passed the quality 
check undertaken by UK Biobank 
(http://www.fmrib.ox.ac.uk/ukbiobank/nnpaper/IDPinfo.txt) (Mean Age=62.20+/-7.56 
years, Male=47.48%, 3576 (85.92%) White, 142 (3.41%) Asian, 31 (0.74%) Black and 
142 (3.41%) mixed).   
Imaging data 
We used the network matrices from the IDPs (imaging-derived phenotypes) which were 
processed by the UK Biobank imaging project team (Miller et al. 2016). The detailed 
methods of the UK Biobank imaging processing can be found in a previous protocol 
paper (Miller et al. 2016). For clarification, these processes are described briefly below. 
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All imaging data were obtained on a Siemens Skyra 3.0 T scanner (Siemens Medical 
Solutions, Germany, see http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367). 
Data pre-processing, group-ICA parcellation and connectivity estimation were carried 
out using FSL packages (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977) by UK 
Biobank. Briefly, pre-processing included motion correction, grand-mean intensity 
normalization, high-pass temporal filtering, EPI unwarping, gradient distortion 
correction unwarping and removal of structured artefacts (Miller et al. 2016). 
Group-ICA were then performed on the preprocessed sample of 4,162 people, and two 
different ICAs were performed with the dimensionality (D) set as 100 and 25. The D 
determines the number of distinct ICA components. The dimensionality of D=100 infers 
a parcellation of high-resolution, whilst setting D=25 results in low-resolution 
parcellation, and larger functional networks that can be extracted as a single 
component(Smith et al. 2015; Miller et al. 2016). After the group-ICA, noise 
components were discarded; this resulted in 55 components in 100-D ICA and 21 
components in 25-D ICA that remained for further analysis. The maps of both ICAs can 
be seen at: http://www.fmrib.ox.ac.uk/datasets/ukbiobank/index.html. 
Finally, connections between pairs of ICA components for each subject were 
estimated. We used the partial correlation matrices calculated using the FSLNets 
toolbox: http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLNets. A partial correlation matrix was 
generated by controlling for the strength of other connections. The normalized 
estimation of partial correlation was conducted with an L2 regularization applied 
(rho=0.5 for Ridge Regression option in FSLnets). More details can be found in Miller 
et al.(2016) (Miller et al. 2016) and the URL: 
https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf.  
The final 55*55 and 21*21 partial correlation matrices were used as measurements of 
functional connections. The two matrices are different. A 100*100 matrix has a much 
higher spatial resolution, therefore gives better spatial details in terms of identifying 
what regions involve in significant connections. On the other hand, a 25*25 matrix has 
a low spatial resolution, but it allows us to estimate the temporal synchronization 
between bulk networks that are well-known, such as DMN. Hence, the functional 
networks that were found in the whole-brain analysis were selected from the 21*21 
matrix as NOI, connections between the NOI were tested.  




A test of verbal-numerical reasoning (VNR) was carried out by UK Biobank according 
to the standard protocol (Parr et al. 2015; Davies et al. 2016; Keyes et al. 2016). 
Questions of the test can be found in the Touch-screen fluid intelligence test protocol 
document: http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=100231). The data used in 
the present study were collected at the time of imaging assessment (N=3,950, 
Age=62.07+/-7.54, Male=47.47%). Descriptive statistics is presented in supplementary 
results and Figure S1.  
Educational attainment and household income 
Educational attainment and household income phenotypes were self-reported. The 
details are reported in the study website 
(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=100471, 
http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=100256). Descriptive statistics of 
educational attainment and household income are presented in supplementary results 
and Figure S1. 
For educational attainment, we used a proxy which was validated in previous 
studies(Davies et al. 2016; Hagenaars et al. 2016). We created a binary variable was 
created to indicate whether or not university/college level education was achieved. This 
proxy covered 4,160 participants (Age=62.20+/-7.56, Male=47.48%). 
Household income was determined by the average total income before tax received by 
the participant’s household in five levels (see supplementary methods). This measure 
had 3,793 non-empty responses (Age=61.98+/-7.57, Male=49.04%). 
Statistical methods 
We used the partial correlation matrix as a measurement of functional connectivity. 
Values in the matrix are normalized correlation coefficients. A higher absolute value 
means stronger strength of connection, and the sign indicates whether the connection 
is positive/negative. To enable clearer interpretation of the results, the values of the 
connections were transformed into connection strength. This was achieved by 
multiplying the raw connection values with the signs of their mean value. This approach 
was used in a previous study by Smith et al.(2015) (Smith et al. 2015).  
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Analyses were performed in the following sequence: (1) A whole-brain analysis of the 
association between cognitive performance (VNR) and resting-state functional 
connectivity using the connectivity matrix derived from high-resolution parcellation. (2) 
Two separate whole-brain analyses on educational attainment and household income, 
respectively. (3) We then performed correlation analyses on the global functional 
connections predicted by the three phenotypic variables over all the connections in the 
55*55 matrix over the whole brain, that is, testing whether the standardized effect sizes 
for the VNR score’s link to functional connections were correlated with the 
corresponding effect sizes for educational attainment and household income. Two 
correlation analyses were then performed respectively on (a) the effect sizes of 
cognitive performance and educational attainment and (b) the effect sizes of cognitive 
performance and household income. (4) Network of interest. This method has been 
validated in various previous studies as well as in the protocol paper for UK Biobank 
imaging project (Reineberg et al. 2015; Miller et al. 2016). 
The associations between brain connections and cognitive performance, educational 
attainment, and household income were tested by separate models using the linear 
GLM function in R (https://stat.ethz.ch/R-manual/R-devel/library/stats/html/glm.html). 
Each trait was set as the independent variable in their individual models, and the 
connectivity matrix (high/low-resolution matrices, 55*55 for whole-brain analysis and 
the selected networks in 21*21 matrix for network-of-interest analysis) was set as the 
dependent variable. All of the models were adjusted for age, age2, and sex. 
False Discovery Rate (FDR) (Benjamini et al. 1995) correction was applied over each 
set of test over the whole brain as a unit (Ntest=1,485 for 55*55 matrix, Ntest=16 for 
connections of bulk networks) using the p.adjust function in R setting q<0.05 for 
significance level (https://stat.ethz.ch/R-manual/R-
devel/library/stats/html/p.adjust.html). All β-values reported in the results are 
standardized effect sizes. 
 
2.4 Results 
Whole-brain test of the association of cognitive performance with functional 
connectivity 
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A group-ICA was applied to parcellate the whole brain into 55 components, and the 
pair-wise functional connectivity between the components was estimated using 
FSLnets (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLNets). The 55*55 partial correlation 
matrix was used for whole-brain analysis. To enable clearer interpretation of the 
results, the values of the connections were transformed into connection strength(Smith 
et al. 2015). 
 
Figure 1. (A) Connections that showed significant associations with cognitive performance. The 
ICA components were clustered into five categories according to the group-mean full correlation 
matrix for better illustration and interpretation of the results. This clustering gives a data-driven, 
gross overview of the structure of the components, consistent with previous studies (ref 26 and 
30). The clusters roughly represent the resting state networks (RSNs) of: default mode network 
(red), extended default mode network and cingulo-opercular network (purple), executive control 
and attention network (green), visual network (blue) and sensorimotor network (orange). Red 
lines are the connections where strength was positively associated with cognitive performance; 
blue lines denote negative associations with cognitive performance. The width of lines indicates 
the effect sizes of the associations between connection strength and cognitive performance 
(bigger width indicates a larger absolute effect size). The significant connections were mostly 
involved in the categories of default mode network, executive control/attention network and 
cingulo-opercular network. (B) The spatial map of regions involved with connections in (A). The 
spatial maps for the ICA nodes that involved in the significant connections were multiplied by 
their effect sizes, then the spatial map in (B) was generated by summing up the weighted maps. 
To better illustrate the regions involving in significant connections, a threshold of 50% of the 
highest intensity was applied, so the regions with intensity higher than the threshold would show 
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on the map. 
 
Better performance in VNR was significantly associated with 26 connections (absolute 
β ranged from 0.054 to 0.097, all pcorrected<0.05, puncorrected<6.73×10-4, see 
Supplementary Table S1). These include 18 connections that showed higher strength 
with higher VNR, and 8 connections that had lower strength of connection in people 
with higher VNR (Supplementary Table S1). The 18 connections largely involved the 
DMN, which includes bilateral posterior cingulate cortex (PCC), bilateral medial 
prefrontal cortex (PFC) and right temporal-parietal junction (TPJ), see Figure 1. 
Additional areas of right inferior PFC, dorsal anterior cingulate cortex (ACC) bilateral 
anterior insula and visual cortex were also involved. The connections that were weaker 
with better cognitive performance included bilateral lateral postcentral gyrus and 
superior ACC (Figure 1). 
We then conducted permutation test on an updated sample of unrelated people 
(N=7,749). Half-sized samples (N=3,572) were selected and tested the distributions of 
the p values for the significant connections found in our initial findings. After 1,000 
times of randomly selecting half of our sample, conducting analyses on them, and then 
compared the distributions of p values for the significant connections with the p values 
for the rest of connections (see supplementary materials). Two connections’ p values 
were higher (t>6.95, p<6.62×10-12), and all others’ were lower, which takes up 92.3% of 
the connections that were significant in the initial findings (all t ranged from -1076.88 to 
-2.21, all p<0.028, see in Appendix 4: Figure S7). 
Whole-brain tests on the association of educational attainment and household 
income with functional connectivity 
There were 33 connections that showed significant associations with educational 
attainment (absolute β ranged from 0.103 to 0.161, all pcorrected<0.05, 
puncorrected<8.53×10-4 see Supplementary Table S2). Of these, the strength of 21 
connections was stronger with higher educational attainment, whereas 12 were 
weaker. The regions involved in connections that were stronger with better educational 
attainment included regions in DMN and dlPFC. A large area of ACC was also 
involved. Connections that were weaker with higher educational attainment were 
located in the Inferior part of PCC and lingual gyrus (Figure 2). 




Figure 2. The connections that showed significant associations with educational attainment and household income. Red lines are the connections of 
which the strength was positively associated with cognitive performance, and the blue lines are the ones having negative associations. The width of 
lines indicates the effect sizes of the strength of the connections, see the legend of Figure 1. The categorisation of components of brain regions in the 
circular brain network illustration is identical with Figure 1. Again like Figure 1, A threshold of 50% of the highest value was applied for better illustration 
of the projection of brain regions on MNI template. 




For household income, 15 connections were significant, 11 of which were stronger with 
higher household income and 4 showed weaker connections (absolute β ranged from 
0.060 to 0.082, all pcorrected<0.05, puncorrected<4.27×10-4 Appendix 4: Table S3). The 
regions of the connections that were stronger for higher household income again fell in 
similar regions as in tests of educational attainment and cognitive performance, which 
included PCC, medial PFC, ventral lateral PFC and dorsal lateral PFC (Figure 2). The 
areas that showed weaker connections for higher household income were smaller, 
which mainly included superior temporal lobe. Full lists of regions for the above results 
are presented in Table S4. 
The spatial maps for the results of cognitive performance in VNR, educational 
attainment, and household income overlapped substantially (Figures 2 and 3). By 
performing correlation analysis at the standardized effect sizes of the whole brain (see 
Methods, Statistical methods), we found a correlation of r=0.47 (df=1,483, p<2Χ10-16) 
between the global effect sizes for cognitive performance and educational attainment. 
The correlation between the effect sizes of cognitive performance and household 
income was r=0.38 (df=1,483, p<2Χ10-16) (Figure 3). 
Similar to the permutation test performed on VNR, the distributions of p values for 
93.3% of the significant connections found in for educational attainment were lower 
than the mean p value for the rest of connections (all t ranged from -1429.77 to 11.54, 
all p<4.22×10-4, Figure S8) and all for household income were lower (all t ranged from -
704.07 to -5.49, all p<4.97×10-8, see Appendix 4: Figure S9). 




Figure 3. Correlations of the effect sizes of (A) cognitive performance and educational 
attainment and (B) cognitive performance and household income on whole-brain connections 
using 55*55 partial correlation matrix as the proxy. Regression line with 95% confident intervals 
(shaded) are shown. 
 
Network-of-interest (NOI) test on VNR, educational attainment, and household 
income  
The whole-brain tests showed that the connections associated with cognitive 
performance in VNR, educational attainment and household income were 
predominantly located within the DMN (covering medial PFC, PCC and TPJ), cingulo-
opecular network (CON, covering ventral lateral PFC, and dorsal ACC) and 
frontoparietal network (FPN, covering dorsal lateral PFC and posterior parietal cortex). 
Therefore, DMN, CON, and FPN were selected as NOI from another group-ICA of 
lower resolution so these networks could be fully extracted (see Methods). The 
pairwise between-network coupling of these five networks (DMN was unilateral, and 
CON and FPN were separately extracted on each hemisphere) were tested to 
determine their association with cognitive performance, educational attainment, and/or 
household income. The above components can be viewed in Figure S2. The valence 
and values for the coupling of the above NOI were shown in Table 1. Similar with the 
analyses at whole-brain connectivity, the values of the connections were transformed 
into coupling strength before they were fed into the model. 
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There were 8 coupling between functional networks significantly associated with VNR 
performance out of 10 connections tested (all pcorrected<0.05, puncorrected<0.035. βreported 
below). For educational attainment, 3 connections were significant, and none was 
found significantly associated with household income.  
For the coupling between DMN and networks involving with lateral PFC, better VNR 
performance was associated with stronger positive connections between DMN and 
bilateral CON (stronger positive connection between DMN and left CON: β=0.061, 
pcorrected=6.7Χ10-3; weaker negative connection of DMN with right CON: β=-0.045, 
pcorrected=0.011).  
On the other hand, greater strength of coupling within the networks involving with 
lateral PFC was significantly associated with better cognitive performance. Stronger 
positive CON-FPN connection was also associated with higher VNR score. In the same 
hemisphere, people with better cognitive performance showed stronger positive CON-
FPN connections (left CON-left FPN: β=0.044, pcorrected=0.011; right CON-right FPN: 
β=0.051, pcorrected=0.005), whilst across hemispheres, stronger negative CON-FPN 
connections were higher (left CON-right FPN: β=0.034, pcorrected=0.044; right CON-left 
FPN: β=0.043, pcorrected=0.011). Finally, higher VNR scores were associated with 
weaker cross-hemisphere connections between the homotopic network components 
(left-right FPN: β=-0.040, pcorrected=0.018. left-right CON: β=-0.063, pcorrected=6.7Χ10-4). 
The above results are presented in Table 1 and Appendix 4: Figure S3. 
Educational attainment and household income had generally smaller associations with 
network coupling, and fewer significant connections were found. People with higher 
educational attainment showed a stronger positive connection between DMN and right 
FPN (β=0.104, pcorrected=0.004) and lower positive connection between DMN and right 
CON (β=-0.149, pcorrected=1.99Χ10-5). A stronger positive connection between right FPN 
and CON was associated with better educational attainment (β=0.086, 
pcorrected=6.24Χ10-3). No significant association between household income and the 
coupling of networks was found (all pcorrected>0.124). 
For the connections that were significant for both cognitive performance and 
educational attainment, we performed mediation analysis using Lavaan in R to test 
whether the effect between educational attainment and bulk network connections were 
mediated by cognitive performance (Appendix 4: Figure S6). Network connectivity was 
set as the predictor, and cognitive performance as the dependent variable. Educational 
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attainment was specified as the mediator. We found that the association between 
rFPN-rCON and rCON-DMN connectivity and educational attainment was mediated by 
cognitive performance (18.4% and 76.2% of direct path mediated by indirect path 
respectively for each model, CFI = TLI = 1, see Appendix 4: Figure S6). 
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Table 1. The significant associations between the connections of networks of interest and cognitive performance (verbal-numerical reasoning) 
and educational attainment. The values of connections were transformed into strength before conducting the analyses, by multiplying the 
connection values with the signs of their means. This approach was consistent with ref 28. Mean values and their 95% confident intervals of 




Type Connections Beta 
Standard 
error 
t.value p pcorrected 
Mean value of 
connection 
95% confident interval of 
value of connection 
inter-
hemisphere 
left FPN - right FPN -0.040 0.016 -2.493 1.27E-02 0.018 1.156 1.127 1.185 
right CON - left CON -0.063 0.016 -3.923 8.89E-05 6.67E-04 0.379 0.356 0.402 
          
CON - FPN 
left CON - right FPN 0.034 0.016 -2.106 3.52E-02 0.044 -1.359 -1.387 -1.330 
right CON - left FPN 0.043 0.016 -2.714 6.68E-03 0.011 -2.088 -2.122 -2.054 
left CON - left FPN 0.044 0.016 2.732 6.33E-03 0.011 1.043 1.018 1.067 
right CON - right FPN 0.051 0.016 3.200 1.38E-03 0.005 0.648 0.620 0.676 
          
DMN-related 
left CON - DMN 0.061 0.016 3.824 1.33E-04 6.67E-04 0.675 0.652 0.698 
right CON - DMN -0.045 0.016 2.797 5.18E-03 0.011 -0.275 -0.300 -0.250 
          
Educational attainment 
Type Connections Beta 
Standard 
error 
t.value p pcorrected 
Mean value of 
connection 
95% CI of value of 
connection 
CON - FPN right CON - right FPN 0.086 0.031 2.736 6.24E-03 0.021 0.648 0.620 0.676 
          
DMN-related 
right FPN - DMN 0.104 0.031 -3.335 8.59E-04 0.004 -0.710 -0.738 -0.682 
right CON - DMN -0.149 0.031 4.761 1.99E-06 1.99E-05 -0.275 -0.300 -0.250 




In the present study, we utilized a large population-based sample of ~4,000 
participants and found that strength of connections involved with DMN regions, anterior 
insula, dorsal lateral prefrontal cortex in FPN and inferior frontal gyrus in CON were 
positively associated with performance in a verbal-numerical reasoning test. The brain 
regions associated with cognitive performance also overlapped with those related to 
educational attainment and household income. These above results were validated in a 
bigger updated sample of N>7,000 people. For cognitive performance in particular, 
better cognitive functioning was marked by a more strongly positive DMN-CON 
connection, weaker cross-hemisphere connections of the left-right CON and left-right 
FPN, and stronger CON-FPN connections. 
We used a large sample and provided evidence that, in addition to the broadly 
suggested idea of lateral PFC, which involves dorsal lateral prefrontal cortex in FPN 
and inferior frontal gyrus in CON, playing a crucial role in cognitive processing, DMN 
was also associated with cognitive performance (β of connections positively associated 
with cognitive ability ranged from 0.054 to 0.097) (Bunge et al. 2005; Kievit et al. 2014; 
Parr et al. 2015). Previous studies showed that DMN serves as a hub for the whole 
brain (Raichle 2015). In comparison with other functional networks, DMN showed a 
higher metabolic rate in resting-state (Raichle et al. 2001), stronger connections with 
the rest of the whole brain in both task-free and task-engaging situations (Buckner et 
al. 2009), and a key role in maintaining basic levels of wakefulness/alertness in the 
brain (Sämann et al. 2011). Higher efficiency within the DMN was reported to be 
associated with various cognitive functions, including memory (Shapira-Lichter et al. 
2013), theory of mind (Spreng and Grady 2010), working memory (Sambataro et al. 
2010), and performance in general intelligence tests (van den Heuvel et al. 2009). The 
high-level cognitive abilities mentioned above often involve the activity of multiple, 
spatially distant brain regions (Corbetta et al. 2008; Shapira-Lichter et al. 2013). 
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Therefore the DMN, as a communicative hub, contributes to functional efficiency over 
the whole brain (van den Heuvel et al. 2009), potentially producing better integration 
and cooperation in core regions that are important for cognitive tasks.  
Additionally, the present study tested the coupling between networks of interest. 
Stronger positive DMN-CON coupling was associated with better cognitive ability 
(absolute β>0.045). In addition to the well-recognised task-positive lateral prefrontal 
cortex (therefore anti-correlated with the DMN), our findings in this large single-scanner 
sample lend substantial credence to increasing evidence that the CON itself (Fox et al. 
2006; Vossel et al. 2014), and its positive coupling with the DMN in both resting-state 
(Anticevic et al. 2012) and event-related studies (Bluhm et al. 2011)) is highly pertinent 
for important aspects of cognitive performance. The role of the CON was related to 
maintaining task-engaging status (Fox et al. 2006; Petersen and Posner 2012) and 
flexibly switching between the DMN and central executive network based on 
experimental context (Cocchi et al. 2013; Goulden et al. 2014). The experimental 
context in which CON and DMN were found to be simultaneously activated was often 
about goal-directed cognition (Cocchi et al. 2013), which involves self-driven retrieval of 
memory or learned experience and self-regulatory planning (Spreng et al. 2010). As 
the DMN is associated with self-referential processing (Raichle 2015) and self-driven 
cognition like retrieval of personal experience (Kamourieh et al. 2015) and planning 
(Spreng et al. 2010; Gerlach et al. 2011), positive coupling of the CON and DMN may 
indicate recruitment of self-referential and goal-oriented activity. Therefore successful 
DMN-CON coupling may be useful in maintaining internal mechanisms that support 
cognitive processing and long-term learning (Cocchi et al. 2013).  
The connections between networks involving lateral PFC showed that better cognitive 
performance was associated with stronger CON-FPN connections (absolute β>0.034). 
This result is consistent with previous structural and functional findings that support the 
key role of prefrontal areas on cognitive performance (Higgins et al. 2007; Kievit et al. 
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2014). We also found that better cognitive performance was related to between-
hemisphere dissociation within networks (absolute β>0.040). Whereas this is the first 
time to our knowledge that this has been examined in a study of a large sample, such 
reduced structural connection between the left and right lateral PFC has been 
observed in schizophrenic patients with impaired cognitive performance(Wheeler et al. 
2014). More lateralization of the brain is associated with better cognitive performance 
(Toga and Thompson 2003; Gotts et al. 2013), whereas, less lateralization, especially 
in prefrontal cortex, is related with reduced specialization of brain functions across 
hemispheres, therefore the advantageous anti-correlated connection we report here 
potentially denotes increased brain efficiency (Toga and Thompson 2003; Hyodo et al. 
2016).  
The whole-brain connection map for cognitive performance overlaps substantially with 
those from educational attainment and household income. Further analyses showed 
that there were global correlations of cognitive ability with educational attainment 
(r=0.47) and with household income (r=0.38). GWAS studies found that cognitive 
performance and educational attainment share a similar genetic architecture (r=0.906) 
(Marioni et al. 2014; Hagenaars et al. 2016). There was, in particular, an overlapping 
finding for educational attainment and cognitive performance in rFPN-rCON 
connection, and rCON-DMN connection. We found that cognitive performance 
significant mediated the association between NOI connectivity and educational 
attainment (Figure S6). The right-hemisphere connection for the two prefrontal 
networks (FPN and CON) may therefore reveal the association between education and 
executive control abilities, which was shows consistently associated with right lateral 
prefrontal cortex (Mohr et al. 2016). Early life intelligence (relatively stable across the 
life-course (Deary et al. 2012; Deary 2014)) and educational attainment show partially 
overlapping associations with some structural brain measures in older age (Cox, 
Dickie, et al. 2016). Taken together, one interpretation of these data is that the 
functional hallmarks of a more ‘intelligent’ and better-educated brain are related to 
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income by virtue of these temporally preceding factors. It could equally be the case that 
income confers additional lifestyle benefits that also influence these cerebral 
characteristics; the causal direction that gives rise to the highly overlapping functional 
connectivity reported here would be more adequately addressed with longitudinal multi-
modal data. 
A limitation for the current study is that the verbal-numerical reasoning test, as a brief 
measure, may not confer the same level of reflection on general cognitive ability as 
other longer, in depth general cognitive measures. The test-retest reliability was 
moderate, mainly because rather than the usual short time period between test and 
retest, this was performed in UK Biobank between 2-5 years which may contribute to 
the relatively low value. However, as previous studies found that verbal-numerical 
reasoning shared significant genetic and phenotypic correlation with the latent 
component of general cognitive performance (Davies et al. 2016; Hagenaars et al. 
2016), it therefore confers adequate representativeness of general cognitive ability. 
Another limitation is that the sample covers an older age range, and there is potential 
bias to healthy, better-educated people. A notable strength of the present study is that 
we used a large sample, providing compelling evidence that both dorsal prefrontal 
areas and DMN were associated with cognitive ability, educational attainment and 
household income. To disentangle how multiple networks involved in the cognitive 
ability, we examined functional connectivity by estimating connections between brain 
components derived in two different resolutions, giving us another strength of studying 
both the connections over the whole brain and the connections of bulk intrinsic 
functional networks within a single dataset. Finally, in addition to visual checking of 
overlapping regions of the significant connections, we statistically compared the 
functional connectivity associated with cognitive ability, educational attainment and 
household income over the whole brain, giving a magnitude of neural associations 
among them.  




The present study used a large, population-based sample, who provided multi-
dimensional rs-fMRI data, and found substantial evidence for functional neural 
associations cognitive ability (verbal-numerical reasoning) both in whole-brain 
dynamics and the coupling for intrinsic functional networks. The findings also 
characterized the degree of rs-fMRI overlap between cognitive ability and educational 
and socioeconomic level, providing evidence of the overlapping biological associations 
on the neurological level. 
 
 
3 Chapter conclusion 
The main finding of the study is the huge neurobiological overlap across cognition, 
educational attainment, and household income. The big sample also allowed further 
permutation tests validated the results in the updated data that contained a different set 
of 4,000 people. The results showed the importance of both the central executive 
system and the default mode network. 
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Chapter 6: Discussion 
The present thesis investigated the relationship between neurobiological traits and 
MDD in four aspects: MDD case-control differences, neurobiological associations with 
longitudinal depressive symptoms, with polygenic risk for depression (in association 
with other wider traits), and with depression related traits (such as cognition). Very 
large samples from the on-going UK Biobank imaging project were used (initially n= 
5,000, then 12,000 people with further releases of data). 
1 Summary of main findings in the present thesis 
1.1 white matter microstructure in thalamic radiations is a key marker for MDD 
One of the main findings in this thesis was the repeated implication of thalamic 
connections in association with MDD. The thesis found lower general FA in thalamic 
radiations in a large sample of MDD cases compared with controls in chapter 2. 
Higher general MD in thalamic radiations was associated with greater variability of 
depressive symptoms, a steeper slope of worsening trajectory of depressive 
conditions in chapter 3, and higher polygenic risk of depression in chapter 4. There 
was a significant mediation effect of general MD in thalamic radiations between 
depression polygenic risk and subjective well-being, and the number of psychiatric 
conditions diagnosed.  
The thalamus is directly associated with negative emotional processing and decision 
making in goal-directed context and is an important part of the wider limbic system. 
Compared with other subcortical regions, the thalamus has its special role, because 
it is highly associated with various behavioural patterns that show robust relations to 
depression. For example, the thalamus is a key region that is sensitive to sleep and 
causally mediates the effect of sleep deprivation to the activity in anatomically 
downstream regions like the brainstem (Krause et al. 2017), and the firing activities of 
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the region is correlated with the transition of sleep phases (Gent et al. 2018). It is also 
highly associated with wakefulness and consciousness (Krause et al. 2017). It is a 
main amplifier of pain (Fischer and Waxman 2010) and highly associated with various 
of addictions (Sullivan et al. 2003; Almeida et al. 2008; James and Dayas 2013).  
One reason why it is so broadly associated with various complex traits relevant to 
depression originates back to its anatomic position as a hub. Thalamus is located at 
the top of the brainstem, with axons generating from dorsal thalamus to amygdala, 
striatum and hippocampus, and a rich amount of fibres projecting from thalamus to 
the anterior, superior and posterior cerebral cortex (Sullivan et al. 2003). The special 
location of the thalamus makes it a hub of the limbic system and the bridge from the 
limbic system to the cortex, especially to prefrontal cortex where emotion regulation 
is involved. Depression is a complex trait, with additive effects contributed by 
abnormal brain cognitive and emotional processes, disrupted HPA-axis activity, 
genetic risks, and various interacting effects from the environment such as traumas, 
parenting styles and lack of education and social support. The impacts of these wide 
ranges of complex and possibly antagonistic factors being associated with thalamus 
and thalamocortical connection, the so-called ‘grand incoming station’ which bears 
the additive effects from the global interactions in the brain, is therefore not completely 
unexpected. The absence of associations of depression with other brain 
regions/connections may due to the counterbalancing effect of various factors that 
contribute to depression, or even subtypes of depression of which the neurobiological 
associations may possibly show opposite effects (Kohler et al. 2010). The important 
role of thalamic radiations being found is largely due to the generous sample sizes, 
which not only allow for heterogeneity, as a big sample is able to cover a large range 
of population-based cases, and the heterogeneity can be overcome by statistic power, 
and therefore the most consistent neurobiological associations with depression can 
be found.  
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1.2 White matter microstructural alterations were associated with not just 
current symptoms, but also cross-sectional symptomology such as variability, 
mean depressive level and longitudinal trajectory, as well as polygenic risk 
Various traits have been tested, including case-control difference, variability and 
longitudinal progression of depression, as well as polygenic risk. Although these traits 
are self-correlated, they differ in which white matter tracts are associated with. Here 
the insights of neurobiological heterogeneity of different depression-related traits are 
summarised. 
First, the largest amount of significant findings were found in the associations between 
white matter microstructure, measured by mean diffusivity (MD), and depressive 
symptoms at the imaging assessment, rather than cross-sectional and lifetime traits. 
Many studies have found white matter microstructural changes related to current 
depressive symptoms, however, comparing cross-sectional and longitudinal 
measures is rare. The reason why we found the largest scale of associations in MD 
may due to that this measure is sensitive to myelination. This notion was supported 
by NODDI findings in chapter 3, where ICVF showed a similarly large scale of 
associations with current depressive symptoms. ICVF is a measure of neurite density, 
highly correlated with myelin development. These indicate that (1) current symptom 
is an unneglectable contributor to white matter microstructural variation, and (2) it is 
important to consider variations of depressive symptoms assessed at different 
occasions, which can potentially contribute to heterogeneity or different levels of 
severity. 
Second, white matter microstructure in MD can be associated with lifetime and cross-
sectional measures of depression or depressive symptoms. Although current 
symptoms of depression showed the association with white matter structure in the 
largest number of tracts, white matter microstructure did not associate with temporal 
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depressive status only. Along with the findings from a recent GWAS study on UK 
Biobank imaging phenotypes, revealing that white matter probabilistic tractography 
has a high heritability of around 20-60% (Bycroft et al. 2017a), these together indicate 
that there is a potential of looking for genetic overlap between psychiatric traits and 
brain imaging phenotypes. 
1.3 Novel associations found between polygenic risk of depression and 
resting-state connectivity 
Resting-state connectivity has been believed to be a more transient measure of the 
brain’s network. However, recent findings suggest that some resting-state connectivity 
and slow-frequency amplitude of the blood-oxygen-level dependent (BOLD) signal 
can have significant heritability, comparable to that of structural measures like white 
matter microstructure and subcortical volumes (Bycroft et al. 2017a). The 
unexpectedly high heritability is likely due to the discrepancy between the former 
understanding of the flexibility of BOLD signal and what temporal correlations of the 
BOLD signal in resting state actually mean in terms of its neurobiological basis. 
Studies suggest that functional connectivity, especially in important networks such as 
the default mode, salience and executive control networks, is formed by joint efforts 
from white matter linkage and a shared metabolic mechanism (Greicius et al. 2009; 
Bero et al. 2011). For instance, Bero et al. found that a protein called amyloid β may 
be the by-product of the metabolic activities in the default mode network, as the 
activity of the network showed a causal impact on its concentration (Bero et al. 2011). 
Another study by Hahn et al. showed that serotonin-1A receptors explained a 
significant amount of individual variability of the synchronised activity in the default 
mode network (Hahn et al. 2012). These indicate that resting-state connectivity is not 
merely an external outcome of white matter structures, but rather a different set of 
measures, of which the biological mechanism is yet to be disentangled. 
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The difference between white matter microstructure and resting-state connectivity is 
also shown in our results. Decreased white matter microstructural integrity was in 
general associated with higher polygenic risk of depression. However, there are 
several regions where hyperconnectivity on resting state is associated with higher 
polygenic risk. One important finding is that the hyper-connectivity in default mode 
network was found associated with higher polygenic risk for depression. This is 
consistent with previous studies that found depressive patients showed hyperactivity 
or stronger connectivity within the default mode network. The connectivity in the 
default mode network has a potentially non-linear relationship with cognitive 
performance and mental health. Lack of activity in the work has been found 
associated with reduced wakefulness and global connectivity (Greicius et al. 2008; 
Krause et al. 2017), whereas extensive strength or duration of the activity in the 
default mode network may cause a higher concentration of interstitial fluid amyloid-β 
which is associated with atrophy (Bero et al. 2011). More studies on the causes of 
individual differences in resting-state network are needed for a clearer conclusion. 
1.4 Depression is likely to be mainly a “connectome-driven” disorder 
Schmaal et al. using ENIGMA data found that the largest difference between MDD 
cases versus controls was shown in the volume of hippocampus (Schmaal et al. 2016). 
However, in our findings, associations for subcortical volumes were absent for all 
depression-related measures, including current symptoms and cross-sectional 
depressive symptoms. This may due to a relatively older age range (age ranged from 
40 to 75 years). In other studies that recruited middle-aged participants, they also 
found that subcortical volumetric differences were null (see Discussion in Chapter 2). 
Despite that the results are different in subcortical differences between ENIGMA and 
UK Biobank, structural and functional connectivity showed much larger effect sizes 
compared to subcortical volumes. Associations presented in white matter 
microstructure and resting-state connectivity for various depression-related traits in 
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UK Biobank have Cohen’s d at around 0.23, and standardised regression coefficients 
were around 0.025 to 0.036. The Cohen’s d found for subcortical volumes in the 
ENIGMA sample was 0.15 for the only significant MDD case-control difference shown 
in the hippocampus (Schmaal et al. 2016). An alternative explanation for the different 
effect sizes could be that ENIGMA in generally still has larger samples compared to 
UK Biobank imaging project, therefore the effect sizes derived from UK Biobank 
imaging data may be comparatively inflated. However, according to our findings 
employing from the first release of around 5,000 people to the latest release of around 
12,000 people, the regression coefficients for significant linear associations stably 
remained around 0.025 to 0.03, regardless of the changes of the sample structure 
and changes in the standard deviations. If the effect sizes estimated by UK Biobank 
imaging project was inflated, it is more likely to observe large variations between 
sample releases, which is contradictory with what we found. Hence, there could be a 
truly larger association of depression with functional/structural connectivity than with 
subcortical volumes. However, a more definite conclusion should be drawn based on 
a replication study when UK Biobank collected similar-sized sample to ENIGMA, or 
that ENIGMA or other large cohorts reveal similar advantageous correlation of 
depression with structural connectivity.  
Another contribution from the studies in the present thesis is that they give a robust 
estimation of effect sizes for the associations between functional/structural 
connectivity and depressive symptoms in a population-based sample. Large variance 
explained can be achieved due to sample bias, chance, or a combination of both 
(Wray et al. 2013). The effect sizes estimated in the present thesis using very large 
cohort data therefore to provide tools for power estimation of new studies for which 
the sample size needs to be pre-defined.  
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2 Limitations and indications of future work 
One limitation for most of the phenotypic studies conducted in the present thesis is 
the depth of phenotyping. MDD definitions and depressive symptoms were assessed 
mainly based on self-reported questionnaires, which are in general shorter than other 
studies (e.g. PHQ-4 instead of PHQ-9 used for self-assessment of depression in the 
National Health Service of the UK, and broad definition of depression was acquired 
based on a simple self-declaration of whether had depression or not). Cognitive 
performance in verbal-numeric reasoning was assessed using a brief questionnaire 
consisting of 12 questions. The rationale is that the depth of phenotyping and the 
scale of phenotypes/sample sizes are two counterbalancing factors. A reasonable 
balance between the two should be able to allow for a large sample to be collected, 
therefore to overcome the noise introduced by the coarseness of phenotypes, as long 
as the phenotypes show acceptable agreement with traditional assessments. 
Acceptably rough phenotyping, though the depth was compromised to some extent, 
allows for more space to fit in more assessments so that data-driven association tests 
as in the PheWAS in chapter 4 can be conducted. It means that it is possible to have 
a large scale of people assessed, especially for longitudinal assessments, which is 
important for heterogeneous conditions such as depression. Thus, the main concern 
for the UK Biobank-style phenotypes is whether they deliver a good estimation of traits 
of interest, in comparison with traditional phenotypes collected in small-sample 
studies. The answer to this question is affirmative. Genetic correlation between self-
declared depression and clinically defined MDD showed a very high correlation with 
a rg=0.79 (Howard, Adams, Shirali, et al. 2018), and the brief assessment of 
depressive symptoms from PHQ-4 showed very high correlation with the full 
questionnaire PHQ-9 with an AUC (area under the curve) at 0.8 (Khubchandani et al. 
2016). 
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Sample selection in UK Biobank has been recently discussed and identified as a 
limitation. The age range did not cover adolescence and early adulthood since the 
study was conceived to investigate neurodegenerative disorders. UK Biobank 
participants typically have higher household income and are relatively better educated 
compared to the overall UK population. The selection bias is a limitation that needs to 
be acknowledged and taken into account when interpretations are made. This bias 
could also be part of the reason for observing the non-conventional prevalence of 
depression in our sample. Although big data is a cutting-edge trend in the recent 
academic world, some carefully balanced studies with very specific hypothesis would 
be extremely helpful for confirming the findings that came from big samples. Having 
acknowledged this, the opinion of this thesis is that UK Biobank imaging project, as 
one of the largest neuroimaging projects so far, and is still on-going, has the 
advantages of very large sample size which still deserves to be appreciated over the 
potential impact of sample biases.  
Another limitation is that larger sample sizes are still needed for studies regarding 
genetic overlaps between psychiatric illness and neuroimaging phenotypes. Even 
though over ten thousand people with both in-depth genotyping and neuroimaging 
phenotyping was un-thinkable within a decade ago, now the hope is given by very 
large cohorts like UK Biobank, ENIGMA, Human Connectome Project and some new 
cohorts like the Adolescent Brain Cognitive Development Study. Though it is 
encouraging to have these large samples, an increase of sample size is still needed 
for other analyses such as GWAS and Mendelian Randomisation. Especially for 
Mendelian Randomisation, which is an important tool for making causative inferences, 
having reliable genetic associations utilising well-powered samples is the primary 
requirement for conducting such analyses. Enlarging sample sizes by including 
independent cohorts may also allow us to conduct replication studies, of which the 
importance has been much more acknowledged in genetic fields, but yet to be more 
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appreciated in the cross-discipline field that looks at the associations between 
genetics, neuroimaging and psychiatry. 
In the present thesis, medication information has been used to rule out medication 
effects on the brain. However, medication usage in UK Biobank largely relies on self-
reported information. Future possibilities of data linkage between UK Biobank 
participants and health care services may be able to provide in-depth information that 
aid analyses of drug effect on the brain and drug efficiency in MDD population. 
The fifth limitation is that the neuroimaging phenotypes used in the thesis are bulk 
illustrations, and more detailed phenotypes such as voxel-wise measures and graph-
theory measures may be able to reveal some other biologically meaningful results, 
and they may potentially have a much higher spatial resolution. However, this does 
not necessarily mean that the bulk measures used in the thesis are inferior compared 
to voxel-wise measures. The latter may include more noise introduced by pre-
processing steps and may likely to survive at a higher chance. 
The findings from the thesis demonstrate the benefits of large sample sizes, 
particularly for such a heterogeneous condition like MDD. These studies are 
beginning to suggest reliable deficits associated with MDD condition in 
thalamocortical connections and resting-state connectivity in the disorder. Taking 
these findings further, in terms of future work, the current studies could be used to 
guide further focussed studies on younger individuals. For example, large cohorts 
such as the Adolescent Brain Cognitive Development study could provide the 
opportunity to determine whether the neuroimaging differences associated with adult 
MDD are apparent earlier in life and whether there are any mechanisms that could 
lead to discoveries of potential early interventions and preventions.  
One important future direction may be using the biomarkers found in the present 
studies, combining machine learning methods to predict MDD status and classify 
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MDD cases. So far, in the present thesis, key biomarkers have been primarily 
identified as whole-genome polygenic risk, white matter microstructure in thalamic 
radiations and superior longitudinal fasciculus, resting-state connectivity in the 
default-mode network and behavioural patterns that associate with HPA-axis activity. 
The relationships between these biomarkers – whether they share a common latent 
component that drives the MDD case-control differences, whether they each provide 
an additive risk of having MDD, and whether these factors have significant interactions 
within themselves – remain largely unknown. After more empirical evidence has been 
provided based on large samples that help disentangle the MDD-related phenotypes, 
future studies should use these biomarkers to identify subtypes of MDD and related 
drug response of the identified subgroups. Successful attempts may largely benefit 
prediction of clinical outcomes, therefore lead to more efficient diagnoses and 
treatments. 
Finally, several questions relating to the biological mechanism of individual differences 
of brain structure and functions have been raised from the findings from the present 
thesis. Firstly, how much genetic effect of common genetic variants may have on brain 
phenotypes, especially the ones that are associated with MDD, is an imminent 
question that should be soon investigated. The recently released genetic and 
neuroimaging data from ENIGMA and UK Biobank may allow for genetic association 
studies to be conducted on brain phenotypes. Studies using these up-to-date datasets 
have shown that some brain phenotypes have very high SNP heritability up to 80% 
(Elliott et al. 2018). However, the earliest attempts were mainly made to investigate at 
a general level about which brain phenotypes are heritable. More sophisticated 
studies on the heritable features of brain phenotypes should be conducted to find out 
the localised genetic effects, especially for the disease-related ones. Secondly, the 
genetic studies on brain phenotypes are restricted to bulk phenotypes, genetic 
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association studies on high spatial resolution data and graph-theory features in 
functional and structural MRI data may possess large potentials in future studies.  
 
3 General conclusions 
MDD poses a major challenge in both genetic and neuroimaging fields, due to its 
clinical and causal heterogeneity, its complex genetic architecture and interactions of 
environmental associations. The small effect sizes reported for both imaging and 
genetic studies suggest a need for better diagnosis and stratification of the disorder. 
However, before any clear stratifying variable is identified, there is a necessity of using 
big samples to give robust findings in relation to the liability of the trait. The findings 
in the present thesis provided evidence of robust neurobiological associations with 
the presence of depression, depressive symptoms and polygenic risk of depression 
in white matter microstructure and resting-state connectivity, indicating a shared 
genetic aetiology of MDD and brain structural/functional connectome. Our findings 
also indicate that neurobiological alterations may be able to explain variances of 
behaviour influenced by the genetic risk, which allow more in-depth inferences 
compared with previous studies finding mere associations. Based on the findings 
presented in the thesis, finding the causal relationship between the brain’s neural 
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MRI data were acquired using a Siemens Skyra 3T scanner running VD13A SP4, 
with a Siemens 32-channel RF receive head coil 
(https://www.healthcare.siemens.com/magnetic-resonance-imaging). The sequence 
for the T1-weighted data was a standard 3D MPRAGE scan (Resolution = 1×1×1 
mm, FoV = 208×256×256 matrix, TR = 2000ms, TE = 2.01ms, Orientation = sagittal, 
in-plane acceleration = 2, Filter = prescan-normalise). The overall duration of T1-
weighted scanning was 5 minutes. For the DTI data, the diffusion preparation was a 
standard (“monopolar”) Stejskal-Tanner pulse sequence (Resolution = 2×2×2 mm, 
FoV = 104×104×72 matrix, TR = 3600ms, TE = 92.00ms, SE-EPI with x3 multislice 
acceleration, in-plane acceleration = off, fat saturation = on). Ten baseline volumes 
were collected (b = 0 s/mm2), with 50 b=1000 s/mm2 and 50 b=2000s/mm2. The 
overall duration was 7 minutes. 
MRI preprocessing 
The MRI preprocessing of both T1-weighted and DTI data were run by UK Biobank 
(https://ww5.aievolution.com/hbm1601/index.cfm?do=abs.viewAbs&abs=3664). 
Images were preprocessed and analysed with the FMRIB Software Library (FSL) 
(http://www.fmrib.ox.ac.uk/fsl). The IDPs from UK Biobank was released in 
September, 2016, which covered more than 8000 participants. 
To prepare the T1-weighted volumes for standard pre-processing procedures, the 
face area was removed to maintain anonymity. Following this, gradient distortion 
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correction was applied for the whole image using BET (Brain Extraction Tool) (Smith 
2002) and FLIRT (FMRIB's Linear Image Registration Tool) (Jenkinson and Smith 
2001; Jenkinson et al. 2002). The brain was non-linearly warped to the MNI152 
"nonlinear 6th generation" standard-space T1-weighted volume template, and the 
brain area of the images was then extracted using FNIRT (FMRIB's Nonlinear 
Image Registration Tool) (Andersson et al. 2007a) for segmentation. Segmentation 
of brain was conducted in two steps: firstly, a tissue-type segmentation using FAST 
(FMRIB's Automated Segmentation Tool) (Zhang et al. 2001) was applied to extract 
cerebrospinal fluid, grey matter and white matter; then subcortical structures are 
extracted using FIRST (FMRIB's Integrated Registration and Segmentation Tool) 
(Patenaude et al. 2011). The volumes of ICV, thalamus, putamen, pallidum, 
hippocampus, caudate, brain stem, amygdala and accumbens were calculated for 
further analysis. 
DTI data was initially corrected by the Eddy tool for eddy currents, head motion 
and outlier-slices (Andersson and Sotiropoulos 2015b), and the following gradient 
distortion correction was applied in the same way as it is applied on T1-weighted 
volumes. The corrected b=1000 s/mm2 shell was then used for modeling whole 
brain water diffusivity biomarkers using DTIFIT, thereby creating the FA (fractional 
anisotropy) maps.  
The DTI data we used was processed by UK biobank using a probabilistic 
tractography based method. FA maps were initially warped to standard space, and 
then the BEDPOSTx tool (Bayesian Estimation of Diffusion Parameters Obtained 
using Sampling Techniques) was used to generate the fibres derived from major 
anatomical seeds (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT/UserGuide). This maps 27 
major tracts (12 bilateral tracts in both hemispheres and 3 tracts that went across 
brain) by utilizing the standard-space start/stop ROI masks defined by AutoPtx (De 
Groot et al. 2013). 




We used lme function in nlme package of R (Bliese 2016) to conduct repeated-effect 
linear model on the structures with bilateral measures, as hemisphere was a within-
subject variable, whereas all other covariates and the variable of interest are 
between-subject variables. The general linear model of unilateral structures was 
conducted using the default glm function of R. Choices of covariates were based on 
the recent meta-analytic studies on big samples of psychiatric illnesses (Schmaal et 
al. 2016; van Erp et al. 2016).  
Participants 
The acquisition and preprocessing were conducted by UK biobank. 5724 
participants finished T1 image acquisition and the scans were preprocessed, while 
4941 participants’ DTI images were acquired and preprocessed. After the outliers 
were excluded, there were 5403 with T1 images and 4594 with DTI images. Outlier 
exclusion was conducted within the overall sample with according imaging data 
available, therefore this step of exclusion is unbiased against the final samples 
which were consisted of only MDD cases and healthy controls. For transparency, 
the results of the main models that tested the effect of MDD definitions, with or 
without excluding outliers, were both presented in the tables below (Table S4, S5, 
S7, S8). Then the participants that had a diagnosis of Parkinson’s disease, bipolar 
disorder, multiple personality disorder, schizophrenia, autism or intellectual disability 
were also excluded.  
After the applying the filters described above, cases and controls for MDD 
definitions were chosen according to their self-reported depressive symptoms and 
hospital admission history (see below in Method, MDD definitions). Details of the 
sample and exclusions were listed in Table S3. 
MDD definitions 
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The putative MDD category summarized by Smith et al. was based on depressive 
symptoms and hospital admission history reported by participants. Self-report 
symptoms included whether they had ever been depressed or had anhedonia, 
whether they experienced a depressive period of over two weeks, and how many 
depressive episodes they had. Hospital admission history was also self-reported by 
answering whether they have seen a GP or psychiatrist for nerves, anxiety, tension or 
depression. As described in Figure S4, people were categorized into four groups: 
single episode major depression, recurrent major depression (moderate), recurrent 
major depression (severe) and absent of depression. These MDD categories were 
tested over phenotypes of lifestyle, demographics, social states, overall health 
condition and emotion disorder related personality. The results showed similar 
patterns with clinical ascertained samples (Smith et al. 2013). The tests were 
conducted in the sample of 172,751 participants of UK Biobank. Though participants 
who had imaging assessments were recruited within this pretested sample, we 
compared neuroticism level between cases and controls in the current, smaller 
sample to validate the MDD definitions we used as below. 
In addition to their MDD categories, we added another category as unspecified group. 
They reported depressive symptoms or relative hospital admission history, but did not 
meet the criteria to be categorized as MDD. They either reported of having had at 
least two weeks duration of low mood or anhedonia, and at least 2 episodes of 
depression, but had not seen a GP/psychiatrist; or reported of having had seen a 
GP/psychiatrist and had at least two weeks duration of low mood or anhedonia, but 
didn't know episodes or duration.  
For the principal definition of MDD, cases included recurrent and single-episode MDD, 
and controls included only those who were identified of being depression absent. For 
the definition of recurrent MDD, cases were only recurrent MDD, whilst the controls 
included the rest of the categories, which included single-episode MDD, depression 
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absent participants and participants who weren’t identified as MDD but self-reported 
of having had depressive symptoms or had hospital admission history of seeing a GP 
or a psychiatrist for nerves, anxiety, depression. See Figure S4. The participants who 
did not respond to any of the questions used as criteria for categorization were 
excluded. 
In the sample with T1-weighted data, MDD cases have significantly higher 
neuroticism level in both principal and recurrent MDD definition, β = 0.678, p < 2e-16; 
β = 0.555, p = 2e-16 respectively. The differences remained the same if age, age2, 
sex were set as covariates, β = 0.600, p < 2e-16; β = 0.480, p = 2.84e-13. 
Comparisons were again conducted within the sample with DTI data. They similarly 
showed that cases were more neurotic than controls in both definitions, with or without 
controlling sex and age, βs = 0.550~0.717, ps < 7.36e-16. The above neuroticism 
scores were calculated using the same method in the prevalence study by Smith et 
al (Smith et al. 2013). 
We tested separately in both MDD definitions on group differences of gender, age 
and level of education between cases and controls. Level of education was coded 
as below: A levels/AS levels = 6, O levels/GCSEs = 5, CSEs = 4, NVQ or HND or 
HNC = 3, Other qualifications =2, No respond/refuse to answer = 1. Gender 
differences were significant in both definitions (χ2probable = 35.43, df = 1, pprobable = 
2.64e-9; χ2recurrent = 4.74, df = 1, precurrent = 0.030 respectively for probable and 
recurrent definition for T1-weighted sample. χ2 probable = 30.90, df = 1, pprobable = 
2.72e-8; χ2 recurrent = 12.90, df = 1, precurrent = 3.29e-4 for DTI sample). Age differences 
were also significant (T1-weighted sample: βprobable = -0.296, pprobable = 1. 57e-6; 
βrecurrent = -0.242, precurrent = 2.57e-4; DTI sample: βprobable = -0.302, pprobable = 3.20e-6; 
βrecurrent = -0.278, precurrent = 6.81e-5). Difference of education level was not significant 
(T1-weighted sample: βprobable = 0.001, pprobable = 0.984; βrecurrent = 0.061, precurrent = 
0.387; DTI sample: βprobable = 0.012, pprobable = 0.861; βrecurrent = 0.063, precurrent = 
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0.387), and the differences were even lower when age and sex were set as 
covariates (ps > 0.369). Many previous meta-analyses included only age and sex as 
covariates, and the recent protocol paper of UKB brain imaging phenotypes stated 
that sex and age could largely influence tests. The above descriptive statistics also 
reassured that the differences of age and sex between cases and controls were 
significant, while education differences were not robustly large. Therefore, we set 
sex, age, age2 and assessment centre as covariates in all the models, whereas 
additional model to test the effect of MDD definitions on FA values included 
education level and number of release as covariates was tested, and the results 
remained the same (Table S10). 
For the findings on the PCA scores on FA, association/commissural fibres, thalamic 
radiations and projection fibres, we similarly checked the effect of self-declare 
depression. Among the DTI-data sample, there were 239 self-declare depression 
cases and 4349 controls. We found that self-declare depression cases showed 
decreased gFA (β=-0.14, p=0.026), gAF (β=-0.14, p=0.032) and gTR (β=-0.17, 
p=0.009). This self-declare status was collected based on a general report of non-
cancer illnesses on data field 20002 of UK Biobank touchscreen-assessment data 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20002). This question was a general 
question to which participants were to recall all non-cancer illnesses that they had, 
and no hospital admission record was considered. Therefore was only used in 
validation tests on the findings of PCA components. 





Figure S1. Sample size change after each step of exclusion. The boxes with grey outline were kept for the next step. For the steps “went 
through UKB preprocess” and “After excluding outliers” , number of participants with imaging data and the numbers of subjects included as a 
case or control in both definitions were stated separately.




Figure S2. Standardised data of subcortical volumes. Each data point represents one person/region. The number of participants excluded as 
outliers was state in Figure S1. The error bars represent +/-3 standard deviation. 
 
  




Figure S3. Standardised data of white matter integrity. Each data point represents one person/region. The number of participants excluded as 
outliers was state in Figure S1. The error bars represent +/-3 standard deviation. 





Figure S4. Principal definition of MDD and the definition of recurrent MDD. The 
categorization of moderate and severe recurrent major depression, single episode 
major depression and depression absent were summarized by Smith et al. (2013). An 
additional group of participants who self-reported of having had depressive 
symptoms or hospital admission history of nerves, anxiety or depression were 
categorized as ‘unspecified’. The principal definition of MDD compared all MDD 
cases with those who were depression absent, and the definition of recurrent MDD 
compared recurrent MDD verses single-episode MDD, participants who were 
depression absent and the unspecified group.
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Table S1. Descriptive statistics of imaging phenotypes. The statistics were concluded 
from the samples with imaging data regardless of MDD definitions (see Figure S1). 
Briefly, the raw T1-weighted data included 5724 people, and there were 5403 
remained after the QC. Raw DTI data included 4941 people, and 4594 remained 




Raw data  Data after QC 
Mean SD  Mean SD 
thalamus (left) 7799.39  752.42   7781.45  709.95  
thalamus (right) 7603.63  728.01   7586.65  689.60  
caudate (left) 3396.74  421.10   3382.02  399.54  
caudate (right) 3573.61  440.54   3555.72  416.01  
putamen (left) 4815.74  604.28   4808.70  567.80  
putamen (right) 4859.38  586.82   4848.13  552.87  
pallidum (left) 1763.60  243.70   1751.53  217.47  
pallidum (right) 1809.15  244.23   1798.13  218.11  
hippocampus (left) 3813.23  474.68   3817.03  438.50  
hippocampus (right) 3925.20  485.96   3926.84  450.72  
amygdala (left) 1277.81  248.99   1273.88  237.74  
amygdala (right) 1246.91  276.44   1243.24  266.44  
accumbens (left) 507.55  120.42   506.79  115.44  
accumbens (right) 402.64  111.31   402.37  107.82  
brain stem 22857.44  2764.28   22772.54  2635.68  




Raw data   Data after QC 
Mean SD   Mean SD 
acoustic radiation (left) 0.423  0.024   0.424  0.022  
acoustic radiation (right) 0.414  0.023   0.415  0.021  
anterior thalamic radiation (left) 0.401  0.020   0.401  0.017  
anterior thalamic radiation (right) 0.393  0.019   0.394  0.017  
cingulate gyrus part of cingulum (left) 0.537  0.036   0.538  0.033  
cingulate gyrus part of cingulum (right) 0.498  0.035   0.499  0.033  
parahippocampal part of cingulum (left) 0.312  0.031   0.315  0.027  
parahippocampal part of cingulum (right) 0.311  0.033   0.314  0.028  
corticospinal tract (left) 0.547  0.025   0.548  0.022  
corticospinal tract (right) 0.541  0.026   0.542  0.022  
forceps major 0.582  0.029   0.583  0.026  
forceps minor 0.466  0.023   0.467  0.020  
inferior fronto occipital fasciculus (left) 0.476  0.025   0.477  0.020  
inferior fronto occipital fasciculus (right) 0.466  0.022   0.467  0.019  
inferior longitudinal fasciculus (left) 0.461  0.022   0.462  0.019  
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inferior longitudinal fasciculus (right) 0.452  0.021   0.453  0.018  
middle cerebellar peduncle 0.477  0.034   0.479  0.030  
medial lemniscus (left) 0.418  0.025   0.419  0.023  
medial lemniscus (right) 0.421  0.025   0.422  0.024  
posterior thalamic radiation (left) 0.458  0.022   0.459  0.020  
posterior thalamic radiation (right) 0.454  0.022   0.456  0.019  
superior longitudinal fasciculus (left) 0.442  0.023   0.443  0.020  
superior longitudinal fasciculus (right) 0.425  0.022   0.426  0.019  
superior thalamic radiation (left) 0.423  0.020   0.424  0.018  
superior thalamic radiation (right) 0.422  0.020   0.423  0.018  
uncinate fasciculus (left) 0.391  0.025   0.392  0.023  
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Table S2. Major depressive disorder criteria summarized by Smith et al. (2013) 
Category Criteria 
Single probable 
episode of major 
depression 
Ever depressed/down for a whole week, plus at least two weeks 
duration, plus only one episode, plus ever seen a GP or a 
psychiatrist for nerves, anxiety, depression. 
OR 
Ever anhedonia (unenthusiasm/uninterest) for a whole week, plus 
at least two weeks, plus only one episode, plus ever seen a GP or 




Ever depressed/down for a whole week, plus at least two weeks 
duration, plus at least two episodes, plus ever seen a GP (but not 
a psychiatrist) for nerves, anxiety, depression 
OR 
Ever anhedonia (unenthusiasm/uninterest) for a whole week, plus 
at least two weeks, plus at least two episodes, plus ever seen a 




Ever depressed/down for a whole week, plus at least two weeks 
duration, plus at least two episodes, plus ever seen a psychiatrist 
for nerves, anxiety, depression 
OR 
Ever anhedonia (unenthusiasm/uninterest) for a whole week, plus 
at least two weeks, plus at least two episodes, plus ever seen a 
psychiatrist for nerves, anxiety, depression 
Depression absent 1. Mood question answered 'no' 
2. Reported symptoms but duration was too short. 
3. Reported symptoms but period was below threshold. 
4. Had not seen GP or psychiatrist and did not self-report 
depression 
Note: Participants needed to meet all four criterion to be categorized as depression absent. 
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Table S3. Demographic features of samples with T1-weighted and DTI data. The 
descriptive statistics below are summarised based on the samples that were 
analysed in the present study (see the final sample size in Figure S1). 
 
Subjects with T1-weighted data: 
 
Subjects with DTI data: 
 Principal MDD definition  Recurrent MDD definition  
 Case Control N Case Control N 
Sample size 354 803 -- 261 1196 -- 
Age (Mean±SD) 54.97±7.38 57.19±7.14 1157 54.99±7.33 56.80±7.21 1457 
Number of Male 123 433 1157 97 593 1457 
Proportion of Male (%) 34.75 53.92 37.16 49.58 
Average Education level 4.74 4.74 1157 4.78 4.69 1157 






A levels/AS levels (%) 13.28 15.82 -- 14.94 15.05 -- 
O levels/GCSEs (%) 18.36 21.30 -- 16.09 21.57 -- 
CSEs (%) 5.93 4.23 -- 6.13 4.68 -- 
NVQ or HND or HNC (%) 5.65 5.48 -- 5.75 5.77 -- 
Other qualifications (%) 5.65 4.61 -- 5.36 4.85 -- 






 Principal MDD definition  Recurrent MDD definition  
 Case Control N Case Control N 
Sample size 335 754 -- 242 1113 -- 
Age (Mean±SD) 54.83±7.40 57.07±7.24 1089 54.63±7.34 56.69±7.24 1355 
Number of Male 119 408 1089 91 563 1355 
Proportion of Male (%) 35.52 54.11 37.60 50.58 
Average Education level 4.74 4.72 1089 4.78 4.69 1355 
College or University degree () 46.27 39.66 -- 47.93 38.90 -- 
A levels/AS levels () 12.84 16.71 -- 14.05 15.45 -- 
O levels/GCSEs () 19.10 21.22 -- 16.94 21.56 -- 
CSEs () 5.97 3.98 -- 6.20 4.58 -- 
NVQ or HND or HNC () 5.37 5.44 -- 5.37 5.84 -- 
Other qualifications () 5.97 4.91 -- 5.79 4.67 -- 
No respond/refuse to answer () 4.48 8.09 -- 3.72 8.98 -- 
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Table S4. The effect of MDD definition on the volumes of subcortical regions and brain matters (without excluding outliers). The same model 
was conducted with age, age2, sex and assessment centre set as covariates. Hemisphere was also set as a covariate when appropriate. 
Sample sizes were Ncase=381, Ncontrol=849 and Ncase=280, Ncontrol=1260 for principal and recurrent definitions respectively. 
Subcortical regions 
 Principal definition   Recurrent definition 
Effect size Standard deviation t value p value pcorrected  Effect size Standard deviation t value p value pcorrected 
Accumbens 0.013  0.048  0.277  0.782  0.879   -0.012  0.051  -0.247  0.805  0.913  
Amygdala -0.032  0.049  -0.658  0.511  0.879   0.026  0.052  0.497  0.620  0.913  
Caudate 0.047  0.050  0.923  0.356  0.879   0.017  0.053  0.329  0.742  0.913  
Hippocampus -0.036  0.049  -0.724  0.469  0.879   -0.056  0.051  -1.089  0.276  0.829  
Pallidum 0.014  0.051  0.277  0.782  0.879   0.006  0.054  0.110  0.913  0.913  
Putamen 0.020  0.046  0.429  0.668  0.879   -0.006  0.047  -0.119  0.905  0.913  
Thalamus -0.058  0.038  -1.543  0.123  0.879   -0.067  0.040  -1.695  0.090  0.813  
Brain stem -0.007  0.051  -0.134  0.893  0.893   0.043  0.054  0.797  0.425  0.913  
ICV -0.058  0.045  -1.287  0.198  0.879   -0.062  0.048  -1.295  0.196  0.829  
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Table S5. The interaction between MDD definition and hemisphere on the volumes of subcortical regions and brain matters. In this model, 
again age, age2, sex and assessment centre were set as covariates. MDD definition, hemisphere and the interaction between MDD definition 
and hemisphere were also included in the model. As brain stem and ICV were unilateral structure/measure, therefore these two measure were 
not tested in this model. 
Subcortical regions 
 Principal definition   Recurrent definition 
Effect size Standard deviation t value p value pcorrected  Effect size Standard deviation t value p value pcorrected 
Accumbens -0.014  0.056  -0.250  0.803  0.907   -0.064  0.059  -1.088  0.277  0.879  
Amygdala 0.066  0.070  0.936  0.349  0.907   -0.011  0.074  -0.143  0.886  0.945  
Caudate 0.011  0.028  0.388  0.698  0.907   -0.008  0.030  -0.280  0.779  0.945  
Hippocampus 0.034  0.054  0.633  0.527  0.907   0.004  0.059  0.070  0.945  0.945  
Pallidum -0.006  0.048  -0.117  0.907  0.907   -0.015  0.051  -0.290  0.772  0.945  
Putamen -0.047  0.034  -1.383  0.167  0.907   -0.047  0.036  -1.312  0.190  0.879  
Thalamus 0.015  0.023  0.671  0.502  0.907   0.022  0.024  0.884  0.377  0.879  
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Table S6. The effect of MDD definition on FA values of DTI tracts (gFA included as a convariate). In order to test whether the significant effect of 
MDD definitions remains significant when general FA change was controlled, this model included gFA score as a covariate. The method to 
extract gFA score was stated in the main text (Methods-Statistical methods-White matter integrity). 
 
DTI tracts 









t value p value pcorrected 
Acoustic radiation 0.030 0.043 0.707 4.80E-001 0.849  0.006 0.046 0.136 8.92E-001 0.946 
Anterior thalamic radiation 0.062 0.039 1.572 1.16E-001 0.372  0.056 0.042 1.349 1.78E-001 0.568 
Cingulate gyrus part of cingulum -0.026 0.046 -0.563 5.74E-001 0.849  -0.008 0.049 -0.173 8.63E-001 0.946 
Corticospinal tract 0.003 0.051 0.053 9.58E-001 0.958  0.023 0.055 0.415 6.78E-001 0.946 
Inferior fronto-occipital fasciculus 0.029 0.031 0.928 3.53E-001 0.808  0.007 0.032 0.221 8.25E-001 0.946 
Inferior longitudinal fasciculus 0.017 0.032 0.548 5.84E-001 0.849  -0.010 0.032 -0.316 7.52E-001 0.946 
Medial lemniscus 0.007 0.056 0.117 9.07E-001 0.958  0.018 0.058 0.312 7.55E-001 0.946 
Parahippocampal part of cingulum -0.012 0.054 -0.218 8.27E-001 0.958  0.010 0.057 0.171 8.64E-001 0.946 
Posterior thalamic radiation 0.037 0.045 0.808 4.19E-001 0.839  0.013 0.047 0.265 7.91E-001 0.946 
Superior longitudinal fasciculus (bilateral) 0.006 0.035 0.174 8.62E-001 0.958  -0.021 0.038 -0.566 5.72E-001 0.946 
Superior longitudinal fasciculus (left) -0.194 0.066 -2.951 3.23E-003 0.038  -0.221 0.070 -3.165 1.59E-003 0.025 
Superior thalamic radiation -0.110 0.051 -2.168 3.03E-002 0.162  -0.077 0.053 -1.442 1.50E-001 0.568 
Uncinate fasciculus 0.013 0.040 0.330 7.42E-001 0.958  -0.003 0.043 -0.068 9.46E-001 0.946 
Forceps major -0.193 0.068 -2.834 4.69E-003 0.038  -0.133 0.072 -1.842 6.57E-002 0.350 
Forceps minor -0.112 0.065 -1.723 8.52E-002 0.341  -0.159 0.070 -2.266 2.36E-002 0.189 
Middle cerebellar peduncle -0.066 0.064 -1.024 3.06E-001 0.808  0.039 0.068 0.576 5.65E-001 0.946 
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Table S7. The effect of MDD definition on FA values of DTI tracts (Without excluding outliers). The same model for Table 2 was conducted, with 
age, age2, sex and assessment centre controlled and hemisphere also controlled when appropriate. Sample sizes were Ncase=367, Ncontrol=803 
and Ncase=269, Ncontrol=1188 for principal and recurrent definitions respectively. The standard effect sizes of significant tracts found within the 
sample that outliers were excluded remained in similar trend. Significant tracts included left superior longitudinal fasciculus, forceps major and 
superior thalamic radiation. 
 
DTI tracts 









t value p value pcorrected 
Acoustic radiation -0.055 0.052 -1.053 2.92E-001 0.425  -0.032 0.065 -0.488 6.26E-001 0.807 
Anterior thalamic radiation -0.042 0.055 -0.759 4.48E-001 0.506  -0.002 0.069 -0.024 9.81E-001 0.981 
Cingulate gyrus part of cingulum -0.072 0.054 -1.348 1.78E-001 0.376  -0.021 0.064 -0.322 7.48E-001 0.854 
Corticospinal tract -0.091 0.056 -1.626 1.04E-001 0.376  -0.071 0.061 -1.151 2.50E-001 0.807 
Inferior fronto-occipital fasciculus -0.038 0.053 -0.715 4.75E-001 0.506  0.013 0.068 0.192 8.47E-001 0.904 
Inferior longitudinal fasciculus -0.049 0.056 -0.866 3.87E-001 0.490  -0.033 0.069 -0.472 6.37E-001 0.807 
Medial lemniscus -0.083 0.054 -1.537 1.24E-001 0.376  -0.063 0.068 -0.922 3.57E-001 0.807 
Parahippocampal part of cingulum 0.014 0.053 0.258 7.96E-001 0.796  0.047 0.062 0.767 4.43E-001 0.807 
Posterior thalamic radiation -0.046 0.054 -0.845 3.98E-001 0.490  -0.044 0.067 -0.648 5.17E-001 0.807 
Superior longitudinal fasciculus (bilateral) -0.066 0.056 -1.188 2.35E-001 0.376  -0.039 0.069 -0.569 5.69E-001 0.807 
Superior longitudinal fasciculus (left) -0.107 0.058 -1.836 6.66E-002 0.355  -0.092 0.071 -1.302 1.93E-001 0.807 
Superior thalamic radiation -0.148 0.056 -2.656 8.01E-003 0.089  -0.079 0.070 -1.122 2.62E-001 0.807 
Uncinate fasciculus -0.064 0.053 -1.195 2.32E-001 0.376  -0.029 0.064 -0.447 6.55E-001 0.807 
Forceps major -0.151 0.059 -2.544 1.11E-002 0.089  -0.086 0.072 -1.197 2.31E-001 0.807 
Forceps minor -0.070 0.057 -1.226 2.21E-001 0.376  -0.066 0.072 -0.922 3.57E-001 0.807 
Middle cerebellar peduncle -0.079 0.058 -1.364 1.73E-001 0.376  0.034 0.067 0.501 6.16E-001 0.807 
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Table S8. The interaction between MDD definition and hemisphere on FA values of DTI tracts. The results below were for follow-up model to 
test whether there was a lateralised effect of MDD definition (see main text, section Methods-Statistical methods-White matter integrity). 
Forceps major and minor and middle cerebellar peduncle were not included in this analysis as they were unilateral tracts. A significant effect of 
the interaction between recurrent definition and hemisphere was found in superior longitudinal fasciculus, therefore individual tests on the FA 
values on each hemisphere of superior longitudinal fasciculus was conducted. As the effect of MDD definitions were significant on left superior 
longitudinal fasciculus, the results were added in Table 1, S6 and S7. 
 
DTI tracts 









t value p value pcorrected 
Acoustic radiation -0.108 0.063 -1.712 8.72E-002 0.348  -0.069 0.067 -1.034 3.01E-001 0.932 
Anterior thalamic radiation -0.061 0.038 -1.631 1.03E-001 0.348  -0.026 0.041 -0.631 5.28E-001 0.932 
Cingulate gyrus part of cingulum -0.026 0.063 -0.411 6.81E-001 0.894  -0.002 0.067 -0.036 9.71E-001 0.971 
Corticospinal tract -0.088 0.060 -1.459 1.45E-001 0.348  -0.033 0.066 -0.494 6.21E-001 0.932 
Inferior fronto-occipital fasciculus 0.005 0.047 0.110 9.12E-001 0.933  0.038 0.050 0.753 4.51E-001 0.932 
Inferior longitudinal fasciculus 0.012 0.038 0.325 7.45E-001 0.894  0.024 0.041 0.582 5.61E-001 0.932 
Medial lemniscus 0.021 0.036 0.579 5.63E-001 0.894  0.031 0.039 0.801 4.23E-001 0.932 
Parahippocampal part of cingulum -0.044 0.071 -0.628 5.30E-001 0.894  -0.008 0.075 -0.111 9.12E-001 0.971 
Posterior thalamic radiation -0.071 0.047 -1.517 1.30E-001 0.348  -0.008 0.050 -0.151 8.80E-001 0.971 
Superior longitudinal fasciculus 0.069 0.036 1.939 5.27E-002 0.348  0.117 0.038 3.076 2.14E-003 0.026 
Superior thalamic radiation -0.003 0.036 -0.085 9.33E-001 0.933  0.023 0.038 0.596 5.51E-001 0.932 
Uncinate fasciculus 0.021 0.057 0.369 7.12E-001 0.894  -0.005 0.062 -0.075 9.40E-001 0.971 
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Table S9. The effect of MDD definition on FA values of DTI tracts (education level and release included as covariates). There was no significant 
effect of education level and number of release on the definitions of MDD (see supplementary materials, Methods-MDD definitions). However, 
in order to double check whether the results would remain the same when these factors were included, a validation test was conducted. The 
regions that were found significant in the section of results in the main text remained significant (left superior longitudinal fasciculus, forceps 
major and superior thalamic radiation). 
 
DTI tracts 









t value p value pcorrected 
Acoustic radiation -0.080 0.058 -1.371 1.71E-001 0.227  -0.089 0.062 -1.428 1.53E-001 0.239 
Anterior thalamic radiation -0.075 0.063 -1.195 2.32E-001 0.266  -0.062 0.067 -0.926 3.55E-001 0.464 
Cingulate gyrus part of cingulum -0.130 0.059 -2.198 2.82E-002 0.090  -0.100 0.063 -1.575 1.15E-001 0.205 
Corticospinal tract -0.079 0.058 -1.351 1.77E-001 0.227  -0.052 0.062 -0.832 4.06E-001 0.464 
Inferior fronto-occipital fasciculus -0.088 0.060 -1.457 1.45E-001 0.227  -0.055 0.065 -0.847 3.97E-001 0.464 
Inferior longitudinal fasciculus -0.120 0.062 -1.959 5.04E-002 0.115  -0.121 0.065 -1.849 6.47E-002 0.171 
Medial lemniscus -0.131 0.062 -2.127 3.36E-002 0.090  -0.138 0.065 -2.119 3.43E-002 0.110 
Parahippocampal part of cingulum -0.040 0.058 -0.696 4.87E-001 0.487  -0.019 0.060 -0.315 7.53E-001 0.753 
Posterior thalamic radiation -0.081 0.061 -1.327 1.85E-001 0.227  -0.090 0.065 -1.392 1.64E-001 0.239 
Superior longitudinal fasciculus (bilateral) -0.140 0.063 -2.220 2.66E-002 0.090  -0.147 0.067 -2.185 2.91E-002 0.110 
Superior longitudinal fasciculus (left) -0.192 0.066 -2.927 3.49E-003 0.027  -0.217 0.069 -3.127 1.80E-003 0.029 
Superior thalamic radiation -0.225 0.065 -3.464 5.53E-004 0.009  -0.178 0.069 -2.571 1.02E-002 0.082 
Uncinate fasciculus -0.104 0.058 -1.787 7.43E-002 0.149  -0.104 0.062 -1.679 9.33E-002 0.187 
Forceps major -0.188 0.067 -2.809 5.06E-003 0.027  -0.127 0.071 -1.784 7.47E-002 0.171 
Forceps minor -0.111 0.065 -1.702 8.91E-002 0.158  -0.156 0.070 -2.233 2.57E-002 0.110 
Middle cerebellar peduncle -0.070 0.064 -1.093 2.75E-001 0.293  0.035 0.068 0.518 6.05E-001 0.645 
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Table S10. Loadings of first latent factor of PCA on global FA, 
association/commissural fibres, thalamic radiations and projection fibres. The 
individual tracts included for these four PCA were stated in the main text (Methods-
Statistical methods-White matter integrity). All the PCA were performed on the overall 
sample after outliers were excluded to maximize the accuracy of the models in the 











Cingulate gyrus part of cingulum (left) 0.583 0.663 -- -- 
Cingulate gyrus part of cingulum (right) 0.544 0.629 -- -- 
Inferior fronto-occipital fasciculus (left) 0.817 0.820 -- -- 
Inferior fronto-occipital fasciculus (right) 0.836 0.824 -- -- 
Inferior longitudinal fasciculus (left) 0.808 0.798 -- -- 
Inferior longitudinal fasciculus (right) 0.839 0.815 -- -- 
Parahippocampal part of cingulum (left) 0.408 0.415 -- -- 
Parahippocampal part of cingulum (right) 0.356 0.356 -- -- 
Superior longitudinal fasciculus (left) 0.798 0.788 -- -- 
Superior longitudinal fasciculus (right) 0.820 0.796 -- -- 
Uncinate fasciculus (left) 0.657 0.678 -- -- 
Uncinate fasciculus (right) 0.673 0.687 -- -- 
Forceps major 0.539 0.551 -- -- 
Forceps minor 0.784 0.782 -- -- 
Anterior thalamic radiation (left) 0.762 -- 0.784 -- 
Anterior thalamic radiation (right) 0.759 -- 0.809 -- 
Posterior thalamic radiation (left) 0.645 -- 0.761 -- 
Posterior thalamic radiation (right) 0.641 -- 0.794 -- 
Superior thalamic radiation (left) 0.636 -- 0.744 -- 
Superior thalamic radiation (right) 0.610 -- 0.744 -- 
Acoustic radiation (left) 0.607 -- -- 0.536 
Acoustic radiation (right) 0.626 -- -- 0.610 
Corticospinal tract (left) 0.554 -- -- 0.782 
Corticospinal tract (right) 0.552 -- -- 0.800 
Medial lemniscus (left) 0.237 -- -- 0.475 
Medial lemniscus (right) 0.232 -- -- 0.490 
Middle cerebellar peduncle 0.325 -- -- 0.571 
 





Figure S5. Scree plot of the four PCA analyses on global FA (FA), 
association/commissural fibres (A/CF), thalamic radiations (TR) and projection fibres 
(PF). Variance explained were stated in the results of the main text. 
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PHQ4 questions include: “Frequency of depressed mood in last 2 weeks”, 
“Frequency of unenthusiasm/disinterest in last 2 weeks”, “Frequency of 
tenseness/restlessness in last 2 weeks” and “Frequency of tiredness / lethargy in 
last 2 weeks”. This questionnaire assesses depression-related symptoms within a 2-
week timeframe. The sum of the score was calculated to indicate depressive 
symptoms. 
The mean time lag between the first and second occasion was 4.25 years with a 
standard deviation of 0.93 years. Between the second and third occasion, mean 
time lag was 2.59 years with a standard deviation of 0.64 years. Between the third 
and the final occasion, mean time lag was 0.95 years with a standard deviation of 
0.60 years.  
For each measure of depressive symptoms derived from cross-sectional 
assessments, mean time lag of mean level of depressive symptoms was 7.91 years 
(sd=0.97 years), variability of depressive symptoms was 7.91 years (sd=0.97 years), 
and slope of longitudinal trajectory was 7.92 years (sd=0.97 years). No significant 
difference was found for the time lags between cross-sectional assessments 
(p>0.05). Also the correlations between cross-sectional measures and time lag was 
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very small and therefore this variable was not included in the main model (r ranged 
from 0.012 to 0.032). 
dMRI measures 
The processed tracts included 12 bilateral tracts that has a value for each brain 
hemisphere (acoustic radiation, anterior thalamic radiation, cingulate gyrus part of 
cingulum, corticospinal tract, inferior fronto-occipital fasciculus, inferior longitudinal 
fasciculus, medial lemniscus, parahippocampal part of cingulum, posterior thalamic 
radiation, superior longitudinal fasciculus, superior thalamic radiation and uncinate 
fasciculus) and 3 unilateral tracts (forceps major, forceps minor and middle 
cerebellar peduncle). 
Depressive symptoms 
For the growth curve model, we used the ‘growth’ function from lavaan package 
(http://lavaan.ugent.be/tutorial/growth.html) in R (Rosseel 2012). Scaled age at each 
assessment was controlled for. The growth curve model showed good fit to the data 
(CFI = 0.989, TLI = 0.986, RMSEA = 0.031, SRMR = 0.023, Chi-square (17) = 99.419 
with a p<0.001). Longitudinal change within the whole population was in a negative 
direction but did not reach to significance (β = -0.110, p = 0.220). Both the intercept 
(β= -0.029, p = 0.007) and variance (β=0.053, p < 0.001) of the mean slope of growth 
curve model was significant. Each individual’s slope of longitudinal trajectory was 
estimated for further analysis. 
Depression-related phenotypes 
These include ‘MDD self’ (self-reported history of whether has seen a 
doctor/psychiatrist for nerves, anxiety, tension or depression , see in: 
http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=2010), ‘MDD status’ definition 
according to Smith et al (based on self-reported depressed symptoms and hospital 
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admission history, http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20126) and CIDI -
based MDD (derived from Composite International Diagnostic Interview results, UK 
Biobank used the questions but the results were self-reported, 
http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=138). CIDI MDD is the most clinical 
definition, whilst MDD broad is the most lenient and has the biggest sample size. 
Other phenotypes include MDD severity assessed by CIDI and length of depression 
(years from first to last episode). Other phenotypes include onset age for the first 
episode (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20433) and whether had 
self-harm behaviour (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20480). 
Coefficients for MDD phenotypes are odds ratios, and for other phenotypes are 
standardised effect sizes of glm models, and age, age2 and gender were set as 
covariates for mean depressive level and temporal change. Only gender was 
controlled for slope of longitudinal trajectory because the measure was derived 
controlling for age in the growth curve model. All MDD definitions and self-harm 
behaviour were binary variables, and other phenotypes were continuous. 
Covariates 
In addition to age, age2 and gender, we also included scanner positions for all three 
axis, alcohol consumption, smoking status and stressful life events. The covariates 
except for age and gender will be explained in detail below. All the covariates 
described here were acquired with the imaging assessments. See also Table S1, S5 
and S6. 
The scanner position was used for controlling for systematic change in the static 
magnetic field (the last four fields in: 
http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=110). These proxies for scanner 
position showed minimal correlation with our white matter phenotypes, but in order 
to achieve a better estimated model, we chose to include them in our models. 
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Alcohol consumption was self-reported weekly consumption which was used in a 
published paper on the overall UK Biobank sample of about 500k people (Clarke et 
al. 2017). We used a slightly different approach to exclude impossible numbers. In 
the referenced study, they excluded values over 5 standard deviations from mean, 
and we employed their values as upper and low thresholds instead of calculating our 
own standard deviations and mean in the sub sample with imaging data, because 
we have much smaller sample, which may introduce more noise and exclude 
excessive amount of people. 
For smoking status, we used the self-reported smoking status information 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20116). Participants could chose 
from one of the four options: (a) current smoker, (b) previous smoker, (c) non-
smoker and (d) prefer not to answer. There were NAs for those did not answer. As 
the number of people who chose ‘prefer not to answer’ was very small, we did not 
transfer this into NA so to maximize our sample size. We treated this covariate as a 
categorical variable in our model. For the sensitivity analysis shown in Table S1, S4 
and S5, in order to make it easier for demonstration, we transferred it into a numeric 
variable (current smoker = 2, previous smoker =1, non-smoker = 0, prefer not to 
answer = NA). This still represent the effects of smoking to depressive symptoms 
and white matter microstructure, as it is generally believed that there should be a 
gradient effect from current smoker to non-smoker. 
Stressful life events described the number of events happened within 2 years before 
scanning session (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=6145). Items 
include: serious illness, injury or assault to oneself, death of a close relative, death 
of a spouse or partner, marital separation/divorce and financial difficulties. 
 
  




Associations between measures of depressive symptoms and NODDI 
measures 
One-time assessment of depressive symptoms 
No general variation for NODDI measures was found associated with one-time 
assessment of depressive symptoms (absolute β ranged from 0.002 to 0.022, all 
pcorr > 0.159). No tract association was found either for ICVF or OD (absolute β 
ranged from 0.003 to 0.019, all pcorr > 0.191). However, ISOVF in anterior thalamic 
radiation was significantly associated with depressive symptoms (β =0.043, pcorr = 
2.49×10-4), as was the cingulate gyrus part of cingulum (β =0.028, pcorr = 0.022). 
The mean and variability of depressive symptoms derived from multiple 
assessments 
No associations were found between ISOVF, ICVF or OD (all pcorr > 0.143) and 
mean of depressive symptoms. ISOVF was associated with greater variability in 
depressive symptoms in total variance (β = 0.031, pcorr = 0.013), thalamic radiations 
(β = 0.024, pcorr = 0.030), and projection fibres (β = 0.047, pcorr = 5.11×10-4). No 
other measures were associated with variability of depressive symptoms (all pcorr > 
0.875). 
Tract-wise analysis showed that ISOVF of anterior thalamic radiations (β = 0.055, 
pcorr = 8.07×10-7), cingulate gyrus part of cingulum (β = 0.032, pcorr = 0.007) and 
uncinate fasciculus (β = 0.029, pcorr = 0.020) were associated with higher mean 
depressive symptoms. ISOVF of anterior thalamic radiation (β = 0.053, pcorr = 
1.45×10-5), cingulate gyrus part of cingulum (β = 0.036, pcorr = 0.002), superior 
thalamic radiation (β = 0.032, pcorr = 0.003), forceps major (β = 0.031, pcorr = 0.003) 
Appendix 2: Supplementary materials of Chapter 3 
164 
 
and middle cerebellar peduncle (β = 0.048, pcorr =5.29×10-4) were both associated 
with variability. 
Longitudinal trajectory of depressive symptoms 
No general variances found associated with slope of longitudinal growth curve for all 
measures (all pcorr > 0.087). Tract-wise, superior thalamic radiation in ISOVF (β = 
0.068, pcorr = 0.004) was associated with worsening depressive symptoms over time. 
Additional analysis comparing temporal change and longitudinal change 
General variations of association fibres (gAF) was associated with both one-time 
assessment of depressive symptoms and longitudinal trajectory (see results, Figure 
3 in the main text). One-time depressive level should be contributed by (1) mean 
level and (2) temporal deviation at the time of assessment. Therefore we derived a 
proxy for temporal deviation by calculating the residuals of one-time depressive level 
from mean level. This proxy has a N of 8,309.  
We then conducted GLM using temporal change of depressive level as a factor on 
the g measures. On the other hand, longitudinal change showed association with 
gAF, gTR and gTotal in both MD and ISOVF (see Figure S3, S4 and Table S7). 
We then further conducted analysis of structural equational modelling to test how 
much variance was mediated by NODDI measures. NODDI measures include ICVF 
(intercellular volume fraction, describing neurite density), ISOVF (isotropic of free 
water volume fraction, i.e. extracellular water proportion describing the proportion of 
water outside of cellular space) and OD (orientation dispersion index, describes 
morphology of tract organisation) (Zhang et al. 2012). There are increasing interests 
on the use of NODDI measures as complementary dMRI measures in addition to FA 
and MD since these measures depict additional sources of FA and MD variations 
which conventional DTI measures cannot distinguish (Beaulieu 2002). These 
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NODDI measures are relatively new but are encouragingly robust (Zhang et al. 
2012) , and importantly have been shown to demonstrate distinct sensitivity to aging 
(Cox, Ritchie, et al. 2016) and within clinical samples (Rae et al. 2017).  
NODDI measures were set as mediators, g of white matter microstructure was the 
outcomes, and finally temporal and longitudinal changes of depressive symptoms 
were the predictors. Results were shown in Figure S6. 
Though both temporal and longitudinal change showed associations with gAF, gTR 
and gTotal, temporal change had associations with ICVF for these g measures, 
whereas the associations for longitudinal change was shown in ISOVF. Although 
both one-time measure and longitudinal trajectory had association with gAF in MD, 
they showed distinct effects in NODDI measures. We conducted an additional 
analysis for temporal change at the one-time assessments in relation to mean level 
across time (supplementary methods) to compare the differences between temporal 
and longitudinal changes in NODDI measures. We found that neurite density (ICVF) 
were more associated with temporal change, and reduced isotropic water proportion 
(ISOVF) was associate with longitudinal change (Figure S9). Neurite density is 
closely related to changeable brain structural features like myelination(Rae et al. 
2017), whereas reduced ISOVF may reflect a more severe level of the dispersed 
structure in neuronal tissue. It therefore indicate that temporal deviation at the one-
time assessment and longitudinal change may have distinct neurobiological 
reversibility and severity(Kamagata et al. 2017).  
Measures of depressive symptoms and their associations with MDD 
phenotypes 
Association with age and gender 
Depressive symptoms at the imaging assessment, as well as the mean and 
variability over time, all showed a negative association with age (β ranged from -
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0.212 to -0.143, p<1X10-6). Each measure was higher in females (Cohen's d ranged 
from -0.197 to -0.150, p<2.35X10-12, male=1, female=0), except for longitudinal 
slope of depressive symptoms (Cohen's d=-0.048, p=0.296). Its association with 
age was not tested because for better estimation of growth curve, age was 
controlled for in each time point of assessment. 
Association with MDD phenotypes 
We then tested the associations between the four measures of depressive 
symptoms and phenotypes for life-time MDD (MDD-self, MDD-status and MDD-
CIDI), (see legend of Table S8 and supplementary methods). All four measures for 
depressive symptoms were positively associated with all MDD phenotypes (odds 
ratios for a standard deviation change in each measure ranged from 1.153 to 3.414, 
p<6.15×10-16). Among the three measures, mean depressive symptoms level 
showed the largest effect sizes for association with major depression, and 
longitudinal slope showed the smallest (Table S8). Correlations between them were 
shown in Table S2. 
Effect of partial-volume contamination to FA and MD 
We observed differences of results for FA and MD. To control for possible effects of 
partial-volume contamination related to structural atrophy, we have included age 
and age2 as covariates(Smith and Nichols 2018). We also conducted an additional 
analysis including brain size as one of the covariates and the results remained 
significant for MD except for one association turned null (Figure S8). 
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Figure S1. Description of sample sizes and changes due to each step of data merging or 
outlier removal. Depre = depressive level at the imaging assessment, depre.mean = mean 
level of depressive symptoms based on multiple assessments for at least two times, 
depre.instability = standard deviation of depressive level of multiple assessments for at least 
three times, and depre.longitudinal = slope of longitudinal changes over all four times of 
assessments. 
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Figure S2. Distributions PHQ-4 and derived measures for depressive symptoms. (a) Density map for all four time points of assessments for PHQ-4. 
Instance 2 was for imaging assessment, and the depressive level acquired from this instance was used as a baseline, one-time measure for 
depressive symptoms. The mean depressive level over a minimum of two time points of assessment was also presented in this sub-figure 
(Depre.mean). (b) Density map for instability of depressive symptoms (Depre.instability). (c) Density map for the distribution of slope for longitudinal 
trajectory of depressive level over four instances (Depre.longitudinal). 
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Figure S3. Results for the main model, including results for NODDI measures. More 
descriptive statistics were shown in Table S2 and S3, results in the main text and 
supplementary results. In the heatmaps, each colour theme represents one dMRI measure. 
For the measures of depressive symptoms: depre = depressive level at the imaging 
assessment, depre.mean = mean level of depressive symptoms based on multiple 
assessments for at least two times, depre.instability = standard deviation of depressive level 
of multiple assessments for at least three times, and depre.longitudinal = slope of 
longitudinal changes over all four times of assessments. As the measures of FA, ICVF and 
OD have negative direction with MD and ISOVF, here in this figure, the effect sizes for FA, 
ICVF and OD were reversed (×-1). Significant associations after FWE correction on 15 
tracts/four g measures (pcorr<0.05) were marked with a single asterisk.  
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Figure S4. Results for the main model using two different multiple correction methods. More 
descriptive statistics were shown in Table S2 and S3, results in the main text and 
supplementary results. In the heatmaps, each colour theme represents one dMRI measure. 
For the measures of depressive symptoms: depre = depressive level at the imaging 
assessment, depre.mean = mean level of depressive symptoms based on multiple 
assessments for at least two times, depre.instability = standard deviation of depressive level 
of multiple assessments for at least three times, and depre.longitudinal = slope of 
longitudinal changes over all four times of assessments. As the measures of FA, ICVF and 
OD have negative direction with MD and ISOVF, here in this figure, the effect sizes for FA, 
ICVF and OD were reversed (×-1). Significant associations after FWE correction on 15 
tracts/four g measures (pcorr<0.05) were marked with a single asterisk, and significant 
associations after FDR-correcting on all the tests within a dMRI measure (15 tracts * 4 
measures for depressive symptoms=60 tests) were marked by a double asterisk.  
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Figure S5. Results for including outliers in the sample. Outlier exclusion procedures were 
shown in methods in the main text. Significant associations appeared in this sample 
including outliers but did not in the main results described in the main text were marked with 
blue squares. No association was exclusively in the main results from which the sample 





Appendix 2: Supplementary materials of Chapter 3 
172 
 
Figure S6. Variance explained by the principal components of PCA on total and subsets of 
white matter tracts. 
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Figure S7. Results for the secondary model without controlling for stressful life events, 
smoking status or alcohol consumption. Significant associations appeared in this secondary 
model but did not in the main model were marked with blue squares. Yellow squares are the 
significant associations exclusively appeared in the main model. The results may indicate 
that controlling for the four covariates helped to remove confounding/mediating factors rather 
than creating bias (more blue squares than yellow ones). More descriptive statistics were 
shown in Table S1,4 and 5. For the abbreviations and multiple correction methods, see the 
legend of Figure S2. 
 





Figure S8. Results for adding brain size as a covariate. The yellow square indicates the 
significant associations exclusively appeared in the main model. No other associations 
turned null after controlling for brain size. 
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Figure S9. Mediation analysis for temporal and longitudinal change of depressive symptoms. 
Details for the analysis were stated in supplementary methods. (a) the path for mediation 
analysis. (b) mediation effect for ICVF. TC = temporal change, and LC = longitudinal change. 





Table S1. Correlation matrix for all measures for depressive symptoms, smoking status, 
alcohol consumption, stressful life events, neuroticism and age range (time lag) for the 
multiple assessments used for generating mean level of depressive symptoms. For the 
measures of depressive symptoms: depre = depressive level at the imaging assessment, 
depre.mean = mean level of depressive symptoms based on multiple assessments for at 
least two times, depre.instability = standard deviation of depressive level of multiple 
assessments for at least three times, and depre.longitudinal = slope of longitudinal changes 
over all four times of assessments. All r>0.3 were highlighted in bold. Measures for 
depressive symptoms were correlated with one another. None of the covariates or age range 
was correlated with measures for depressive symptoms apart from neuroticism. This justifies 
that controlling for smoking status, alcohol consumption, stressful life events (SLE) would 
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serve for adjusting the effects rather than creating bias (Figure S3). For neuroticism, we did 
not find any significant association with any of the dMRI measures in the overall IDP sample 
after outliers were removed (N~=8,200, sample size varies according to the dMRI measure, 
see Table S4,5).  
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Table S2. Correlation loadings of each tract of PCA. For each dMRI measure, PCA on all tracts, association fibres, thalamic radiations and projection fibres were 
performed respectively. The loadings were reported as correlation loadings. 
 
Tract 
FA MD ICVF ISOVF OD 
gTotal gAF gTR gPF gTotal gAF gTR gPF gTotal gAF gTR gPF gTotal gAF gTR gPF gTotal gAF gTR gPF 
Parahippocampal part of cingulum 0.363 0.363 -- -- 0.47 0.575 -- -- 0.619 0.627 -- -- 0.577 0.821 -- -- 0.724 0.864 -- -- 
Parahippocampal part of cingulum 0.412 0.423 -- -- 0.444 0.55 -- -- 0.637 0.648 -- -- 0.584 0.832 -- -- 0.669 0.831 -- -- 
Forceps major 0.544 0.557 -- -- 0.502 0.562 -- -- 0.796 0.795 -- -- 0.272 0.267 -- -- 0.185 0.1 -- -- 
Cingulate gyrus part of cingulum 0.558 0.634 -- -- 0.653 0.611 -- -- 0.792 0.806 -- -- 0.419 0.248 -- -- 0.251 0.183 -- -- 
Cingulate gyrus part of cingulum 0.585 0.662 -- -- 0.657 0.626 -- -- 0.795 0.81 -- -- 0.396 0.261 -- -- 0.251 0.178 -- -- 
Uncinate fasciculus 0.654 0.675 -- -- 0.675 0.727 -- -- 0.801 0.818 -- -- 0.47 0.404 -- -- 0.48 0.445 -- -- 
Uncinate fasciculus 0.694 0.709 -- -- 0.762 0.791 -- -- 0.845 0.862 -- -- 0.531 0.427 -- -- 0.519 0.491 -- -- 
Forceps minor 0.805 0.806 -- -- 0.731 0.678 -- -- 0.912 0.928 -- -- 0.473 0.215 -- -- 0.384 0.255 -- -- 
Superior longitudinal fasciculus 0.822 0.813 -- -- 0.866 0.813 -- -- 0.933 0.935 -- -- 0.672 0.373 -- -- 0.431 0.193 -- -- 
Superior longitudinal fasciculus 0.836 0.818 -- -- 0.849 0.789 -- -- 0.93 0.93 -- -- 0.682 0.378 -- -- 0.449 0.197 -- -- 
Inferior longitudinal fasciculus 0.827 0.821 -- -- 0.872 0.872 -- -- 0.939 0.942 -- -- 0.696 0.453 -- -- 0.511 0.407 -- -- 
Inferior fronto-occipital fasciculus 0.817 0.824 -- -- 0.865 0.854 -- -- 0.942 0.948 -- -- 0.68 0.439 -- -- 0.477 0.379 -- -- 
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Inferior longitudinal fasciculus 0.852 0.833 -- -- 0.91 0.892 -- -- 0.946 0.944 -- -- 0.753 0.48 -- -- 0.561 0.458 -- -- 
Inferior fronto-occipital fasciculus 0.853 0.843 -- -- 0.912 0.884 -- -- 0.953 0.956 -- -- 0.708 0.45 -- -- 0.516 0.401 -- -- 
Superior thalamic radiation 0.661 -- 0.75 -- 0.778 -- 0.853 -- 0.881 -- 0.923 -- 0.626 -- 0.708 -- 0.512 -- 0.902 -- 
Superior thalamic radiation 0.645 -- 0.752 -- 0.74 -- 0.829 -- 0.87 -- 0.918 -- 0.598 -- 0.698 -- 0.52 -- 0.911 -- 
Posterior thalamic radiation 0.681 -- 0.778 -- 0.762 -- 0.86 -- 0.877 -- 0.9 -- 0.64 -- 0.867 -- 0.41 -- 0.287 -- 
Posterior thalamic radiation 0.683 -- 0.805 -- 0.778 -- 0.882 -- 0.879 -- 0.905 -- 0.675 -- 0.888 -- 0.429 -- 0.349 -- 
Anterior thalamic radiation 0.78 -- 0.806 -- 0.841 -- 0.864 -- 0.906 -- 0.936 -- 0.624 -- 0.618 -- 0.536 -- 0.587 -- 
Anterior thalamic radiation 0.775 -- 0.818 -- 0.833 -- 0.87 -- 0.898 -- 0.931 -- 0.629 -- 0.651 -- 0.557 -- 0.669 -- 
Medial lemniscus 0.267 -- -- 0.501 0.209 -- -- 0.169 0.49 -- -- 0.721 0.349 -- -- 0.262 0.223 -- -- 0.288 
Medial lemniscus 0.287 -- -- 0.534 0.183 -- -- 0.137 0.481 -- -- 0.719 0.36 -- -- 0.258 0.292 -- -- 0.328 
Middle cerebellar peduncle 0.359 -- -- 0.545 0.305 -- -- 0.975 0.53 -- -- 0.738 0.331 -- -- 0.972 0.345 -- -- 0.781 
Acoustic radiation 0.623 -- -- 0.553 0.512 -- -- 0.241 0.876 -- -- 0.867 0.317 -- -- 0.039 0.324 -- -- 0.355 
Acoustic radiation 0.646 -- -- 0.619 0.546 -- -- 0.199 0.873 -- -- 0.874 0.366 -- -- -0.007 0.37 -- -- 0.361 
Corticospinal tract 0.566 -- -- 0.809 0.59 -- -- 0.237 0.787 -- -- 0.852 0.351 -- -- 0.039 0.425 -- -- 0.629 
Corticospinal tract 0.574 -- -- 0.828 0.593 -- -- 0.237 0.771 -- -- 0.843 0.412 -- -- 0.075 0.454 -- -- 0.654 
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Table S3. Main results for DTI measures (FA and MD). Betas were standardised effect sizes. P values were un-corrected p values. All pcorrected<0.05 were 
marked by asterixis. FDR correction was applied on subsets of brain measures within a unit of a whole brain (n=15 for tract analysis, and n=4 for g 
analysis). For the measures of depressive symptoms: depre = depressive level at the imaging assessment, depre.mean = mean level of depressive 
symptoms based on multiple assessments for at least two times, depre.instability = standard deviation of depressive level of multiple assessments for at 
least three times, and depre.longitudinal = slope of longitudinal changes over all four times of assessments. 
 
    Depre Depre.mean Depre.instability Depre.longitudinal 
Tract name Measure Beta p Beta p Beta p Beta p 
g.Total 
FA -0.011 (0.011) 0.315 -0.004 (0.011) 0.735 -0.01 (0.012) 0.394 -0.022 (0.023) 0.341 
MD 0.028 (0.01) 0.008* 0.015 (0.011) 0.146 0.022 (0.011) 0.046 0.056 (0.023) 0.014* 
g.AF 
FA -0.009 (0.011) 0.393 -0.003 (0.011) 0.8 -0.007 (0.012) 0.531 -0.024 (0.023) 0.302 
MD 0.023 (0.011) 0.032* 0.011 (0.011) 0.323 0.016 (0.011) 0.172 0.05 (0.023) 0.026* 
g.TR 
FA -0.024 (0.011) 0.029 -0.02 (0.011) 0.072 -0.023 (0.012) 0.052 -0.021 (0.023) 0.361 
MD 0.029 (0.01) 0.003* 0.021 (0.01) 0.031 0.024 (0.01) 0.022* 0.053 (0.022) 0.016* 
g.PF 
FA 0.003 (0.011) 0.802 0.012 (0.011) 0.262 -1.41e-04 (0.012) 0.99 -0.004 (0.022) 0.873 
MD 0.013 (0.011) 0.259 0.012 (0.011) 0.3 0.045 (0.012) 2.05e-04* 0.034 (0.022) 0.122 
          
Acoustic radiation FA 0.003 (0.01) 0.784 0.009 (0.01) 0.333 0.003 (0.01) 0.783 -0.019 (0.019) 0.336 
Appendix 2: Supplementary materials of Chapter 3 
182 
 
MD 0.016 (0.01) 0.102 6.63e-04 (0.01) 0.945 0.005 (0.01) 0.646 0.023 (0.019) 0.225 
Anterior thalamic radiation 
FA -0.021 (0.01) 0.05 -0.018 (0.011) 0.091 -0.017 (0.011) 0.145 -0.018 (0.022) 0.413 
MD 0.036 (0.01) 1.48e-04* 0.032 (0.01) 8.90e-04* 0.032 (0.01) 0.002* 0.05 (0.022) 0.024 
Cingulate gyrus part of cingulum 
FA 4.43e-04 (0.01) 0.964 0.006 (0.01) 0.546 0.004 (0.011) 0.702 -0.01 (0.02) 0.614 
MD 0.027 (0.01) 0.005* 0.013 (0.01) 0.193 0.02 (0.011) 0.057 0.03 (0.02) 0.13 
Parahippocampal part of cingulum 
FA -0.003 (0.01) 0.749 -4.52e-04 (0.01) 0.964 -0.004 (0.011) 0.741 -0.014 (0.02) 0.476 
MD 0.006 (0.01) 0.541 -0.004 (0.01) 0.676 -0.001 (0.011) 0.919 0.025 (0.02) 0.195 
Corticospinal tract 
FA 0.003 (0.01) 0.759 0.01 (0.01) 0.343 0.003 (0.011) 0.758 0.007 (0.021) 0.735 
MD 0.031 (0.01) 0.003* 0.02 (0.011) 0.055 0.021 (0.012) 0.075 0.049 (0.02) 0.016 
Inferior fronto occipital fasciculus 
FA -0.009 (0.011) 0.405 -0.004 (0.011) 0.683 -0.01 (0.011) 0.387 -0.019 (0.022) 0.384 
MD 0.021 (0.01) 0.037 0.01 (0.01) 0.319 0.015 (0.011) 0.171 0.036 (0.021) 0.094 
Inferior longitudinal fasciculus 
FA -0.013 (0.01) 0.212 -0.01 (0.011) 0.332 -0.011 (0.011) 0.343 -0.017 (0.022) 0.455 
MD 0.019 (0.01) 0.056 0.007 (0.01) 0.473 0.009 (0.011) 0.414 0.036 (0.021) 0.097 
Medial lemniscus 
FA -0.001 (0.009) 0.897 0.004 (0.01) 0.656 0.002 (0.01) 0.852 0.006 (0.019) 0.76 
MD -0.002 (0.01) 0.841 -0.011 (0.01) 0.255 -0.007 (0.011) 0.493 0.018 (0.019) 0.356 
Posterior thalamic radiation 
FA -0.026 (0.01) 0.01 -0.026 (0.01) 0.013 -0.021 (0.011) 0.054 -0.019 (0.021) 0.365 
MD 0.017 (0.01) 0.07 0.009 (0.01) 0.344 0.013 (0.01) 0.218 0.04 (0.021) 0.055 
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Superior longitudinal fasciculus 
FA -0.013 (0.011) 0.217 -0.005 (0.011) 0.61 -0.011 (0.011) 0.332 -0.031 (0.022) 0.162 
MD 0.022 (0.01) 0.036 0.01 (0.01) 0.342 0.014 (0.011) 0.209 0.039 (0.022) 0.08 
Superior thalamic radiation 
FA -0.007 (0.011) 0.488 -6.68e-04 (0.011) 0.951 -0.016 (0.012) 0.183 -0.011 (0.022) 0.609 
MD 0.024 (0.009) 0.008* 0.016 (0.009) 0.081 0.02 (0.01) 0.041 0.051 (0.02) 0.013 
Uncinate fasciculus 
FA 0.002 (0.01) 0.859 0.008 (0.01) 0.41 0.003 (0.011) 0.8 -0.012 (0.021) 0.572 
MD 0.018 (0.009) 0.053 0.013 (0.01) 0.159 0.014 (0.01) 0.165 0.04 (0.02) 0.047 
Forceps major 
FA -0.014 (0.011) 0.189 -0.023 (0.011) 0.04 -0.025 (0.012) 0.035 -0.023 (0.022) 0.298 
MD 0.017 (0.011) 0.128 0.025 (0.011) 0.027 0.03 (0.012) 0.012 0.052 (0.022) 0.018 
Forceps minor 
FA -0.017 (0.011) 0.132 -0.005 (0.011) 0.655 -0.007 (0.012) 0.557 -0.006 (0.023) 0.801 
MD 0.014 (0.011) 0.183 -0.001 (0.011) 0.897 0.002 (0.011) 0.831 0.024 (0.022) 0.263 
Middle cerebellar peduncle 
FA 0.002 (0.011) 0.841 0.008 (0.011) 0.505 -0.013 (0.012) 0.301 -0.009 (0.023) 0.702 
MD 0.009 (0.011) 0.412 0.012 (0.011) 0.305 0.045 (0.012) 2.05e-04* 0.028 (0.022) 0.207 
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Table S4. Main results for NODDI measures (ICVF, ISOVF, and OD). Betas were standardised effect sizes. P values were un-corrected p values. All 
pcorrected<0.05 were marked by asterixis. FDR correction was applied on subsets of brain measures within a unit of a whole brain (n=15 for tract 
analysis, and n=4 for g analysis). For the abbreviations of measures for depressive symptoms, see the legend of Table S2. 
 
    Depre Depre.mean Depre.instability Depre.longitudinal 
Tract name Measure Beta p Beta p Beta p Beta p 
g.Total 
ICVF -0.016 (0.011) 0.157 -0.003 (0.011) 0.8 -0.002 (0.012) 0.858 -0.031 (0.023) 0.19 
ISOVF 0.021 (0.01) 0.04 0.022 (0.011) 0.036 0.031 (0.011) 0.006* 0.045 (0.022) 0.044 
OD -0.009 (0.011) 0.406 -2.83e-04 (0.011) 0.979 -4.74e-04 (0.012) 0.967 -0.028 (0.021) 0.2 
g.AF 
ICVF -0.014 (0.011) 0.2 -0.001 (0.011) 0.909 -0.002 (0.012) 0.875 -0.032 (0.023) 0.175 
ISOVF 0.017 (0.011) 0.119 0.016 (0.011) 0.144 0.012 (0.012) 0.302 0.02 (0.023) 0.376 
OD 0.002 (0.011) 0.825 0.012 (0.011) 0.278 0.007 (0.012) 0.552 -0.013 (0.022) 0.533 
g.TR 
ICVF -0.022 (0.011) 0.044 -0.012 (0.011) 0.259 -0.008 (0.012) 0.48 -0.03 (0.023) 0.188 
ISOVF 0.015 (0.01) 0.117 0.017 (0.01) 0.078 0.024 (0.011) 0.022* 0.047 (0.021) 0.025 
OD -0.016 (0.01) 0.124 -0.014 (0.01) 0.176 -0.003 (0.011) 0.754 -0.035 (0.021) 0.097 
g.PF 
ICVF -0.008 (0.011) 0.484 0.007 (0.011) 0.506 0.008 (0.012) 0.502 -0.019 (0.023) 0.387 
ISOVF 0.007 (0.011) 0.516 0.01 (0.011) 0.39 0.047 (0.012) 1.28e-04* 0.025 (0.023) 0.27 
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OD -0.012 (0.011) 0.275 -0.011 (0.011) 0.319 -0.011 (0.012) 0.356 -0.013 (0.022) 0.541 
          
Acoustic radiation 
ICVF -0.009 (0.011) 0.39 0.006 (0.011) 0.587 0.004 (0.012) 0.746 -0.028 (0.022) 0.213 
ISOVF 0.01 (0.009) 0.302 0.004 (0.01) 0.662 0.007 (0.01) 0.497 0.012 (0.019) 0.539 
OD -0.018 (0.009) 0.051 -0.008 (0.009) 0.41 -0.003 (0.01) 0.756 -0.006 (0.018) 0.756 
Anterior thalamic 
radiation 
ICVF -0.015 (0.01) 0.157 -0.005 (0.01) 0.612 -0.004 (0.011) 0.706 -0.029 (0.023) 0.204 
ISOVF 0.043 (0.01) 1.66e-05* 0.055 (0.01) 5.38e-08* 0.053 (0.011) 9.65e-07* 0.051 (0.021) 0.016 
OD -0.015 (0.01) 0.151 -0.007 (0.01) 0.475 -0.012 (0.011) 0.262 -0.037 (0.021) 0.078 
Cingulate gyrus part 
of cingulum 
ICVF -0.004 (0.01) 0.733 0.01 (0.01) 0.351 0.01 (0.011) 0.398 -0.024 (0.022) 0.268 
ISOVF 0.028 (0.009) 0.003* 0.032 (0.01) 9.93e-04* 0.036 (0.01) 4.60e-04* 0.003 (0.019) 0.895 
OD -0.008 (0.009) 0.398 -0.005 (0.009) 0.552 -0.011 (0.01) 0.26 -0.007 (0.018) 0.681 
Parahippocampal 
part of cingulum 
ICVF 0.007 (0.01) 0.474 0.021 (0.01) 0.043 0.01 (0.011) 0.362 -0.028 (0.021) 0.174 
ISOVF 0.011 (0.01) 0.261 0.007 (0.01) 0.452 0.002 (0.01) 0.815 0.008 (0.019) 0.686 
OD 0.009 (0.009) 0.302 0.018 (0.009) 0.058 0.012 (0.01) 0.221 -0.001 (0.019) 0.954 
Corticospinal tract 
ICVF -0.01 (0.011) 0.351 0.003 (0.011) 0.819 0.005 (0.012) 0.678 -0.005 (0.021) 0.799 
ISOVF 0.02 (0.01) 0.053 0.017 (0.01) 0.092 0.019 (0.011) 0.081 0.052 (0.021) 0.011 
OD -0.013 (0.01) 0.195 -0.019 (0.01) 0.059 -0.01 (0.011) 0.36 -0.021 (0.02) 0.286 





ICVF -0.018 (0.011) 0.095 -0.006 (0.011) 0.572 -0.005 (0.012) 0.643 -0.031 (0.023) 0.166 
ISOVF 0.002 (0.01) 0.88 0.01 (0.01) 0.339 0.017 (0.011) 0.13 0.015 (0.021) 0.484 
OD -0.027 (0.01) 0.007 -0.019 (0.01) 0.064 -0.01 (0.011) 0.354 -0.042 (0.02) 0.039 
Inferior longitudinal 
fasciculus 
ICVF -0.017 (0.011) 0.117 -0.006 (0.011) 0.585 -0.006 (0.012) 0.596 -0.029 (0.023) 0.207 
ISOVF 0.007 (0.01) 0.529 0.009 (0.011) 0.416 0.006 (0.011) 0.582 0.021 (0.022) 0.337 
OD -0.024 (0.01) 0.018 -0.011 (0.01) 0.286 -0.011 (0.011) 0.313 -0.051 (0.02) 0.013 
Medial lemniscus 
ICVF 0.003 (0.009) 0.735 0.014 (0.01) 0.139 0.015 (0.01) 0.142 -0.004 (0.019) 0.824 
ISOVF -0.004 (0.01) 0.645 -0.01 (0.01) 0.332 -0.004 (0.011) 0.718 0.011 (0.02) 0.581 
OD 0.023 (0.01) 0.023 0.027 (0.01) 0.01 0.019 (0.011) 0.093 -0.016 (0.02) 0.43 
Posterior thalamic 
radiation 
ICVF -0.025 (0.011) 0.021 -0.019 (0.011) 0.085 -0.014 (0.012) 0.239 -0.033 (0.022) 0.136 
ISOVF 0.002 (0.01) 0.8 0.001 (0.01) 0.904 0.007 (0.011) 0.51 0.024 (0.02) 0.232 




ICVF -0.016 (0.011) 0.136 -0.005 (0.011) 0.648 -0.005 (0.012) 0.702 -0.022 (0.023) 0.342 
ISOVF 0.019 (0.01) 0.051 0.019 (0.01) 0.065 0.021 (0.011) 0.056 0.052 (0.02) 0.012 
OD -0.009 (0.009) 0.31 -0.009 (0.009) 0.344 -0.002 (0.01) 0.817 5.94e-04 (0.019) 0.974 
Superior thalamic 
radiation 
ICVF -0.02 (0.01) 0.055 -0.01 (0.011) 0.369 -0.004 (0.011) 0.711 -0.02 (0.023) 0.375 
ISOVF 0.019 (0.009) 0.03 0.022 (0.009) 0.014 0.032 (0.009) 7.43e-04* 0.068 (0.019) 2.66e-04* 
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OD -0.012 (0.01) 0.241 -0.014 (0.01) 0.169 4.93e-04 (0.011) 0.964 -0.023 (0.02) 0.255 
Uncinate fasciculus 
ICVF -0.009 (0.01) 0.36 -9.03e-04 (0.01) 0.931 -0.004 (0.011) 0.699 -0.031 (0.022) 0.147 
ISOVF 0.022 (0.01) 0.028 0.029 (0.01) 0.004* 0.025 (0.011) 0.022 0.015 (0.019) 0.444 
OD -0.015 (0.009) 0.12 -0.016 (0.01) 0.092 -0.016 (0.01) 0.121 -0.03 (0.019) 0.119 
Forceps major 
ICVF -0.018 (0.011) 0.119 -0.013 (0.011) 0.245 -0.01 (0.012) 0.406 -0.041 (0.024) 0.079 
ISOVF 0.011 (0.011) 0.313 0.025 (0.011) 0.021 0.031 (0.012) 0.009* 0.044 (0.022) 0.045 
OD -0.019 (0.011) 0.077 -0.004 (0.011) 0.728 0.002 (0.012) 0.876 -0.014 (0.021) 0.501 
Forceps minor 
ICVF -0.015 (0.011) 0.172 -0.002 (0.011) 0.843 -3.67e-04 (0.012) 0.975 -0.02 (0.023) 0.379 
ISOVF 0.006 (0.01) 0.559 0.006 (0.01) 0.597 0.011 (0.011) 0.339 0.006 (0.021) 0.76 
OD -0.01 (0.011) 0.342 -0.012 (0.011) 0.278 -0.008 (0.012) 0.483 -0.045 (0.022) 0.04 
Middle cerebellar 
peduncle 
ICVF -0.003 (0.011) 0.75 0.003 (0.011) 0.782 0.006 (0.011) 0.624 -0.02 (0.02) 0.332 
ISOVF 0.008 (0.011) 0.455 0.012 (0.011) 0.299 0.048 (0.012) 7.06e-05* 0.024 (0.023) 0.292 
OD -0.006 (0.011) 0.568 -0.007 (0.011) 0.553 -0.013 (0.012) 0.296 0.002 (0.023) 0.942 
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Table S5. The effects of stressful life events (SLE), neuroticism, smoking status and alcohol consumption as covariates for DTI measures. The test 
was conducted on the full sample of IDP from UK Biobank imaging team, without outlier exclusion or phenotypic data merging (N~=8,200). Betas 
were standardised effect sizes. P values were un-corrected p values. All pcorrected<0.05 were marked by asterixis. FDR correction was applied on 
subsets of brain measures within a unit of a whole brain (n=15 for tract analysis, and n=4 for g analysis). 
 
    SLE Smoking Alcohol 
Tract name Measure Beta p Beta p Beta p 
g.Total 
FA -0.015 (0.015) 0.318 -0.025 (0.019) 0.18 -3.03e-04 (7.61e-04) 0.691 
MD 0.01 (0.015) 0.514 0.034 (0.018) 0.057 0.004 (7.26e-04) 1.01e-06* 
g.AF 
FA -0.02 (0.015) 0.187 -0.028 (0.019) 0.139 -7.39e-04 (7.58e-04) 0.329 
MD 0.013 (0.015) 0.401 0.023 (0.018) 0.207 0.003 (7.40e-04) 4.76e-04* 
g.TR 
FA -0.002 (0.016) 0.921 -0.04 (0.019) 0.034 -0.001 (7.69e-04) 0.058 
MD 0.009 (0.014) 0.525 0.053 (0.017) 0.001* 0.004 (6.74e-04) 2.70e-11* 
g.PF 
FA -0.003 (0.015) 0.867 6.36e-04 (0.019) 0.973 0.002 (7.56e-04) 0.001* 
MD -0.003 (0.016) 0.859 0.078 (0.019) 4.63e-05* 0.004 (7.79e-04) 7.85e-07* 
        
Acoustic radiation FA -0.028 (0.014) 0.042 0.015 (0.017) 0.359 9.89e-04 (6.72e-04) 0.141 
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MD 0.011 (0.013) 0.417 -0.028 (0.017) 0.092 3.57e-04 (6.67e-04) 0.592 
Anterior thalamic radiation 
FA -0.006 (0.015) 0.689 0.009 (0.018) 0.636 -0.002 (7.28e-04) 0.008* 
MD 0.001 (0.013) 0.919 0.012 (0.016) 0.476 0.003 (6.63e-04) 6.98e-07* 
Cingulate gyrus part of cingulum 
FA -0.015 (0.014) 0.287 -0.036 (0.017) 0.033 -8.71e-04 (6.78e-04) 0.199 
MD 0.003 (0.014) 0.829 0.016 (0.017) 0.333 5.62e-04 (6.76e-04) 0.406 
Parahippocampal part of cingulum 
FA -0.014 (0.014) 0.308 -0.025 (0.017) 0.146 0.001 (6.82e-04) 0.081 
MD 0.016 (0.014) 0.24 0.022 (0.017) 0.19 4.79e-05 (6.70e-04) 0.943 
Corticospinal tract 
FA 0.007 (0.015) 0.614 -0.02 (0.018) 0.267 0.002 (7.22e-04) 5.90e-04* 
MD -0.004 (0.015) 0.79 6.30e-04 (0.018) 0.972 0.002 (7.27e-04) 0.022* 
Inferior fronto occipital fasciculus 
FA -0.002 (0.015) 0.895 -0.023 (0.018) 0.214 -1.61e-04 (7.32e-04) 0.825 
MD 0.002 (0.014) 0.871 0.022 (0.018) 0.205 0.003 (7.07e-04) 2.35e-05* 
Inferior longitudinal fasciculus 
FA -0.009 (0.015) 0.544 -0.029 (0.018) 0.113 -3.95e-04 (7.28e-04) 0.588 
MD 0.008 (0.014) 0.584 0.013 (0.018) 0.454 0.003 (7.07e-04) 4.01e-06* 
Medial lemniscus 
FA 0.006 (0.013) 0.646 -0.002 (0.016) 0.887 5.77e-04 (6.61e-04) 0.383 
MD -0.032 (0.014) 0.018 0.001 (0.017) 0.933 6.84e-04 (6.79e-04) 0.314 
Posterior thalamic radiation 
FA -0.01 (0.014) 0.481 -0.073 (0.018) 3.65e-05* -0.001 (7.09e-04) 0.037 
MD 0.017 (0.014) 0.222 0.069 (0.017) 3.17e-05* 0.004 (6.71e-04) 3.82e-11* 
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Superior longitudinal fasciculus 
FA -0.027 (0.015) 0.071 -0.011 (0.018) 0.559 -2.87e-04 (7.35e-04) 0.696 
MD 0.006 (0.014) 0.662 0.012 (0.018) 0.497 0.002 (7.16e-04) 0.001* 
Superior thalamic radiation 
FA 0.005 (0.015) 0.748 -0.036 (0.019) 0.053 5.97e-04 (7.53e-04) 0.428 
MD 0.005 (0.013) 0.71 0.045 (0.016) 0.004* 0.003 (6.31e-04) 1.17e-05* 
Uncinate fasciculus 
FA -0.024 (0.014) 0.089 2.29e-04 (0.017) 0.989 -8.46e-04 (6.87e-04) 0.218 
MD 0.002 (0.013) 0.859 -0.008 (0.016) 0.623 0.002 (6.58e-04) 4.13e-04* 
Forceps major 
FA -0.041 (0.015) 0.009 -0.014 (0.019) 0.456 4.88e-05 (7.65e-04) 0.949 
MD 0.026 (0.015) 0.094 0.015 (0.019) 0.43 0.002 (7.62e-04) 0.034* 
Forceps minor 
FA -3.77e-04 (0.015) 0.981 -0.016 (0.019) 0.41 -0.002 (7.66e-04) 0.049 
MD -0.002 (0.015) 0.882 0.031 (0.018) 0.09 0.002 (7.36e-04) 0.005* 
Middle cerebellar peduncle 
FA -0.007 (0.016) 0.676 0.006 (0.019) 0.776 0.002 (7.79e-04) 0.007* 
MD -0.001 (0.016) 0.935 0.084 (0.019) 1.38e-05* 0.004 (7.81e-04) 1.91e-06* 
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Table S6. The effects of stressful life events (SLE), neuroticism, smoking status and alcohol consumption as covariates for NODDI measures. The test was 
conducted on the full sample of IDP from UK Biobank imaging team, without outlier exclusion or phenotypic data merging (N~=8,200). Betas were 
standardised effect sizes. P values were un-corrected p values. All pcorrected<0.05 were marked by asterixis. FDR correction was applied on subsets of brain 
measures within a unit of a whole brain (n=15 for tract analysis, and n=4 for g analysis). 
 
    SLE Smoking Alcohol 
Tract name Measure Beta p Beta p Beta p 
g.Total 
ICVF -0.014 (0.015) 0.368 -0.027 (0.019) 0.16 -0.002 (7.62e-04) 0.002* 
ISOVF 7.46e-04 (0.015) 0.959 0.016 (0.018) 0.385 0.003 (7.27e-04) 3.76e-05* 
OD 0.015 (0.015) 0.334 0.028 (0.018) 0.133 -0.003 (7.46e-04) 4.04e-06* 
g.AF 
ICVF -0.015 (0.015) 0.329 -0.024 (0.019) 0.203 -0.002 (7.63e-04) 0.002* 
ISOVF 0.008 (0.015) 0.586 3.25e-04 (0.019) 0.986 3.19e-04 (7.64e-04) 0.676 
OD 0.015 (0.015) 0.327 0.038 (0.018) 0.038 -0.002 (7.42e-04) 0.001* 
g.TR 
ICVF -0.011 (0.015) 0.466 -0.03 (0.018) 0.105 -0.003 (7.45e-04) 2.78e-04* 
ISOVF 0.008 (0.014) 0.553 0.043 (0.017) 0.01* 0.004 (6.82e-04) 5.39e-11* 
OD -0.003 (0.014) 0.823 0.02 (0.018) 0.25 -0.002 (7.12e-04) 7.06e-04* 
g.PF ICVF -0.009 (0.015) 0.571 -0.025 (0.019) 0.185 -6.51e-04 (7.61e-04) 0.392 
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ISOVF -0.007 (0.016) 0.638 0.08 (0.019) 3.60e-05* 0.004 (7.79e-04) 1.75e-06* 
OD 0.002 (0.015) 0.913 -0.023 (0.019) 0.211 -0.004 (7.57e-04) 2.71e-07* 
        
Acoustic radiation 
ICVF -0.018 (0.015) 0.217 -0.019 (0.018) 0.304 -0.001 (7.40e-04) 0.073 
ISOVF 0.003 (0.013) 0.85 -0.043 (0.016) 0.009* -1.76e-04 (6.59e-04) 0.789 
OD 0.022 (0.013) 0.084 -0.034 (0.016) 0.031 -0.002 (6.38e-04) 0.012* 
Anterior thalamic radiation 
ICVF -0.011 (0.014) 0.46 -0.002 (0.018) 0.89 -0.002 (7.15e-04) 0.002* 
ISOVF -0.012 (0.014) 0.388 0.017 (0.017) 0.334 0.003 (6.90e-04) 1.35e-05* 
OD 0.007 (0.014) 0.638 -3.21e-04 (0.018) 0.985 1.74e-04 (7.11e-04) 0.807 
Cingulate gyrus part of cingulum 
ICVF -0.017 (0.015) 0.238 -0.024 (0.018) 0.175 -0.001 (7.20e-04) 0.156 
ISOVF -0.017 (0.013) 0.21 -0.001 (0.016) 0.951 1.10e-04 (6.56e-04) 0.866 
OD 0.01 (0.013) 0.442 0.027 (0.016) 0.084 1.44e-04 (6.31e-04) 0.819 
Parahippocampal part of cingulum 
ICVF -0.01 (0.014) 0.507 -0.018 (0.018) 0.301 -8.63e-04 (7.10e-04) 0.224 
ISOVF 0.012 (0.013) 0.379 0.016 (0.016) 0.34 -3.81e-04 (6.65e-04) 0.567 
OD 0.009 (0.013) 0.472 0.025 (0.016) 0.112 -0.002 (6.41e-04) 0.01* 
Corticospinal tract 
ICVF -0.012 (0.015) 0.423 -0.037 (0.019) 0.051 -5.42e-04 (7.62e-04) 0.477 
ISOVF -0.008 (0.014) 0.567 -0.015 (0.017) 0.389 0.001 (7.03e-04) 0.051 
OD -0.02 (0.014) 0.155 0.01 (0.017) 0.544 -0.004 (6.97e-04) 2.59e-07* 
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Inferior fronto occipital fasciculus 
ICVF -0.011 (0.015) 0.46 -0.028 (0.019) 0.133 -0.002 (7.48e-04) 0.002* 
ISOVF -0.011 (0.015) 0.462 -0.013 (0.018) 0.482 0.002 (7.18e-04) 0.002* 
OD -0.003 (0.014) 0.831 4.89e-04 (0.017) 0.978 -0.003 (7.01e-04) 4.13e-05* 
Inferior longitudinal fasciculus 
ICVF -0.011 (0.015) 0.461 -0.026 (0.019) 0.158 -0.002 (7.54e-04) 0.003* 
ISOVF -0.001 (0.015) 0.931 -0.015 (0.018) 0.411 0.002 (7.21e-04) 5.48e-04* 
OD 0.002 (0.014) 0.882 0.015 (0.017) 0.402 -0.003 (7.05e-04) 6.46e-06* 
Medial lemniscus 
ICVF 0.016 (0.013) 0.228 -0.006 (0.016) 0.72 0.002 (6.52e-04) 0.012* 
ISOVF -0.022 (0.014) 0.106 0.002 (0.017) 0.897 0.001 (6.79e-04) 0.053 
OD -0.002 (0.014) 0.912 0.026 (0.018) 0.135 7.01e-04 (7.12e-04) 0.325 
Posterior thalamic radiation 
ICVF -0.007 (0.015) 0.636 -0.047 (0.018) 0.011 -0.002 (7.44e-04) 0.002* 
ISOVF 0.017 (0.014) 0.213 0.052 (0.017) 0.002* 0.004 (6.70e-04) 1.07e-09* 
OD 0.005 (0.013) 0.712 0.027 (0.017) 0.103 -0.002 (6.68e-04) 0.011* 
Superior longitudinal fasciculus 
ICVF -0.014 (0.015) 0.352 -0.019 (0.019) 0.312 -0.002 (7.56e-04) 0.009* 
ISOVF -0.006 (0.014) 0.677 -0.006 (0.017) 0.724 0.002 (6.95e-04) 0.015* 
OD 0.029 (0.013) 0.029 -0.006 (0.016) 0.722 -0.003 (6.47e-04) 1.46e-05* 
Superior thalamic radiation 
ICVF -0.014 (0.015) 0.351 -0.039 (0.018) 0.032 -0.002 (7.29e-04) 0.002* 
ISOVF -0.007 (0.012) 0.587 0.027 (0.015) 0.069 0.002 (6.07e-04) 9.54e-04* 
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OD -0.008 (0.014) 0.558 0.016 (0.017) 0.342 -0.003 (6.94e-04) 2.39e-04* 
Uncinate fasciculus 
ICVF -0.015 (0.014) 0.283 -0.014 (0.018) 0.43 -0.003 (7.13e-04) 4.18e-04* 
ISOVF -0.014 (0.014) 0.316 -0.023 (0.017) 0.186 6.85e-04 (6.87e-04) 0.319 
OD 0.016 (0.013) 0.221 0.005 (0.016) 0.739 -8.15e-04 (6.61e-04) 0.217 
Forceps major 
ICVF -0.026 (0.016) 0.099 -0.029 (0.019) 0.131 -0.002 (7.82e-04) 0.005* 
ISOVF 0.021 (0.015) 0.171 5.21e-04 (0.019) 0.978 5.53e-04 (7.60e-04) 0.467 
OD 0.044 (0.015) 0.004 -0.022 (0.019) 0.245 -0.002 (7.50e-04) 0.003* 
Forceps minor 
ICVF -0.007 (0.015) 0.662 -0.013 (0.019) 0.497 -0.002 (7.60e-04) 0.003* 
ISOVF -0.008 (0.015) 0.561 0.016 (0.018) 0.382 9.63e-04 (7.21e-04) 0.182 
OD 0.005 (0.015) 0.721 0.004 (0.019) 0.841 -0.001 (7.59e-04) 0.188 
Middle cerebellar peduncle 
ICVF -5.21e-05 (0.015) 0.997 -0.014 (0.019) 0.439 -5.33e-04 (7.48e-04) 0.476 
ISOVF -0.003 (0.016) 0.834 0.081 (0.019) 2.92e-05* 0.004 (7.80e-04) 6.90e-06* 
OD 0.004 (0.016) 0.784 -0.037 (0.019) 0.055 -0.003 (7.74e-04) 8.81e-04* 
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Table S7. The associations between temporal change of depressive level at the imaging 
assessment compared with mean level and g measures in MD, ISOVF and ICVF. P values 
were uncorrected. Significant p value after FDR correction were marked by asterixis. 
 
g measure 
MD ISOVF ICVF 
Beta std p Beta std p Beta std p 
g.Total 0.027  0.010  0.007*  0.005  0.010  0.598  -0.025  0.011  0.017*  
g.AF 0.025  0.010  0.015*  0.006  0.011  0.586  -0.025  0.011  0.019*  
g.TR 0.022  0.009  0.019*  0.002  0.009  0.832  -0.023  0.010  0.029*  





Table S8. Measures for depressive symptoms and MDD-related phenotypes. MDD phenotypes include three definitions of life-time MDD status (Howard, 
Adams, et al. 2017). These include MDD self (self-reported status of ever had depression or not), smith’s MDD definition (based on self-reported 
depressed symptoms and hospital admission history) and CIDI MDD (derived from Composite International Diagnostic Interview results). CIDI MDD is the 
most clinical definition, whilst MDD self is the most lenient and has the biggest sample size. Other phenotypes include MDD severity assessed by CIDI, 
whether had self-harm behaviour ever in the life time and length of depression (years from first to last episode). Coefficients for MDD phenotypes and 
gender are odds ratios, and for other phenotypes are standardised effect sizes of glm models, and age, age2 and gender were set as covariates for depre, 
depre.mean and depre.instability. Only gender was controlled for depre.longitudinal because the measure was derived controlling for age in the growth 
curve model. All MDD definitions and self-harm behaviour were binary variables, and other phenotypes were continuous. 
 
  Depre Depre.mean Depre.instability Depre.longitudinal 
Dependent variable Coefficient std p Coefficient std p Coefficient std p Coefficient std p 
MDD self 1.867 0.029 <1.00E-16 2.239 0.03 <1.00E-16 1.797 0.026 <1.00E-16 1.27 0.049 4.64E-07 
MDD smith 1.59 0.027 <1.00E-16 1.824 0.029 <1.00E-16 1.654 0.026 <1.00E-16 1.148 0.053 6.87E-03 
MDD CIDI 2.514 0.042 <1.00E-16 4.096 0.052 <1.00E-16 2.363 0.037 <1.00E-16 1.808 0.068 <1.00E-16 
Self harm 1.581  0.041 <1.00E-16 1.714  0.041 <1.00E-16 1.507  0.039 <1.00E-16 1.325 0.089 1.56E-03 
Age of onset -0.102 0.015 2.10E-11 -0.128 0.015 <1.00E-16 -0.057 0.015 1.97E-04 -0.029 0.026 0.266 
             
             
  Depre Depre.mean Depre.instability Depre.longitudinal 
Factor Coefficient std p Coefficient std p Coefficient std p Coefficient std p 
Age -0.173  0.011  <1.00E-16 -0.212  0.011  <1.00E-16 -0.152  0.011  <1.00E-16 -- -- -- 
Gender -0.155  0.022  1.59E-12 -0.197  0.021  <1.00E-16 -0.142  0.021  3.67E-09 -0.048  0.045  0.285  
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Table S1. All phenotypes used in the study. 
 
Category Phenotype Modality Field ID N Note 
Early life factor Breast fed Touchscreen 1677 8173 
 
Early life factor Bodysize at age=10 Touchscreen 1687 10878 
 
Early life factor Height at age=10 Touchscreen 1697 10902 
 
Early life factor Adopted Touchscreen 1767 11006 
 
Early life factor Maternal smoking Touchscreen 1787 9633 
 
Early life factor Multiple birth Touchscreen 1777 10872 
Question asked: Are you a twin, triplet or other 
multiple birth? 
Early life factor Age father death Touchscreen 1807 9180 
if age<40 then coded as 1, age<=40 then 
coded as 0 
Early life factor Age mother death Touchscreen 3526 7742 
if age<40 then coded as 1, age<=40 then 
coded as 0 
Early life factor Birth weight Interview 20022 11017 
 
Early life factor Cancer early Interview 20007 11017 
if age<30 then coded as 1, age<=30 then 
coded as 0 
Sociodemographic Household income Touchscreen 738 9964 
 
Sociodemographic Education Touchscreen 6138 10258 
 
Sociodemographic Ethnicity Touchscreen 21000 8318 
Dimensions were reduced down to: White, 
Black, Asian, Chinese, Mixed and others 





Touchscreen 189 8333 
 
Life style 
Length of mobile phone 
use 
Touchscreen 1110 11014 
 




Weekly usage of mobile 
phone in last 3 months 
Touchscreen 1120 10350 
 
Life style 
Hands free device 
speakerphone use with 
mobile phone in last 3 
month 
Touchscreen 1130 10360 
 
Life style 
Difference in mobile phone 
use compared to two 
years previously 
Touchscreen 1140 10358 
 
Life style 
Usual side of head for 
mobile phone use 
Touchscreen 1150 10344 
 
Life style Plays computer games Touchscreen 2237 11017 
 
Life style Sleep duration Touchscreen 1160 11017 
 
Life style 
Easy to get up in the 
morning 
Touchscreen 1170 11017 
 
Life style Morning or evening person Touchscreen 1180 10586 
 
Life style Nap during the day Touchscreen 1190 11017 
 
Life style Insomnia Touchscreen 1200 11017 
 
Life style Snoring Touchscreen 1210 10814 
 
Life style Daytime dozing sleeping Touchscreen 1220 11017 
 
Life style Sleep too much Touchscreen 20534 3231 
 
Life style Sleep trouble start Touchscreen 20533 3231 
 
Life style Sleep trouble end Touchscreen 20535 3231 
 
Life style Sleep any problem Touchscreen 20517 8327 
 
Life style Ever smoked Touchscreen 20160 11017 
 
Life style Smoking status Touchscreen 20116 11017 
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Life style Current tobacco smoking Touchscreen 1239 11017 
 
Life style Past tobacco smoking Touchscreen 1249 10778 
 
Life style 
Light smokers at least 100 
smokes in lifetime 
Touchscreen 2644 4057 
 
Life style 
Age started smoking in 
former smokers 
Touchscreen 2867 2995 
 
Life style 
Type of tobacco previously 
smoked 
Touchscreen 2877 2995 
 
Life style 
Number of cigarettes 
previously smoked daily 
Touchscreen 2887 2880 
 
Life style Age stopped smoking Touchscreen 2897 2995 
 
Life style 
Ever stopped smoking for 
6 months 
Touchscreen 2907 2963 
 
Life style 
Number of unsuccessful 
stop smoking attempts 
Touchscreen 2926 2993  
Life style 
Likelihood of resuming 
smoking 
Touchscreen 2936 2971  
Life style 
Smoking smokers in 
household 
Touchscreen 1259 10775  
Life style 
Exposure to tobacco 
smoke at home 
Touchscreen 1269 10782  
Life style 
Exposure to tobacco 
smoke outside home 
Touchscreen 1279 10782  
Life style Cooked vegetable intake Touchscreen 1289 11017  
Life style 
Salad raw vegetable 
intake 
Touchscreen 1299 11017  
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Life style Fresh fruit intake Touchscreen 1309 11017  
Life style Dried fruit intake Touchscreen 1319 11017  
Life style Oily fish intake Touchscreen 1329 11016  
Life style Non oily fish intake Touchscreen 1339 11016  
Life style Processed meat intake Touchscreen 1349 11017  
Life style Poultry intake Touchscreen 1359 11017  
Life style Beef intake Touchscreen 1369 11016  
Life style Lamb mutton intake Touchscreen 1379 11017  
Life style Pork intake Touchscreen 1389 11013  
Life style 
Never eat eggs dairy 
wheat sugar 
Touchscreen 6144 11017  
Life style Cheese intake Touchscreen 1408 10954  
Life style Bread intake Touchscreen 1438 11017  
Life style Cereal intake Touchscreen 1458 11017  
Life style Salt added to food Touchscreen 1478 11017  
Life style Tea intake Touchscreen 1488 11017  
Life style Coffee intake Touchscreen 1498 11017  
Life style Hot drink temperature Touchscreen 1518 11017  
Life style Water intake Touchscreen 1528 11017  
Life style 
Major dietary changes in 
the last 5 years 
Touchscreen 1538 11017  
Life style Variation in diet Touchscreen 1548 11016 
 
Life style 
Time spend outdoors in 
summer 
Touchscreen 1050 11017 
 
Life style 
Time spent outdoors in 
winter 
Touchscreen 1060 11017 
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Life style Skin colour Touchscreen 1717 10987 
 





Touchscreen 1737 11017 
 
Life style Hair colour Touchscreen 1747 11015 
 
Life style Facial ageing Touchscreen 1757 10708 
 
Life style Use of sun protection Touchscreen 2267 11017 
 
Life style 
Frequency of solarium 
sunlamp use 
Touchscreen 2277 11017  
Life style 
Frequency of friend family 
visits 
Touchscreen 1031 11016  
Life style Leisure activities Touchscreen 6160 11016  
Life style Able to confide Touchscreen 2110 10970  
Life style 
Vitamin and mineral 
supplements 
Touchscreen 6155 11016 
 
Life style 
Mineral and other dietary 
supplements 
Touchscreen 6179 11017 
 
Life style Alcohol weekly unit Touchscreen 
1568, 1578, 1588, 
1598, 5364, 1608, 
4407, 4418, 4429, 
4440, 4451, 4462 
11017 
Derived based on multiple fields. Ref: Clarke 
et al. (2017) Mol Psychiatry (22),1376–1384 
Physical measure Overall health rating Touchscreen 2178 11016  
Physical measure 
Long standing illness, 
disability or infirmity 
Touchscreen 2188 10996  
Physical measure Falls in the last year Touchscreen 2296 11017  




Weight change compared 
with 1 year ago 
Touchscreen 2306 11003  
Physical measure Leg pain on walking Touchscreen 4728 10964  
Physical measure 
Leg pain when standing 
still or sitting 
Touchscreen 5452 2455  
Physical measure Leg pain in calf/calves Touchscreen 5463 2491  
Physical measure 
Leg pain when walking 
uphill or hurrying 
Touchscreen 5474 2436  
Physical measure 
Leg pain when walking 
normally 
Touchscreen 5485 2473  
Physical measure 
Leg pain on walking action 
taken 
Touchscreen 5507 2491  
Physical measure 
Leg pain on walking effect 
of standing still 
Touchscreen 5518 2227  
Physical measure 
Surgery on leg arteries 
other than for varicose 
veins 
Touchscreen 5529 2513  
Physical measure 
Surgery amputation of toe 
or leg 
Touchscreen 5540 2507  
Physical measure Ever pain last month Touchscreen 6159 11017  
Physical measure Headaches for 3 months Touchscreen 3799 2865  
Physical measure 
Neck shoulder pain for 3 
months 
Touchscreen 3404 3507  
Physical measure Back pain for 3 months Touchscreen 3571 3803  
Physical measure Knee pain for 3 months Touchscreen 3773 3401  




Ever vascular heart 
problem diagnosed 
Touchscreen 6150 11014  
Physical measure 
Age high blood pressure 
diagnosed 
Touchscreen 2966 3201  
Physical measure 
Blood clot problem 
diagnosed 
Touchscreen 6152 11017  
Physical measure 
Age hay fever, rhinitis or 
eczema diagnosed 
Touchscreen 3761 3406  
Physical measure 
Diabetes diagnosed by 
doctor 
Touchscreen 2443 11016  
Physical measure 
Cancer diagnosed by 
doctor 
Touchscreen 2453 11016  
Physical measure 
Fractured broken bones in 
last 5 years 
Touchscreen 2463 11011  
Physical measure 
Other serious medical 
condition diagnosed by 
doctor 
Touchscreen 2473 11000  
Physical measure 
Medication for cholesterol, 
blood pressure, diabetes 
or take exogenous 
hormones 
Touchscreen 6153 5700  
Physical measure 
Medication for pain relief, 
constipation or heartburn 
Touchscreen 6154 11015  
Physical measure 
Diastolic blood pressure 
(automated reading) 
Physical measure 4079 10983  




Pulse rate (automated 
reading) 
Physical measure 94 10983  
Physical measure 
Systolic blood pressure 
(automated reading) 
Physical measure 95 10983  
Physical measure Pulse rate Physical measure 4194 10951  
Physical measure 
Pulse wave Arterial 
Stiffness Index 
Physical measure 21021 10932  
Physical measure 
Pulse wave peak to peak 
time 
Physical measure 4196 10946  
Physical measure 
Pulse wave Reflection 
Index 
Physical measure 4195 10951  
Physical measure Body Mass Index Physical measure 23104 10883  
Physical measure Leg fat free mass (right) Physical measure 23113 10883  
Physical measure Leg predicted mass (left) Physical measure 23118 10883  
Physical measure Leg predicted mass (right) Physical measure 23114 10883  
Physical measure Arm fat percentage (left) Physical measure 23123 10882  
Physical measure Arm fat percentage (right) Physical measure 23119 10883  
Physical measure Arm fat mass (left) Physical measure 23124 10881  
Physical measure Arm fat mass (right) Physical measure 23120 10881  
Physical measure Arm fat free mass (right) Physical measure 23121 10882  
Physical measure Arm fat free mass (left) Physical measure 23125 10880  
Physical measure Arm predicted mass (left) Physical measure 23126 10879  
Physical measure Arm predicted mass (right) Physical measure 23122 10882  
Physical measure Trunk fat percentage Physical measure 23127 10877  
Physical measure Trunk fat mass Physical measure 23128 10875  
Physical measure Trunk fat free mass Physical measure 23129 10870  
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Physical measure Trunk predicted mass Physical measure 23130 10869  
Physical measure Basal metabolic rate Physical measure 23105 10883  
Physical measure Body fat percentage Physical measure 23099 10876  
Physical measure Whole body fat mass Physical measure 23100 10868  
Physical measure Whole body fat free mass Physical measure 23101 10883  
Physical measure Whole body water mass Physical measure 23102 10883  
Physical measure Leg fat percentage (left) Physical measure 23115 10883  
Physical measure Leg fat percentage (right) Physical measure 23111 10883  
Physical measure Leg fat mass (left) Physical measure 23116 10883  
Physical measure Leg fat mass (right) Physical measure 23112 10883 
 
Physical measure Leg fat free mass (left) Physical measure 23117 10883 
 
Physical measure Impedance of whole body Physical measure 23106 10882 
 
Physical measure Impedance of arm (left) Physical measure 23110 10883 
 
Physical measure Impedance of arm (right) Physical measure 23109 10883 
 
Physical measure Impedance of leg (left) Physical measure 23108 10883 
 
Physical measure Impedance of leg (right) Physical measure 23107 10883 
 
Physical measure Hand grip strength (left) Physical measure 46 11016 
 
Physical measure Hand grip strength (right) Physical measure 47 11017 
 
Cognition Trail making Touchscreen 6348, 6350 5699 Derived by substuding Trail#1 by Trail#2 
Cognition Digit substitute Touchscreen 23324 6075 
 
Cognition Numeric memory Touchscreen 100029 5781 
 
Cognition gCog NA NA 5247 
Derived by conducting PCA on all cognition 
results. The scores of the first un-rotated 
principal component were extracted as the g 
measure. 
Mental health MDD-Nerves Touchscreen 2090 8164 
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Mental health MDD-Smith Touchscreen 20126 7137 
 
Mental health MDD-ICD Interview 135 4430 
 






Over four items met then coded as 1, 
otherwise 0 
Mental health Recurrent depression Online follow-up 20442 3788 MDD-CIDI=1, plus episodes reported > 1 
Mental health Single depression Online follow-up 20442 3788 MDD-CIDI=1, plus episodes reported = 1 
Mental health Postnatal depression Online follow-up 20445 7201 





Online follow-up 20447 3788 
Single depression=1, plus trauma reported 
Mental health Neuroticism Touchscreen 20127 7085 
 
Mental health Loneliness Online follow-up 2020 8257 
 






8340 Add up score 





8340 Add up score 
Mental health Depression age onset Online follow-up 20433 4702 
 
Mental health 
Depression age last 
episode 
Online follow-up 20434 4702 
 




























Mental health Wider Bipolar definition Online follow-up 20548 8269 Total manifestations >=3 items 
Mental health Bipolar disorder (type I) Online follow-up 20493 8269 
MDD-CIDI=1, plus schizophrenic symptoms 
reported 
Mental health Bipolar disorder (type II) Online follow-up 20493 8269 
MDD-CIDI=1, plus schizophrenic symptoms 
absent 
Mental health 







5816 Total manifestations >=5 items 
Mental health 
Total bipolar disorder 
manifestations 
Online follow-up 20548 8340 
 
Mental health 
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Reported cannabis use or AUDIT score >=16 






























8317 PCL (PTSD check list) score > 13 






Mental health Self harm ever Online follow-up 20480 8317 
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Mental health Not worth living Online follow-up 20479 8340 
 





Mental health Any comorbidity Online follow-up NA 8340 
Summary of whether is case in wider bipolar 
definition, GAD ever, addiction ever, and 
unusual experience ever. If is case in any of 
the conditions then coded as 1, otherwise 0. 
Mental health Multiple comorbidity Online follow-up NA 8340 
Summary of total conditions in wider bipolar 
definition, GAD ever, addiction ever, and 
unusual experience ever 




Mental health Schizophrenia Interview 8340 
 
Mental health 
Psychosis (other than 




Mental health Any phychosis Interview 8340 
 
Mental health Personality disorder Interview 8340 
 
Mental health Uncategorised phobia Interview 8340 
 







Mental health Mania bipolar Interview 8340 
 
Mental health Mood disorder Interview 8340 
 
Mental health Bulimia nervosa Interview 8340 
 
Mental health Binge eating Interview 8340 
 
Mental health Autism spectrum disorder Interview 8340 
 








Mental health Anorexia nervosa Interview 8340 
 
Mental health Any eating disorder Interview 8340 
 
Mental health Agoraphobia Interview 8340 
 




















































Intracranial volume Imaging 
25088, 25006, 
25004 
Add-up of grey matter, white matter and 
ventricular cerebrospinal fluid was generated 
as a measure of intracranial volume. 
White matter 
microstructure 
g.FA.Total Imaging NA 
9,699 




g.FA.Association fibres Imaging NA 
White matter 
microstructure 
g.FA.Thalamic radiations Imaging NA 
White matter 
microstructure 
g.FA.Projection fibres Imaging NA 
White matter 
microstructure 




g.MD.Association fibres Imaging NA 
White matter 
microstructure 
g.MD.Thalamic radiations Imaging NA 
White matter 
microstructure 
g.MD.Projection fibres Imaging NA 
White matter 
microstructure 
FA.Acoustic radiation Imaging 25488, 25489 





Imaging 25490. 25491 
White matter 
microstructure 
FA.Cingulate gyrus part of 
cingulum 
Imaging 25492, 25493 







Imaging 25494, 25495 
White matter 
microstructure 










Imaging 25502, 25503 
White matter 
microstructure 















Imaging 25511, 25512 
White matter 
microstructure 
FA.Uncinate fasciculus Imaging 25513, 25514 
White matter 
microstructure 














MD.Acoustic radiation Imaging 25516, 25517 9671 Bilateral tracts. Hemisphere was controlled for. 







Imaging 25517, 25518 
White matter 
microstructure 
MD.Cingulate gyrus part of 
cingulum 





Imaging 25523, 25524 
White matter 
microstructure 










Imaging 25529, 25530 
White matter 
microstructure 















Imaging 25538, 25539 
White matter 
microstructure 
MD.Uncinate fasciculus Imaging 25540, 25541 
White matter 
microstructure 




MD.Forceps minor Imaging 25526 
 











1548 connections between 
55 nodes 
Imaging 25753 10121 
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g.Total gAF gTR gPF g.Total gAF gTR gPF 
Parahippocampal part of cingulum 0.353 0.361 -- -- 0.461 0.575 -- -- 
Parahippocampal part of cingulum 0.397 0.413 -- -- 0.433 0.544 -- -- 
Forceps major 0.546 0.557 -- -- 0.489 0.54 -- -- 
Cingulate gyrus part of cingulum 0.563 0.639 -- -- 0.633 0.598 -- -- 
Cingulate gyrus part of cingulum 0.586 0.662 -- -- 0.638 0.614 -- -- 
Uncinate fasciculus 0.647 0.665 -- -- 0.665 0.716 -- -- 
Uncinate fasciculus 0.684 0.698 -- -- 0.749 0.777 -- -- 
Superior longitudinal fasciculus 0.823 0.801 -- -- 0.85 0.788 -- -- 
Superior longitudinal fasciculus 0.814 0.802 -- -- 0.865 0.809 -- -- 
Forceps minor 0.804 0.804 -- -- 0.725 0.668 -- -- 
Inferior longitudinal fasciculus 0.824 0.818 -- -- 0.855 0.856 -- -- 
Inferior longitudinal fasciculus 0.844 0.824 -- -- 0.902 0.878 -- -- 
Inferior fronto-occipital fasciculus 0.822 0.828 -- -- 0.859 0.848 -- -- 
Inferior fronto-occipital fasciculus 0.852 0.842 -- -- 0.892 0.868 -- -- 
Superior thalamic radiation 0.651 -- 0.739 -- 0.778 -- 0.853 -- 
Superior thalamic radiation 0.641 -- 0.744 -- 0.746 -- 0.83 -- 
Posterior thalamic radiation 0.672 -- 0.779 -- 0.756 -- 0.86 -- 
Posterior thalamic radiation 0.677 -- 0.804 -- 0.775 -- 0.884 -- 
Anterior thalamic radiation 0.775 -- 0.806 -- 0.837 -- 0.863 -- 
Anterior thalamic radiation 0.769 -- 0.818 -- 0.83 -- 0.863 -- 
Medial lemniscus 0.273 -- -- 0.505 0.22 -- -- 0.231 
Middle cerebellar peduncle 0.364 -- -- 0.525 0.325 -- -- 0.956 
Medial lemniscus 0.286 -- -- 0.53 0.197 -- -- 0.2 
Acoustic radiation 0.621 -- -- 0.57 0.492 -- -- 0.289 
Acoustic radiation 0.635 -- -- 0.627 0.524 -- -- 0.245 
Corticospinal tract 0.579 -- -- 0.817 0.585 -- -- 0.268 
Corticospinal tract 0.586 -- -- 0.834 0.585 -- -- 0.274 
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Table S3. List of regions for the functional connectivity that positively associate with higher 
Depression-PGRS. The report was generated using the ‘report’ function in SPM 12. 
 
Coordination of 
the voxel with 
the highest 
intensity in the 
cluster 
AAL regions Number of voxels Highest intensity 
-10, -60, 18 Precuneus_L (aal) 5236 0.16795 
-34, 36, -10 Frontal_Inf_Orb_L (aal) 2807 0.14045 
-22, 28, 40 Frontal_Mid_L (aal) 1930 0.17721 
26, 32, 34 Frontal_Mid_R (aal) 1575 0.14386 
58, -8, -10 Temporal_Mid_L (aal) 933 0.096372 
14, -78, -32 Cerebelum_Crus1_R (aal) 897 0.092922 
-52, -12, 32 Postcentral_L (aal) 886 0.17333 
-20, 58, , 0 Frontal_Sup_L (aal) 851 0.10166 
-40, -70, 34 Occipital_Mid_L (aal) 545 0.074744 
50, -12, -12 Temporal_Mid_R (aal) 540 0.078985 
-32, -40, -12 Fusiform_L (aal) 462 0.11144 
22, 60, -2 Frontal_Sup_Orb_R (aal) 372 0.097698 
-12, 48, 14 Frontal_Sup_Medial_L (aal) 243 0.082818 
16, -60, -24 Cerebelum_6_L (aal) 224 0.086436 
0, -60, -24 Vermis_6 (aal) 203 0.076384 
24, -20, -16 Hippocampus_R (aal) 192 0.090945 
24, -38, -12 Fusiform_R (aal) 174 0.085587 
24, -20, -16 Hippocampus_L (aal) 141 0.10302 
16, -62, -18 Cerebelum_6_R (aal) 137 0.075099 
36, -6, 14 Insula_R (aal) 130 0.09974 
-36, -8, 14 Rolandic_Oper_L (aal) 91 0.086849 
46, -52, -10 Temporal_Inf_L (aal) 84 0.061853 
-10, -78, -32 Cerebelum_Crus2_L (aal) 56 0.05745 
-10, -2, 14 Caudate_L (aal) 54 0.077763 
48, -66, 36 Angular_R (aal) 42 0.047485 
10, -68, -50 Cerebelum_8_L (aal) 40 0.061126 
2, -52, -18 Vermis_4_5 (aal) 33 0.060399 
42, -16, -24 Fusiform_R (aal) 27 0.071946 
40, -4, -44 Temporal_Inf_R (aal) 22 0.066757 
10, 48, -10 Frontal_Med_Orb_R (aal) 22 0.062801 
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Table S4. List of regions for the functional connectivity that negatively associate with 




the voxel with the 
highest intensity 
in the cluster 
AAL regions Number of voxels 
Lowest 
intensity 
18, 64, -6 Frontal_Sup_Orb_R, (aal) 13358 -0.10955 
26, -96, -4 Occipital_Inf_R, (aal) 3818 -0.16348 
-52, -48,, 4 Temporal_Mid_L, (aal) 1244 -0.06084 
-30, -46, 38 Parietal_Inf_L, (aal) 1207 -0.07073 
44, 12, 32 Frontal_Inf_Oper_R, (aal) 977 -0.06305 
32, 22, 10 Insula_R, (aal) 565 -0.08861 
-10, -66, 32 Precuneus_L, (aal) 514 -0.09174 
14, -64, 34 Precuneus_R, (aal) 376 -0.08152 
30, -6, 52 Precentral_R, (aal) 374 -0.06178 
44, -24, 38 Postcentral_R, (aal) 300 -0.0564 
60, -22, -6 Temporal_Sup_R, (aal) 245 -0.04927 
38, -54, -42 Cerebelum_Crus1_L, (aal) 180 -0.05439 
44, -52, -12 Temporal_Inf_L, (aal) 150 -0.05388 
64, -50, , 6 Temporal_Mid_R, (aal) 65 -0.03867 
22, -68, -50 Cerebelum_8_L, (aal) 64 -0.04105 
22, -38, -44 Cerebelum_10_R, (aal) 50 -0.0544 
16, -42, -44 Cerebelum_9_L, (aal) 50 -0.05161 
-28, -70, 26 Occipital_Mid_L, (aal) 50 -0.04033 
-10, -2, 14 Caudate_L, (aal) 33 -0.06296 
-38, -4, 16 Insula_L, (aal) 33 -0.06194 
22, 28, -16 Frontal_Sup_Orb_R, (aal) 26 -0.0404 
44, -8, 54 Precentral_R, (aal) 26 -0.03745 
20, -28, -6 Hippocampus_L, (aal) 25 -0.06612 
38, -2, 16 Insula_R, (aal) 24 -0.05134 
24, -56, -50 Cerebelum_8_L, (aal) 23 -0.04057 
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The UK Biobank covers an age range from 40 to 70 at the initial visit, and by the time 
of the imaging assessment, the age range was from 45 to 75, because the imaging 
assessment took place after the initial visit. The imaging sample was selected within 
the overall sample for predominantly healthy participants to achieve a selection of 
population-based sample. The UK Biobank sample chose mainly white people with 
European ancestry. The education level was comparatively high, with a proportion of 
53.15% received college or university level degree. 
Clustering of 55*55 matrix 
The clustering for the whole-brain analyses on 55*55 connectivity matrix was for better 
illustration, using hierarchical clustering approach described in: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076315. The 
number of cluster was user-defined as n=5. 
Educational attainment and household income 
For educational attainment, participants could choose at least one of the following 
options: College or university degree, A levels/AS levels or equivalent, O 
levels/GCSEs or equivalent, CSEs or equivalent, NVQ or HND or HNC or equivalent, 
other professional qualifications, none of the above, and prefer not to answer. 
For household income, available choices were: <£18,000, £18,000 to £30,999, 
£31,000 to £51,999, £52,000 to £100,000, >£100,000, do not know and prefer not to 
answer. An ordinal variable from 1 to 5 was created to determine the level of 
household income (<£18,000 as 1, >£100,000 as 5). 
PCA analysis for cognitive performance, educational attainment and household 




As the results in the main text showed that the regions involved in the three traits were 
highly overlapping, we have conducted a PCA analysis to extract the first unrotated 
latent component of the three traits, and used the scores for the factor to test the 
resting-state-network associations with the common variance of all three traits. 
PCA was conducted using princomp in R (https://stat.ethz.ch/R-manual/R-
devel/library/stats/html/princomp.html). Results are shown in supplementary results 
and Figure S5. 
Permutation test 
As we now have an updated sample of 7,144 people (from the latest data release), 
we have now additionally conducted two further sets of analyses to validate our results. 
First we performed permutation test on half-sized sample (N=3,572) and tested the 
distributions of the p values for the significant connections found in 55*55 matrix 
described in our initial findings. After 1,000 times of randomly selecting half of our 
sample, conducting analyses on them, we found that the distributions of p values for 
over 90% of the significant connections found in our initial results were lower, 
compared with the mean p value for the rest of connections (Figure S7-S9).  
Second, another permutation test was performed to test whether the results found in 
a training subsample can predict the results in a separate testing sample. We cut the 
sample in halves, and used the first half as a training dataset and the second half as 
a testing dataset. We extracted the effect sizes for the 55*55 connectivity matrix 
acquired from the training sample and applied them on the testing dataset to calculate 
a neural connectivity score for the trait. And then we used the neural connectivity 
score to predict the variances for the traits in the testing sample. For instance, we 
used the effect sizes of cognitive performance in the training sample (βtraining), and 
calculated the sum of βtraining*Connectivitytesting as the neural-network score of 
cognitive performance in the testing sample. We then used this score to predict the 
cognitive performance, educational attainment and household income in the testing 
sample. Age, age2, gender, scanner positions and mean motion were controlled. 
Likewise permutation tests were conducted to use the neural associations of 
educational attainment or household income to predict other traits in the testing 
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sample. Results are shown in Figure S10.  
Supplementary Results 
Phenotypic associations 
The mean test performance score for the VNR was 6.92 (SD = 2.15). Age and sex 
both showed significant associations with VNR score (age: β=-0.07, p=3.50Χ10-5, 
sex: β=0.19, p=3.18Χ10-9; Male=1, Female=0).  
In total, 1,801 participants reported having obtained a college/university-level degree 
(43.29% of the overall sample). The mean age of people with a college/university-
level degree was 61.62 (SD=7.49), which was significantly lower than the group 
without (Mean age=62.65, SD=7.58, t=4.37, p=1.27Χ10-5). Men reported a 
significantly higher proportion of college degrees (48.80%) than women (39.73%), 
χ2=34.8, df=1, p=3.65Χ10-9. Educational attainment showed positive association with 
cognitive performance, with age, age2 and sex controlled (β=0.457, p<2Χ10-16). 
The proportion of people who reported having household income at each level is 
shown in Figure S1. The income band of £31,000 to £51,999 contained the highest 
proportion (29.98%) of individuals, and the band >£100,000 contained the lowest 
proportion (6.06%). Both age and sex showed significant associations with household 
income (age: β=-0.29, p<2Χ10-16; sex: β=0.20, p=1.04Χ10-9). Higher household 
income was associated with better cognitive performance (β=0.167, p<2Χ10-16), with 
age, age2, and sex controlled in the model. 
PCA analysis of cognitive performance, educational attainment and household 
income 
The first latent component (g) of the three traits explains a major portion of total 
variance (75.6%), it was heavily loaded on cognitive performance (correlation 
loadings: cognitive performance: 0.998, educational attainment: 0.261, household 
income: 0.220).  
We have conducted an additional analysis using the first latent component as a 
predictor and tested the shared component of cognitive performance, educational 
attainment and household income on the resting-state networks (see supplementary 
methods). Results are shown in Figure S7. As expected, the regions involved with 
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stronger connections with latent g of the three traits were mainly located in default 
mode network areas and lateral prefrontal cortex.  




Figure S1. Descriptive statistics of (a) cognitive performance on the verbal-numerical 
reasoning test; (b) educational attainment (those with [0] and without [1] a college degree; and 
(c) household income (GBP per annum). 
 
  





Figure S2. (A) Five intrinsic functional networks selected from the 21 components generated 
by low-dimension ICA (see Methods, Imaging data). Component 1 was identified as the default 
mode network (DMN, red). Component 13 and 21 were left and right cingulo-opercular network 
(CON) respectively (yellow). And finally, component 5 and 6 were identified as right and left 
fronto-parietal network (FPN, blue). (B) The mean values of couplings of networks of interest. 
The values are standardised temporal correlation coefficient between networks of interest. A 
higher absolute value indicates a higher strength, and the sign indicates the directionality of 
the connection. A negative value means an anti-correlated connection, whilst a positive value 
indicates a positive connection. Mean values and 95% confident intervals of the connections 
can be viewed in Table 1. 
 
  




Figure S3. (A) Significant network couplings associated with cognitive performance in verbal-
numerical reasoning (absolute β ranged from 0.034 to 0.063, all effect sizes of the significant 
connections are reported in Table 1). An orange arrow means positive association between 
cognitive ability with the absolute strength of a connection, whilst a blue arrow indicates 
decreased absolute strength of a connection with better cognitive performance. Solid arrows 
are positive connections and dashed ones are negative. An orange arrow reflects positive 
associations between cognitive ability with the absolute strength of a connection, whilst a blue 
arrow indicates decreased absolute strength of a connection with better cognitive performance. 
(B) and (C) represent the association of cognitive performance in verbal-numerical reasoning 
and the connection between left/right CON (β=0.061 and -0.045 respectively for left/right CON) 
and DMN (β=-0.045). Y-axis represent the normalised correlation coefficient between temporal 
modulations of networks. Better cognitive performance was associated with more positive 
connections between DMN and bilateral CON. The spatial maps of the functional networks 
can be found in Figure S2. 
 
  





Figure S4. Results for whole-brain analysis of non-binary proxy for educational attainment. 








Figure S5. Results for whole brain analysis of the first latent component of cognitive 
performance (VNR), educational attainment and household income. The first latent component 
was extracted from unrotated PCA by using princomp in R (https://stat.ethz.ch/R-manual/R-
devel/library/stats/html/princomp.html). This component explains 75.6% of total variance. 
Correlation loadings for the factor are: cognitive performance: 0.998, educational attainment: 
0.261, household income: 0.220. 
  




Figure S6. Mediation analysis for NOI results. Network connectivity was set as the predictor, 
and educational attainment as the dependent variable. Mediator was set as cognitive 
performance. We tested on two network connections that were significant for both educational 
attainment and cognitive performance. The association between rFPN-rCON and rCON-DMN 
connectivity and educational attainment was mediated by cognitive performance (18.4% and 
76.2% of direct path mediated by indirect path respectively for each model, CFI = TLI = 1). 
 
 





Figure S7. Permutation test on cognitive performance (VNR). X axis shows the connections, and y axis shows the uncorrected p value transformed by -log10 
function. T-test was performed on the p-value distributions for each connection that was found associated with VNR to test whether these tested connections 
have significantly lower p values compared to the non-significant connections in the initial finding. The dashed blue line is the mean uncorrected p value of 
all other connections. Two connections’ p values were not significantly lower than the mean p value of all other connections (N44-N17: t(999)=18.25, p<1E-
16, and N45-N44: t(999)=6.95, p=6.50E-12). All other connections have lower p values compared to the non-significant ones, which takes up 92.3% of all 26 
connections (t-test p<1E-16).  




Figure S8. Permutation test on educational attainment. X axis shows the connections, and y axis shows the uncorrected p value transformed by -log10 
function. T-test was performed on the p-value distributions for each connection that was found associated with educational attainment to test whether these 
tested connections have significantly lower p values compared to the non-significant connections in the initial finding. The dashed blue line is the mean 
uncorrected p value of all other connections. Three connections’ p values were not significantly lower than the mean p value of all other connections (N44-
N25: t(999)=1.22, p=0.22, N45-N44: t(999)=11.55, p<1E-16, and N47-N45: t(999)=4.98, p=7.34E-7). All other connections have lower p values compared 
to the non-significant ones, which takes up 90.0% of all 33 connections (t-test p<1E-16). 
  




Figure S9. Permutation test on household income. X axis shows the connections, and y axis shows the uncorrected p value transformed by -log10 function. 
T-test was performed on the p-value distributions for each connection that was found associated with household income to test whether these tested 
connections have significantly lower p values compared to the non-significant connections in the initial finding. The dashed blue line is the mean uncorrected 
p value of all other connections. All the connections have lower p values compared to the non-significant ones (t-test p<4.91E-8). 
 




Figure S10. Using the model built by the training sample to predict the traits in the testing 
sample. The x axis is the models of using predictors derived from training sample to predict 
the trait as the dependent variable in the testing sample. In panel a, the y axis is the 
uncorrected p value transformed by -log10. In panel a, the red dashed line is the p=0.05 
significance line, as there is no baseline mean p value to compare with like in Figure S6-8. In 
Figure b, the y axis is the standardised effect size. We also conducted t-test to compare the 
effect sizes with 0, and all models showed significant difference from 0 (income_income: p = 
0.009, for all other models: p < 1×10-16). 
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Table S1. Connections that showed significant association with cognitive performance in VNR on 55*55 partial correlation matrix. All reported betas are 
standardised effect sizes. The regression model was applied to test the association between VNR and absolute strength of connections, which was achieved 
by multiplying values of connections with the sign of their mean value (see Methods). The spatial maps of the nodes in the table indicated by numbers can 
be found in Figure 2. 
 
 
Beta Standard error t.value p p.corrected 
Valence of 
connection 
95% CI of value of connection 
N17_N15 0.054  0.016  -3.403  6.73E-04 0.038  + 1.215  1.275  
N21_N11 0.062  0.016  3.901  9.72E-05 0.014  - -1.939  -1.881  
N21_N7 0.097  0.016  6.140  9.09E-10 0.000  + 3.746  3.829  
N22_N1 0.061  0.016  -3.789  1.53E-04 0.018  - -0.561  -0.510  
N24_N4 -0.066  0.016  -4.092  4.37E-05 0.007  - -1.136  -1.075  
N24_N9 -0.083  0.016  5.196  2.14E-07 <0.001  + 0.319  0.363  
N25_N5 -0.072  0.016  4.488  7.39E-06 0.002  - -0.639  -0.579  
N26_N12 0.081  0.016  5.036  4.96E-07 0.000  + 3.746  3.829  
N28_N24 0.076  0.016  4.737  2.25E-06 0.001  + 0.151  0.206  
N29_N11 0.059  0.016  3.671  2.45E-04 0.021  + 0.762  0.830  
N31_N12 -0.066  0.016  -4.109  4.06E-05 0.007  + 1.234  1.300  
N33_N13 0.060  0.016  -3.751  1.78E-04 0.018  - -0.702  -0.649  
N33_N22 0.055  0.016  3.412  6.52E-04 0.038  + 0.649  0.701  
N39_N33 0.074  0.016  -4.580  4.80E-06 0.001  - -0.561  -0.510  
N42_N18 0.055  0.016  3.445  5.77E-04 0.037  + 1.671  1.737  
N42_N6 -0.056  0.016  3.516  4.43E-04 0.031  - -0.594  -0.548  
N44_N17 0.054  0.016  3.425  6.21E-04 0.038  + 0.276  0.314  
N44_N25 0.071  0.016  4.477  7.78E-06 0.002  + 2.321  2.383  
N45_N15 0.059  0.016  3.682  2.34E-04 0.021  + 1.233  1.291  
N45_N44 0.055  0.016  -3.494  4.81E-04 0.032  - -1.264  -1.217  




Beta Standard error t.value p p.corrected 
Valence of 
connection 
95% CI of value of connection 
N45_N5 -0.058  0.016  -3.625  2.93E-04 0.024  + 0.026  0.095  
N46_N25 -0.057  0.016  -3.543  4.00E-04 0.030  + 0.002  0.046  
N47_N31 0.059  0.016  3.766  1.68E-04 0.018  + 1.096  1.159  
N48_N19 0.061  0.016  -3.780  1.59E-04 0.018  - -0.679  -0.627  
N48_N21 -0.061  0.016  -3.804  1.44E-04 0.018  + 0.005  0.053  
N50_N7 0.057  0.016  -3.591  3.33E-04 0.026  - -0.251  -0.213  
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Table S2. Connections that showed significant association between their absolute strength with educational attainment on the whole brain proxied by 55*55 
partial correlation matrix. The spatial maps of the nodes in the table indicated by numbers can be found in Figure 2. 
 
 Beta Standard error t.value p p.corrected 
Valence of 
connection 
95% CI of value of connection 
N5-N4 -0.103  0.031  3.290  1.01E-03 0.045  - -0.720  -0.660  
N8-N3 -0.119  0.031  -3.809  1.42E-04 0.018  + 0.903  0.994  
N12-N5 0.132  0.031  -4.201  2.71E-05 0.007  - -2.111  -2.036  
N12-N11 0.106  0.031  3.394  6.94E-04 0.040  + 6.507  6.608  
N15-N7 0.122  0.031  3.949  7.96E-05 0.015  + 0.875  0.929  
N17-N15 0.121  0.031  -3.905  9.59E-05 0.015  - -0.825  -0.784  
N19-N18 -0.136  0.031  4.338  1.47E-05 0.005  - -0.747  -0.689  
N20-N10 -0.109  0.031  3.488  4.91E-04 0.038  - -0.443  -0.399  
N24-N4 -0.108  0.031  -3.428  6.15E-04 0.038  + 0.588  0.651  
N25-N3 0.137  0.031  -4.355  1.36E-05 0.005  - -0.264  -0.223  
N25-N4 -0.161  0.031  -5.150  2.73E-07 <0.001  + 0.995  1.059  
N26-N12 0.108  0.031  3.457  5.51E-04 0.038  + 3.746  3.829  
N29-N25 0.108  0.031  -3.440  5.88E-04 0.038  + 0.180  0.241  
N31-N7 0.125  0.031  -3.995  6.57E-05 0.014  - -1.939  -1.881  
N33-N2 -0.103  0.031  -3.294  9.96E-04 0.045  + 0.257  0.310  
N34-N26 -0.133  0.031  -4.254  2.14E-05 0.006  + 0.320  0.378  
N35-N33 0.108  0.031  -3.452  5.63E-04 0.038  - -0.075  -0.035  
N36-N35 0.105  0.031  -3.363  7.79E-04 0.041  - -0.636  -0.596  
N40-N7 0.118  0.031  -3.761  1.72E-04 0.020  - -0.694  -0.648  
N40-N34 0.122  0.031  -3.888  1.03E-04 0.015  - -0.479  -0.429  
N42-N8 -0.108  0.031  3.439  5.89E-04 0.038  - -0.756  -0.699  
N44-N25 0.112  0.031  3.589  3.35E-04 0.029  + 2.321  2.383  
N44-N36 0.139  0.031  -4.431  9.61E-06 0.005  - -1.469  -1.424  
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 Beta Standard error t.value p p.corrected 
Valence of 
connection 
95% CI of value of connection 
N45-N15 0.117  0.031  3.717  2.05E-04 0.022  + 1.233  1.291  
N45-N36 0.105  0.031  3.348  8.20E-04 0.041  + 0.617  0.662  
N45-N44 0.105  0.031  -3.403  6.74E-04 0.040  - -1.264  -1.217  
N46-N36 0.110  0.031  -3.509  4.54E-04 0.037  - -0.935  -0.890  
N47-N36 0.105  0.031  3.358  7.93E-04 0.041  + 0.721  0.766  
N47-N45 0.110  0.031  3.590  3.35E-04 0.029  + 2.071  2.130  
N48-N5 -0.114  0.031  3.641  2.75E-04 0.027  - -0.123  -0.055  
N50-N10 -0.121  0.031  3.861  1.15E-04 0.015  - -0.606  -0.569  
N52-N37 0.104  0.031  3.343  8.37E-04 0.041  + 0.303  0.344  
N55-N10 -0.105  0.031  3.337  8.53E-04 0.041  - -0.063  -0.034  
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Table S3. Connections that showed significant association between their absolute strength with household income on the whole brain proxied by 55*55 partial 
correlation matrix. The significant connections presented in the table is identical with those connections shown in Figure 2. 
 
 Beta Standard error t.value p p.corrected 
Valence of 
connection 
95% CI of value of connection 
N12_N11 0.072  0.017  4.208  2.64E-05 0.010  + 6.507  6.608  
N15_N11 0.082  0.017  -4.806  1.60E-06 0.002  - -1.246  -1.185  
N18_N8 0.064  0.017  3.720  2.02E-04 0.033  + 0.216  0.267  
N18_N12 0.067  0.017  -3.909  9.42E-05 0.020  - -2.099  -2.035  
N24_N4 -0.067  0.017  -3.908  9.49E-05 0.020  + 0.588  0.651  
N25_N4 -0.062  0.017  -3.629  2.88E-04 0.039  + 0.995  1.059  
N26_N12 0.078  0.017  4.531  6.04E-06 0.004  + 3.746  3.829  
N30_N6 0.062  0.017  3.634  2.83E-04 0.039  + 0.350  0.411  
N31_N7 0.062  0.017  -3.603  3.19E-04 0.039  - -1.939  -1.881  
N34_N26 -0.073  0.017  -4.269  2.01E-05 0.010  + 0.320  0.378  
N40_N2 0.060  0.017  -3.526  4.27E-04 0.042  - -1.806  -1.752  
N40_N19 0.060  0.017  -3.539  4.06E-04 0.042  - -1.136  -1.075  
N40_N22 -0.061  0.017  3.554  3.84E-04 0.042  - -0.548  -0.506  
N44_N40 0.065  0.017  -3.812  1.40E-04 0.026  - -0.509  -0.460  
N47_N18 0.068  0.017  -3.967  7.42E-05 0.020  - -0.724  -0.679  
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Table S4. Regions involved in the significant connections of VNR. The regions were extracted 
using the “result” function of SPM (http://www.fil.ion.ucl.ac.uk/spm/). Clusters that were above 
50% of the highest global intensity and cluster size above 20 are reported in the following 











1 -22, -74, -26 Cerebelum_Crus1_L 2804 6.4319 
2 36, -72, -40 Cerebelum_Crus2_R 2661 4.765 
3 -12, -48, -42 Cerebelum_9_L 159 3.0327 
4 50, 4, -38 Temporal_Inf_R 157 3.0399 
5 2, -68, -32 Vermis_8 36 2.5446 
6 56, 34, 0 Frontal_Inf_Tri_R 35023 6.9587 
7 -48, -54, -12 Temporal_Inf_L 313 2.8549 
8 26, -20, -14 Hippocampus_R 58 3.2229 
9 10, 0, 14 Caudate_R 78 3.1414 
10 -10, -4, 16 Caudate_L 35 2.8065 
11 4, -20, 8 Thalamus_R 29 2.6283 
12 -40, -46, 40 Parietal_Inf_L 713 3.1276 
13 -24, -10, 50 Frontal_Sup_L 147 2.5947 











1 32, -70, -48 Cerebelum_7b_R 351 -3.5296 
2 8, -74, -24 Cerebelum_Crus1_R 1982 -3.4538 
3 -2, -52, -34 Cerebelum_9_L 225 -2.4617 
4 -22, -34, -42 Cerebelum_10_L 56 -2.3538 
5 48, -60, -8 Temporal_Inf_R 2456 -3.9686 
6 -28, -74, 22 Occipital_Mid_L 8857 -8.2862 
7 30, -64, -28 Cerebelum_6_R 147 -2.8812 
8 -46, 14, -14 Temporal_Pole_Sup_L 26 -1.8379 
9 -8, 38, -12 Frontal_Med_Orb_L 275 -2.3001 
10 -30, 26, -2 Insula_L 988 -3.4967 
11 34, 38, -8 Frontal_Inf_Orb_R 144 -3.0886 
12 32, 26, -2 Insula_R 260 -3.2563 
16 -50, -12, 30 Postcentral_L 6311 -4.4245 
17 26, 52, -2 Frontal_Mid_R 338 -2.4291 
19 32, -72, 22 Occipital_Mid_R 3881 -7.9954 











22 -10, -40, 34 Cingulum_Mid_L 1340 -3.8093 
23 -8, 0, 12 Caudate_L 51 -2.1585 
24 -34, -32, 20 Insula_L 20 -1.757 
25 36, -30, 18 Insula_R 23 -1.7716 
26 6, 4, 56 Supp_Motor_Area_R 71 -2.3897 
27 -4, 6, 54 Supp_Motor_Area_L 31 -1.6887 
28 12, -32, 66 Paracentral_Lobule_R 32 -1.8698 
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Table S5. Regions involved in the significant connections of educational attainment. The 












1 12, -46, -44 Cerebelum_9_R 311 8.8438 
2 -38, -66, -42 Cerebelum_Crus2_L 3413 11.1 
3 -2, -68, -34 Vermis_8 29 4.7242 
4 2, -58, -24 Vermis_6 22 5.1606 
5 58, -6, -14 Temporal_Mid_R 402 8.8827 
6 -26, -36, -16 Fusiform_L 75 6.8778 
7 -24, -20, -16 Hippocampus_L 55 7.7283 
8 0, -58, 44 Precuneus_L 13050 15.5606 
9 22, 28, 46 Frontal_Sup_R 8148 14.3976 
10 -20, 30, 38 Frontal_Mid_L 6549 14.9328 
11 -32, 36, -10 Frontal_Inf_Orb_L 421 10.9456 
12 -60, -12, -10 Temporal_Mid_L 212 7.2928 
13 -54, -46, -12 Temporal_Inf_L 55 6.1464 
14 -20, -84, -10 Fusiform_L 739 6.1887 
15 56, -40, -10 Temporal_Mid_R 40 4.8633 
16 24, -76, -6 Lingual_R 187 6.9006 
17 -8, 4, 6 Caudate_L 40 7.5075 
18 8, 6, 4 Caudate_R 73 7.6276 
19 -48, -24, 6 Temporal_Sup_L 56 5.9954 
20 36, -84, 10 Occipital_Mid_R 25 4.1809 
21 -46, -48, 12 Temporal_Mid_L 26 4.5143 
22 50, -44, 26 SupraMarginal_R 1413 6.1332 
23 34, -26, 18 Insula_R 37 5.3353 
24 30, -74, 20 Occipital_Mid_R 26 4.8628 
25 38, -14, 20 Insula_R 20 5.6089 
26 -34, -18, 42 Postcentral_L 189 7.0578 
27 -50, -40, 46 Parietal_Inf_L 343 5.4355 
28 -16, -4, 68 Frontal_Sup_L 40 5.1036 
 
  












1 -10, -72, -26 Cerebelum_Crus1_L 453 -5.7127 
2 34, -70, -48 Cerebelum_7b_R 77 -5.1072 
3 -16, -42, -46 Cerebelum_9_L 109 -6.2768 
4 18, -42, -46 Cerebelum_9_R 114 -7.2587 
5 10, -84, -38 Cerebelum_Crus2_R 60 -4.8257 
6 -2, -52, -34 Cerebelum_9_L 78 -6.9646 
7 10, -74, -24 Cerebelum_6_R 27 -4.779 
8 -16, -58, 16 Precuneus_L 15001 -15.7718 
9 24, -20, -16 Hippocampus_R 43 -4.5335 
10 -22, -22, -16 Hippocampus_L 25 -4.972 
11 56, -4, -18 Temporal_Mid_R 110 -5.2959 
12 -34, 36, -12 Frontal_Inf_Orb_L 111 -5.2593 
13 32, 38, -8 Frontal_Inf_Orb_R 851 -6.4684 
14 50, -58, -6 Temporal_Inf_R 366 -6.3365 
15 -40, -66, -6 Occipital_Inf_L 689 -6.7649 
16 8, 52, -10 Frontal_Med_Orb_R 35 -4.3472 
17 -10, 46, -6 Frontal_Med_Orb_L 30 -4.1374 
18 40, -18, 0 Insula_R 22 -4.7318 
19 38, 0, 14 Insula_R 35 -5.385 
20 -46, -22, 20 Rolandic_Oper_L 111 -5.0322 
21 -38, -4, 16 Insula_L 38 -7.1293 
22 60, -26, 32 SupraMarginal_R 106 -4.2938 
23 50, 4, 34 Precentral_R 151 -4.4223 
24 -20, 28, 38 Frontal_Sup_L 144 -5.3051 
25 -38, -24, 60 Precentral_L 373 -7.4667 
26 -26, -8, 48 Precentral_L 89 -4.6457 
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Table S6. Regions involved in the significant connections of household income. The 











1 24, 26, 50 Frontal_Sup_R 21182 5.4614 
2 12, -72, -48 Cerebelum_8_R 394 2.7072 
3 64, -16, -16 Temporal_Mid_R 1409 3.2367 
4 42, 18, -36 Temporal_Pole_Mid_R 41 1.8175 
5 54, 10, -32 Temporal_Pole_Mid_R 21 2.0982 
6 28, -70, -24 Cerebelum_6_R 182 2.1569 
7 -16, -62, -22 Cerebelum_6_L 56 2.2845 
8 10, 44, -20 Rectus_R 35 2.7192 
9 40, -2, 16 Insula_R 7530 5.667 
10 -38, -4, 16 Insula_L 6699 6.2029 
11 -42, -44, -14 Temporal_Inf_L 38 1.8629 
12 -24, 42, -14 Frontal_Sup_Orb_L 116 2.5622 
13 -38, 48, 2 Frontal_Mid_L 1066 2.6366 
14 -46, -68, 8 Temporal_Mid_L 381 2.5717 




Coordinate of peak 
region 
AAL label Number of voxels 
Intensity of 
peak region 
1 -28, -70, -50 Cerebelum_8_L 89 -1.7068 
2 -14, -52, -48 Cerebelum_9_L 20 -1.5 
3 -6, -74, -40 Cerebelum_7b_L 147 -1.8434 
4 22, -38, -44 Cerebelum_10_R 34 -1.7134 
5 -20, -36, -44 Cerebelum_10_L 31 -1.6446 
6 6, -76, -34 Cerebelum_Crus2_R 42 -1.6713 
7 -2, -52, -34 Cerebelum_9_L 33 -1.7678 
8 -40, -72, -28 Cerebelum_Crus1_L 29 -1.5027 
9 -28, -62, -30 Cerebelum_6_L 52 -1.994 
10 30, -64, -28 Cerebelum_6_R 21 -1.5615 
11 32, -46, -8 Fusiform_R 227 -2.5744 
12 52, -16, 6 Temporal_Sup_R 1372 -2.9145 
13 44, -56, -6 Temporal_Inf_R 270 -2.3303 
14 -40, -32, 10 Temporal_Sup_L 922 -3.1724 
15 34, 36, -10 Frontal_Inf_Orb_R 43 -1.6368 
16 -28, -60, -8 Fusiform_L 165 -2.5173 




Coordinate of peak 
region 
AAL label Number of voxels 
Intensity of 
peak region 
17 -40, -66, -6 Occipital_Inf_L 319 -2.3311 
18 32, 28, 0 Insula_R 39 -1.5766 
19 -28, -74, 22 Occipital_Mid_L 3066 -5.032 
20 32, -70, 24 Occipital_Mid_R 4320 -5.2122 
21 46, 6, 24 Frontal_Inf_Oper_R 793 -2.1462 
22 -34, 8, 28 Frontal_Inf_Oper_L 413 -1.8625 
23 8, 16, 50 Supp_Motor_Area_R 58 -1.5919 
24 -24, -4, 50 Frontal_Mid_L 707 -2.2576 
25 -14, -42, 48 Cingulum_Mid_L 20 -1.436 
26 16, -40, 48 Paracentral_Lobule_R 33 -1.5304 
27 -6, 16, 48 Supp_Motor_Area_L 29 -1.5881 
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Table S7. Network-of-interest (NOI) results for cognitive performance (VNR) and educational attainment. The significant between-network connections were 
shown in the results below. 
 
VNR 
Type Connections Beta Std t.value p pcorrected 
Mean value of 
connection 
95% CI of value of 
connection 
inter-hemisphere 
left FPN - right FPN -0.040 0.016 -2.493 1.27E-02 0.018 1.156  1.127  1.185  
right CON - left CON -0.063 0.016 -3.923 8.89E-05 6.67E-04 0.379  0.356  0.402  
          
CON - FPN 
left CON - right FPN 0.034 0.016 -2.106 3.52E-02 0.044 -1.359  -1.387  -1.330  
right CON - left FPN 0.043 0.016 -2.714 6.68E-03 0.011 -2.088  -2.122  -2.054  
left CON - left FPN 0.044 0.016 2.732 6.33E-03 0.011 1.043  1.018  1.067  
right CON - right FPN 0.051 0.016 3.200 1.38E-03 0.005 0.648  0.620  0.676  
          
DMN-related 
left CON - DMN 0.061 0.016 3.824 1.33E-04 6.67E-04 0.675  0.652  0.698  
right CON - DMN -0.045 0.016 2.797 5.18E-03 0.011 -0.275  -0.300  -0.250  
          
EDUCATION 
Type Connections Beta Std t.value p pcorrected 
Mean value of 
connection 
95% CI of value of 
connection 
CON - FPN right CON-right FPN 0.086 0.031 2.736 6.24E-03 0.021 0.648 0.620  0.676  
          
DMN-related 
right FPN - DMN 0.104 0.031 -3.335 8.59E-04 0.004 -0.710 -0.738  -0.682  
right CON - DMN -0.149 0.031 4.761 1.99E-06 1.99E-05 -0.275 -0.300  -0.250  
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Table S7. Correlation matrix between average motion during resting-state assessment, first 
four genetic principal components, cognitive performance (VNR), educational attainment and 
household income. Motions and genetic principal components showed very weak correlations 



























Age 1 0.085 0.155 -0.061 -0.021 -0.28 
Sex 0.085 1 0.147 0.081 0.071 0.079 
Motion 0.155 0.147 1 -0.085 -0.094 -0.113 
VNR -0.061 0.081 -0.085 1 0.257 0.202 
Edu -0.021 0.071 -0.094 0.257 1 0.237 
Income -0.28 0.079 -0.113 0.202 0.237 1 
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Table S8. Replication analyses on the (1) unrelated sample, which related people were removed (N=3,253), and (2) updated unrelated sample (N=7,144). 
Three connections turned null in both unrelated 4k sample and unrelated 7k sample, which takes up 4.05% of 74 significant connections found in the main 
results. None of the significant connections showed opposite direction of effect in the additional analyses. 
 
  Main model Unrelated people (N~=4k) Unrelated people (N~=7k) 





N17_N15 0.054 (0.016) 6.73E-04 3.85E-02 0.053 (0.018) 3.36E-03 0.049 (0.012) 7.30E-05 
N21_N7 0.097 (0.016) 9.09E-10 1.35E-06 0.09 (0.018) 5.38E-07 0.074 (0.012) 2.71E-09 
N21_N11 0.062 (0.016) 9.72E-05 1.44E-02 0.067 (0.018) 2.28E-04 0.058 (0.012) 3.14E-06 
N22_N1 0.061 (0.016) 1.53E-04 1.77E-02 0.051 (0.018) 4.99E-03 0.025 (0.012) 4.66E-02 
N24_N4 -0.066 (0.016) 4.37E-05 7.21E-03 -0.064 (0.018) 4.36E-04 -0.052 (0.013) 3.71E-05 
N24_N9 -0.083 (0.016) 2.14E-07 1.59E-04 -0.073 (0.018) 6.33E-05 -0.059 (0.012) 2.45E-06 
N25_N5 -0.072 (0.016) 7.39E-06 1.65E-03 -0.084 (0.018) 3.57E-06 -0.057 (0.012) 3.75E-06 
N26_N12 0.081 (0.016) 4.96E-07 2.45E-04 0.061 (0.018) 7.47E-04 0.052 (0.012) 2.57E-05 
N28_N24 0.076 (0.016) 2.25E-06 8.35E-04 0.081 (0.018) 1.01E-05 0.074 (0.013) 4.02E-09 
N29_N11 0.059 (0.016) 2.45E-04 2.14E-02 0.057 (0.018) 1.71E-03 0.055 (0.013) 9.99E-06 
N31_N12 -0.066 (0.016) 4.06E-05 7.21E-03 -0.079 (0.018) 1.47E-05 -0.074 (0.012) 3.61E-09 
N33_N13 0.06 (0.016) 1.78E-04 1.77E-02 0.05 (0.018) 5.90E-03 0.043 (0.012) 5.67E-04 
N33_N22 0.055 (0.016) 6.52E-04 3.85E-02 0.055 (0.018) 2.76E-03 0.055 (0.013) 1.11E-05 
N39_N33 0.074 (0.016) 4.80E-06 1.43E-03 0.046 (0.018) 1.23E-02 0.047 (0.013) 1.78E-04 
N42_N6 -0.056 (0.016) 4.43E-04 3.13E-02 -0.057 (0.018) 1.80E-03 -0.044 (0.013) 4.75E-04 
N42_N18 0.055 (0.016) 5.77E-04 3.73E-02 0.035 (0.018) 5.63E-02 0.025 (0.012) 4.60E-02 
N44_N17 0.054 (0.016) 6.21E-04 3.84E-02 0.041 (0.018) 2.33E-02 <0.001, >-0.001 (0.012) 9.68E-01 
N44_N25 0.071 (0.016) 7.78E-06 1.65E-03 0.057 (0.018) 1.48E-03 0.054 (0.012) 1.19E-05 
N45_N5 -0.058 (0.016) 2.93E-04 2.42E-02 -0.045 (0.018) 1.28E-02 -0.05 (0.012) 7.09E-05 
N45_N15 0.059 (0.016) 2.34E-04 2.14E-02 0.037 (0.018) 4.03E-02 0.039 (0.012) 1.72E-03 
N45_N44 0.055 (0.016) 4.81E-04 3.25E-02 0.034 (0.018) 5.71E-02 0.019 (0.012) 1.27E-01 
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  Main model Unrelated people (N~=4k) Unrelated people (N~=7k) 
 Connection Beta (std) Puncorrected Pcorrected Beta (std) Puncorrected Beta (std) Puncorrected 
N46_N25 -0.057 (0.016) 4.00E-04 2.97E-02 -0.039 (0.018) 3.18E-02 -0.02 (0.012) 1.09E-01 
N47_N31 0.059 (0.016) 1.68E-04 1.77E-02 0.056 (0.018) 1.87E-03 0.034 (0.012) 5.23E-03 
N48_N19 0.061 (0.016) 1.59E-04 1.77E-02 0.046 (0.018) 1.10E-02 0.041 (0.013) 1.14E-03 
N48_N21 -0.061 (0.016) 1.44E-04 1.77E-02 -0.057 (0.018) 1.75E-03 -0.021 (0.012) 8.73E-02 



















N5_N4 -0.103 (0.031) 1.01E-03 4.54E-02 -0.056 (0.018) 2.28E-03 -0.045 (0.013) 3.91E-04 
N8_N3 -0.119 (0.031) 1.42E-04 1.75E-02 -0.056 (0.018) 2.34E-03 -0.036 (0.013) 4.51E-03 
N12_N5 0.132 (0.031) 2.71E-05 6.71E-03 0.056 (0.018) 2.25E-03 0.033 (0.013) 8.67E-03 
N12_N11 0.106 (0.031) 6.94E-04 3.97E-02 0.032 (0.018) 7.50E-02 0.038 (0.012) 2.24E-03 
N15_N7 0.122 (0.031) 7.96E-05 1.48E-02 0.041 (0.018) 2.35E-02 0.044 (0.012) 4.66E-04 
N17_N15 0.121 (0.031) 9.59E-05 1.53E-02 0.046 (0.018) 1.21E-02 0.054 (0.012) 1.65E-05 
N19_N18 -0.136 (0.031) 1.47E-05 5.47E-03 -0.058 (0.019) 1.74E-03 -0.039 (0.013) 1.99E-03 
N20_N10 -0.109 (0.031) 4.91E-04 3.80E-02 -0.071 (0.018) 1.28E-04 -0.043 (0.013) 6.06E-04 
N24_N4 -0.108 (0.031) 6.15E-04 3.80E-02 -0.049 (0.018) 7.95E-03 -0.038 (0.013) 2.33E-03 
N25_N3 0.137 (0.031) 1.36E-05 5.47E-03 0.068 (0.018) 2.36E-04 0.042 (0.013) 8.17E-04 
N25_N4 -0.161 (0.031) 2.73E-07 4.06E-04 -0.081 (0.018) 1.06E-05 -0.077 (0.013) 8.59E-10 
N26_N12 0.108 (0.031) 5.51E-04 3.80E-02 0.029 (0.018) 1.12E-01 0.032 (0.013) 1.05E-02 
N29_N25 0.108 (0.031) 5.88E-04 3.80E-02 0.042 (0.018) 2.29E-02 0.038 (0.013) 2.75E-03 
N31_N7 0.125 (0.031) 6.57E-05 1.39E-02 0.039 (0.018) 3.21E-02 0.038 (0.012) 2.19E-03 
N33_N2 -0.103 (0.031) 9.96E-04 4.54E-02 -0.064 (0.018) 5.00E-04 -0.024 (0.013) 6.05E-02 
N34_N26 -0.133 (0.031) 2.14E-05 6.37E-03 -0.051 (0.018) 5.55E-03 -0.059 (0.013) 2.69E-06 
N35_N33 0.108 (0.031) 5.63E-04 3.80E-02 0.055 (0.019) 3.26E-03 0.037 (0.013) 3.41E-03 
N36_N35 0.105 (0.031) 7.79E-04 4.09E-02 0.055 (0.018) 2.59E-03 0.027 (0.013) 3.49E-02 
N40_N7 0.118 (0.031) 1.72E-04 1.96E-02 0.06 (0.018) 1.24E-03 0.019 (0.013) 1.46E-01 
N40_N34 0.122 (0.031) 1.03E-04 1.53E-02 0.049 (0.018) 7.75E-03 0.044 (0.013) 4.62E-04 
N42_N8 -0.108 (0.031) 5.89E-04 3.80E-02 -0.052 (0.018) 4.56E-03 -0.018 (0.013) 1.55E-01 
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  Main model Unrelated people (N~=4k) Unrelated people (N~=7k) 
 Connection Beta (std) Puncorrected Pcorrected Beta (std) Puncorrected Beta (std) Puncorrected 
N44_N25 0.112 (0.031) 3.35E-04 2.93E-02 0.047 (0.018) 9.83E-03 0.012 (0.012) 3.30E-01 
N44_N36 0.139 (0.031) 9.61E-06 5.47E-03 0.071 (0.018) 1.09E-04 0.044 (0.013) 4.38E-04 
N45_N15 0.117 (0.031) 2.05E-04 2.17E-02 0.028 (0.018) 1.33E-01 0.037 (0.013) 3.59E-03 
N45_N36 0.105 (0.031) 8.20E-04 4.09E-02 0.061 (0.018) 1.07E-03 0.031 (0.013) 1.46E-02 
N45_N44 0.105 (0.031) 6.74E-04 3.97E-02 0.036 (0.018) 5.18E-02 0.008 (0.013) 5.02E-01 
N46_N36 0.11 (0.031) 4.54E-04 3.74E-02 0.047 (0.018) 1.09E-02 0.029 (0.013) 1.91E-02 
N47_N36 0.105 (0.031) 7.93E-04 4.09E-02 0.046 (0.018) 1.29E-02 0.028 (0.013) 2.42E-02 
N47_N45 0.11 (0.031) 3.35E-04 2.93E-02 0.029 (0.018) 1.02E-01 0.016 (0.012) 1.88E-01 
N48_N5 -0.114 (0.031) 2.75E-04 2.72E-02 -0.061 (0.018) 8.06E-04 -0.046 (0.013) 2.78E-04 
N50_N10 -0.121 (0.031) 1.15E-04 1.55E-02 -0.059 (0.018) 1.31E-03 -0.029 (0.013) 2.30E-02 
N52_N37 0.104 (0.031) 8.37E-04 4.09E-02 0.052 (0.018) 4.74E-03 0.043 (0.013) 5.31E-04 
















N12_N11 0.072 (0.017) 2.64E-05 9.80E-03 0.063 (0.019) 9.81E-04 0.043 (0.013) 1.17E-03 
N15_N11 0.082 (0.017) 1.60E-06 2.38E-03 0.082 (0.019) 1.91E-05 0.043 (0.013) 1.21E-03 
N18_N8 0.064 (0.017) 2.02E-04 3.34E-02 0.06 (0.02) 2.40E-03 0.019 (0.013) 1.50E-01 
N18_N12 0.067 (0.017) 9.42E-05 2.01E-02 0.047 (0.02) 1.69E-02 0.035 (0.013) 9.10E-03 
N24_N4 -0.067 (0.017) 9.49E-05 2.01E-02 -0.062 (0.02) 1.65E-03 -0.052 (0.013) 1.23E-04 
N25_N4 -0.062 (0.017) 2.88E-04 3.89E-02 -0.065 (0.02) 9.67E-04 -0.056 (0.013) 2.66E-05 
N26_N12 0.078 (0.017) 6.04E-06 4.49E-03 0.074 (0.019) 1.54E-04 0.062 (0.013) 3.55E-06 
N30_N6 0.062 (0.017) 2.83E-04 3.89E-02 0.049 (0.02) 1.24E-02 0.039 (0.013) 3.19E-03 
N31_N7 0.062 (0.017) 3.19E-04 3.94E-02 0.049 (0.019) 1.09E-02 0.035 (0.013) 7.45E-03 
N34_N26 -0.073 (0.017) 2.01E-05 9.80E-03 -0.079 (0.02) 5.35E-05 -0.071 (0.013) 1.25E-07 
N40_N2 0.06 (0.017) 4.27E-04 4.23E-02 0.041 (0.019) 3.63E-02 0.024 (0.013) 7.07E-02 
N40_N19 0.06 (0.017) 4.06E-04 4.23E-02 0.051 (0.019) 8.10E-03 0.044 (0.013) 8.49E-04 
N40_N22 -0.061 (0.017) 3.84E-04 4.23E-02 -0.073 (0.02) 2.14E-04 -0.051 (0.013) 1.51E-04 
N44_N40 0.065 (0.017) 1.40E-04 2.59E-02 0.062 (0.019) 1.58E-03 0.042 (0.013) 1.58E-03 
Appendix 4: Supplementary materials of Chapter 5 
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  Main model Unrelated people (N~=4k) Unrelated people (N~=7k) 
 Connection Beta (std) Puncorrected Pcorrected Beta (std) Puncorrected Beta (std) Puncorrected 
N47_N18 0.068 (0.017) 7.42E-05 2.01E-02 0.053 (0.02) 6.36E-03 0.024 (0.013) 7.24E-02 
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